Calibration for multi-stage physiological monitors

Information

  • Patent Grant
  • 12186079
  • Patent Number
    12,186,079
  • Date Filed
    Monday, December 19, 2022
    2 years ago
  • Date Issued
    Tuesday, January 7, 2025
    5 days ago
Abstract
A physiological monitor is provided for determining a physiological parameter of a medical patient with a multi-stage sensor assembly. The monitor includes a signal processor configured to receive a signal indicative of a physiological parameter of a medical patient from a multi-stage sensor assembly. The multi-stage sensor assembly is configured to be attached to the physiological monitor and the medical patient. The monitor of certain embodiments also includes an information element query module configured to obtain calibration information from an information element provided in a plurality of stages of the multi-stage sensor assembly. In some embodiments, the signal processor is configured to determine the physiological parameter of the medical patient based upon said signal and said calibration information.
Description
BACKGROUND

Hospitals, nursing homes, and other patient care facilities typically include patient monitoring devices at one or more bedsides in the facility. Patient monitoring devices generally include sensors, processing equipment, and displays for obtaining and analyzing a medical patient's physiological parameters. Physiological parameters include, for example, respiratory rate, oxygen saturation (SpO2) level, pulse, and blood pressure, among others. Clinicians, including doctors, nurses, and certain other medical personnel, use the physiological parameters obtained from the medical patient to diagnose illnesses and to prescribe treatments. Clinicians also use the physiological parameters to monitor a patient during various clinical situations to determine whether to increase the level of medical care given to the patient.


Many monitoring devices receive physiological signals from one or more sensors, such as pulse oximetry sensors, other types of optical sensors, acoustic sensors, and the like. Medical cables attached to the sensors transmit signals from the sensors to the monitoring device.


Physiological signals in some monitoring systems can be relatively small or otherwise difficult to measure with a high degree of accuracy. As such, manufacturing tolerances for the various components in the system may be relatively tight, possibly leading to low yields, increased manufacturing cost and/or reduced flexibility in component design.


Additionally, sensors, cables and other components in the sensor path may be sold with a specific monitoring device and are factory calibrated for use with only that monitoring device, reducing flexibility in component selection. Alternatively, some systems may be manually calibrated in the field, increasing cost and setup time. Accordingly, there remains a need for a monitoring system capable of providing accurate physiological measurement while addressing these and other issues.


SUMMARY

According to certain aspects, a physiological monitor is provided for determining a physiological parameter of a medical patient with a multi-stage sensor assembly. The physiological monitor can include a signal processor configured to receive a signal indicative of a physiological parameter of a medical patient from a multi-stage sensor assembly. The multi-stage sensor assembly can be configured to be attached to the physiological monitor and the medical patient. The physiological monitor can further include an information element query module configured to obtain calibration information from an information element provided in a plurality of stages of the multi-stage sensor assembly. In certain embodiments, the signal processor is configured to determine the physiological parameter of the medical patient based upon said signal and said calibration information.


A method of determining a physiological parameter of a medical patient with a physiological monitor is provided according to certain aspects. The method may include receiving a signal indicative of a physiological parameter of a medical patient from a multi-stage sensor assembly. In some embodiments, the method further includes obtaining calibration from an information element provided in a plurality of stages of the multi-stage sensor assembly. The method can further include determining the physiological parameter of the medical patient based upon the signal and the calibration information.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments will be described hereinafter with reference to the accompanying drawings. These embodiments are illustrated and described by example only, and are not intended to limit the scope of the disclosure. In the drawings, similar elements have similar reference numerals.



FIG. 1 illustrates a perspective view of an embodiment of a physiological monitoring system;



FIG. 2 is a top perspective view illustrating an embodiment of an example sensor assembly and cable;



FIGS. 3A and 3B illustrate block diagrams of example monitoring systems that include one or more information elements usable for multi-stage calibration, according to certain embodiments;



FIG. 3C illustrates an embodiment of a circuit for communicating with one or more information elements and a sensor;



FIG. 4 illustrates a block diagram showing calibration information and other exemplary forms of data that can be stored in an information element;



FIG. 5 illustrates a functional block diagram of an embodiment of a physiological monitoring system configurable to perform multi-stage calibration according to certain embodiments;



FIG. 6 illustrates a flowchart diagram of an example physiological monitoring process implementing multi-stage calibration according to certain embodiments;



FIGS. 7A and 7B illustrate block diagrams of example physiological monitoring systems having splitter cables;



FIG. 8 illustrates a block diagram of another embodiment of a physiological monitoring system having multiple cables;



FIG. 9 illustrates a block diagram of yet another embodiment of a physiological monitoring system having multiple cables;



FIGS. 10A through 10C illustrate embodiments of decoupling circuits;



FIG. 11A illustrates a side view of an example splitter cable;



FIG. 11B illustrates a bottom view of the example splitter cable of FIG. 6A;



FIG. 12 illustrates a perspective view of an example sensor and cable assembly;



FIG. 13 illustrates an embodiment of a physiological monitoring system having multiple networked physiological monitors;



FIGS. 14 and 15 illustrate flowchart diagrams of example cable management processes;



FIGS. 16 and 17 illustrate flowchart diagrams of example patient context management processes;



FIG. 18 illustrates an embodiment of a coextruded cable; and



FIG. 19 illustrates an embodiment of a splitter cable.





DETAILED DESCRIPTION

Systems described herein include various components, such as one or more cables, front end processing circuitry, and the like, interposed in the path between the sensor and signal processing circuitry in a monitoring device. The sensor and these components or portions thereof may be described as stages in the sensor path. Systems described herein may accordingly be referred to as multi-stage systems.


Multi-Stage Calibration Overview


Each stage in the sensor path has particular behavioral characteristics defining a response for that stage. Generally, each stage receives a version of the detected sensor signal and produces a modified version of that signal according to a characteristic response of the respective stage. The behavioral characteristics defining the characteristic responses of the stages can include a variety of parameters such as electrical properties (e.g., capacitances, impedances, etc.), mechanical properties, response characteristics (e.g., frequency responses, gain characteristics, etc.), among others. Information relating to these characteristics may be referred to through this disclosure interchangeably as calibration information, behavioral information and behavioral characteristic information, for example.


Due to inconsistencies in manufacture, materials, etc., certain behavioral characteristics and corresponding calibration information can vary significantly between components of the same type. Characteristics subject to these types of inconsistencies may be referred to as process variable characteristics as they are dependent on material or manufacturing inconsistencies. It is generally desirable for a monitoring system to be able to cooperate with components having as wide a range of process variable characteristics as possible. For example, manufacturing tolerances can be expanded as a result, leading to improved accuracy and repeatability, higher yields and reduced cost.


In addition to process variable characteristics, design variable characteristics can arise based on various component design schemes and associated parameters. Because they are based on known design choices, design variable characteristics are generally predetermined, unlike process variable characteristics.


As one example of a scenario involving design variable characteristics, an acoustic sensor of a first design scheme may include design characteristics optimized to use relatively low amplitude signals, such as for use with patients having a particularly shallow breath or to detect a certain type of relatively quiet physiological sound. Design choices for this sensor are tailored for such a use. For example, a relatively sensitive material may be used for the sensing element (e.g., a piezoelectric film), or the sensing element may be manufactured for relatively high sensitivity. Moreover, programmable variables such as gain settings may be set to a relatively high level. On the other hand, an acoustic sensor according to a second design may be optimized to detect relatively louder physiological sounds. For this sensor, different design parameters are used such as a relatively less sensitive sensing element, lower gain settings, etc. Beyond this illustrative example, a broad universe of design variable characteristics associated with monitoring systems exists, such as design variable characteristics associated with non-sensor components (e.g., cables, processing circuitry, etc.) or those related to other types of sensors (e.g., optical sensors such as SpO2 sensors).


It is desirable for monitoring systems to be able to adapt to components having generally as wide a range of design variable characteristics as possible. For example, this can allow system designers to develop an array of components that are customized for particular applications.


Systems described herein are advantageously capable of accounting for process characteristic variability and/or design characteristic variability, allowing for system calibration (e.g., automatic calibration) based on the properties of the particular attached components. This calibration technique may be referred to interchangeably throughout this disclosure as automatic, dynamic, adaptive, or intelligent calibration. In some embodiments, the process may also be referred to as sensor path or signal acquisition, or as having an equalization effect on the sensor signal, for example. These terms are used for the purpose of illustration and are not intended to be limiting. In some other embodiments, at least a portion of the calibration process is achieved manually.


According to some embodiments, one or more of the stages in the sensor path has at least one information element storing calibration information relating to that stage. The calibration information may be determined and stored, such as during manufacture. For example, a test signal may be injected into a component such as a physiological sensor. Various characteristics such as frequency responses, capacitances, etc., of the sensor may be measured using the test signal and are stored in an information element on the sensor. Additionally, certain predetermined characteristics, which may primarily include design variable characteristics, may be stored on the information element without any separate calibration process.


According to certain embodiments, the monitoring device is configured to receive the calibration information from the sensor path stages. Based on the calibration information, the monitoring device can then intelligently adjust processing of the received sensor signal, accounting for the particular behavioral properties of the attached components.


Because monitoring systems according to such embodiments can adapt to the specific properties of the attached components, these systems can provide interchangeable use with a wide variety of components. For example, these systems can be used with components having a wide range of process and/or design characteristic variability.


Allowable manufacturing tolerances can be greatly expanded. Improved manufacturing repeatability and yields are achieved, as a result while maintaining a high degree of measurement accuracy.


The multi-stage calibration capability provides a generally fully interchangeable system in which existing components can be swapped out for components of the same type or for components customized for particular purposes. This type of mix and match capability provides enhanced ease of use and can also allow for the use of disposable components, such as disposable sensor components. The use of disposable components can provide a number of advantages including improved sanitation and convenience.


For example, a user can select a sensor for use with a monitoring device from a batch of sensors of the same type without verifying that the particular sensor has been calibrated for use with that particular monitoring device. The user can additionally combine this sensor with another component, such as an instrument cable selected from a batch of instrument cables having the same type. Again, the user can attach the cable and sensor to the monitor and begin monitoring without verifying that the particular cable has been calibrated for use with that particular monitoring device or sensor.


In some cases, sensor path components can be initially characterized at the factory, and the appropriate characterization information is stored on the component. The factory calibration can advantageously be transferred to the field as clinicians deploy the components with generally any compatible system without the need for independent field calibration.


For example, in one scenario, a user first attaches a first sensor to a first cable connected to a first monitoring device. The monitoring device reads the behavioral characteristics of the components and adjusts the signal processing parameters accordingly, such as when new sensor path components are attached. The user then replaces the first sensor with a second sensor of the same type, but having different behavior characteristics, such as process variable characteristics. In another scenario, the user replaces the first sensor with a second sensor having a different type, such as a sensor tailored for a particular use, and having different design variable characteristics. In both scenarios, the monitoring device reads the behavioral characteristics of the second sensor and again performs multi-stage calibration so as to cooperate with the second sensor.


The multi-stage calibration techniques described herein can benefit physiological monitoring systems incorporating generally any type of sensor. Additionally, in part because dynamic calibration allows for improved manufacturing tolerance, they can be of particular benefit to systems which measure relatively small signals, such as those including acoustic sensors for measuring respiratory rate, heart sounds, and the like.


Further embodiments of monitoring systems capable of multi-stage calibration techniques are described below with respect to FIGS. 1 through 6, for example.


Turning to FIG. 1, an embodiment of a physiological monitoring system 100 for monitoring a medical patient is shown. The physiological monitoring system 100 can be configured to implement the multi-stage calibration techniques described herein, and includes a physiological monitor 110 coupled with a sensor assembly 150 through a cable 130. The monitor 110 includes various visual indicia and user controls 105 for displaying sensor parameters, alarms, and the like and for receiving user input. The sensor assembly 150 could include any of a variety of physiological sensors. For example, the sensor assembly 150 could include one or more optical sensors that allow the measurement of blood constituents and related parameters, acoustic respiratory sensors, electrocardiogramansors, and the like.


More generally, the sensor assembly 150 can include one or more sensors that measure one or more of a variety of physiological parameters, including oxygen saturation, carboxyhemologbin (HbCO), methemoglobin (HBMet), fractional oxygen, total hemoglobin (HbT/SpHb), pulse rate, perfusion index, electrical heart activity via electrocardiography, and blood pressure. Other examples of physiological parameters that may be measured include respiratory rate, inspiratory time, expiratory time, inspiration-to-expiration ratio, inspiratory flow, expiratory flow, tidal volume, end-tidal CO2 (ETCO2), CO2, minute volume, apnea duration, breath sounds, rales, rhonchi, stridor, changes in breath sounds such as decreased volume or change in airflow, heart rate, heart sounds (e.g., S1, S2, S3, S4, and murmurs), and changes in heart sounds such as normal to murmur or split heart sounds indicating fluid overload.


In some embodiments, the sensor assembly 150 can be an optical sensor having one or more emitters, such as light emitting diodes. The emitters may emit multiple wavelengths of light that impinge on body tissue of a living patient, such as a finger, foot, ear, or the like. The emitters may also emit non-visible radiation. The sensor assembly 150 may further include one or more detectors that can receive light attenuated by the body tissue of the patient. The detectors can generate physiological signals responsive to the detected light. The sensor assembly 150 can provide these physiological signals to the monitor 110 for processing to determine one or more physiological parameters, such as certain of the parameters described above. An example of such a sensor assembly 150 is described in U.S. Publication No. 2006/0211924, filed Mar. 1, 2006, titled “Multiple Wavelength Sensor Emitters,” the disclosure of which is hereby incorporated by reference in its entirety.


The cable 130 is connected to the sensor assembly 150 and to the monitor 110. In some embodiments, the cable 130 includes two or more cables or cable assemblies, although it should be noted that the cable 130 can also be a single cable 130. In the illustrated embodiment, the cable 130 includes a sensor cable 112 and an instrument cable 114. The sensor cable 114 is connected directly to the sensor assembly 150 through connectors 133, 151, and the instrument cable 114 is connected directly to the monitor 110 through a connector 131. The sensor cable 112 is connected to the instrument cable 114 through connectors 135, 137.


In certain embodiments, the sensor cable 112 is a lightweight, flexible cable used for a single medical patient and disposed of after use with that patient. In contrast, the instrument cable 112 of certain embodiments is used for multiple patients and may be more durable than the sensor cable 112. For example, the instrument cable 112 may be thicker, stiffer, or heavier than the sensor cable 112. Advantageously, in certain embodiments, the lightweight, flexible characteristics of the sensor cable 112 make the sensor cable 112 more comfortable to attach to a patient. A patient with a sensor assembly 150 attached to her finger, for instance, could more easily move her hand with a lightweight sensor cable 112 attached to the sensor assembly 150. However, if some or all of the cable 130 were lightweight and flexible, it might be less durable. Hence, a portion of the cable 130 (e.g., the instrument cable 114) is stronger and more durable, yet potentially heavier and less flexible. The instrument cable 114 could therefore be used for multiple patients, while the sensor cable 112 might be used for fewer patients, such as a single patient.


While the physiological monitor 110 of FIG. 1 is shown connecting to a single sensor assembly 150, it may be advantageous in certain embodiments to connect to multiple sensors, such as sensors that monitor different physiological parameters. For instance, the physiological monitor 110 could connect to a pulse oximetry sensor and an acoustic sensor that measures respiratory rate, heart sounds, and related parameters. One way to provide multiple sensor functionality to the physiological monitor 110 is to provide a splitter cable between the monitor and the cable 130 (see FIGS. 7 and 11). A splitter cable reduces or eliminates a need to build a second cable port into the chassis of the physiological monitor 110 to accommodate a second cable 130. Consequently, using a splitter cable can reduce costs. Moreover, using a splitter cable can reduce cross-talk noise between signal lines from the sensors.


However, as described above, upgrading the physiological monitor 110 to receive input from multiple sensors using a splitter cable or the like can create electrical shock hazards to the patient due to the possibility of conductive paths forming through the sensors, cabling, and the patient. For example, if an acoustic sensor is placed on the chest and a defibrillator paddle touches the acoustic sensor, a surge of current could discharge through a conductive path formed in the patient between the acoustic sensor and a second sensor, and through the physiological monitor 110. This current surge could injure the patient and damage the monitor 110.


Consequently, various embodiments of the cable 130 or an attached splitter cable can include one or more decoupling circuits (not shown) for reducing the risk of electric shock to the patient. Each decoupling circuit can electrically decouple the sensor assembly 150 from the monitor 110 or can decouple multiple sensor assemblies 150. In addition to having its ordinary meaning, electrical decoupling can mean breaking a conductive path (e.g., by providing a dielectric between two conductors) or increasing the resistance between conductors. Electrical decoupling can be accomplished using transformers and/or optocouplers, as described below. The electrical decoupling of the decoupling circuit can prevent or reduce harmful current surges from harming the patient. Example decoupling circuits compatible with certain embodiments are provided below with respect to FIGS. 7 through 11.


In addition to including decoupling circuitry in the cable 130 or in an attached splitter cable, it may be desirable to include other circuitry in the cable 130 or splitter cable. For example, the cable 130, a splitter cable, and/or the sensor assembly 150 may include one or more information elements (not shown), which can be memory devices such as EEPROMs or the like. The information elements may further store calibration information related to one or more of the components in the system. The monitoring device may use such calibration information to calibrate a multi-stage sensor path according to embodiments described herein. Example compatible information elements are described below with respect to FIGS. 3 through 6 and 11 through 17. In some embodiments, the information element stores other information such as cable management information, patient context information, and/or physiological information.



FIG. 2 illustrates an embodiment of another sensor system capable of incorporating certain multi-stage calibration techniques described herein. The sensor system includes a sensor assembly 201, an instrument cable 211, and a hub 220 suitable for use with any of the physiological monitors and cables described herein. The sensor assembly 201 includes a sensor 215, a cable assembly 217, and a first connector 205, while the cable assembly 217 of one embodiment includes a sensor cable 207 and a patient anchor 203.


The sensor assembly 201 is removably attachable to the instrument cable 211 via the matable first and second connectors 205, 209. In turn, the instrument cable 211 can be attached to a cable hub 220, which includes a port 221 for receiving a connector 212 of the instrument cable 211 and a second port 223 for receiving another cable. The hub 220 is an example of the splitter cable described above, and as such, can include decoupling circuitry (see, e.g., FIG. 19). In certain embodiments, the second port 223 can receive a cable connected to an optical sensor (e.g., pulse oximeter) or other sensor. In addition, the cable hub 220 could include additional ports in other embodiments for receiving additional cables. The example hub 220 includes a cable 222 which terminates in a connector 224 adapted to connect to a physiological monitor (not shown).


In an embodiment, the acoustic sensor assembly 201 includes a sensing element, such as, for example, a piezoelectric device or other acoustic sensing device. The sensing element can generate a voltage that is responsive to vibrations generated by the patient, and the sensor can include circuitry to transmit the voltage generated by the sensing element to a processor for processing. In an embodiment, the acoustic sensor assembly 201 includes circuitry for detecting and transmitting information related to biological sounds to a physiological monitor. These biological sounds can include heart, breathing, and/or digestive system sounds, in addition to many other physiological phenomena. The acoustic sensor 215 in certain embodiments is a biological sound sensor, such as the sensors described or incorporated by reference herein. In some embodiments, the biological sound sensor is one of the sensors such as those described in U.S. patent application Ser. No. 12/044,883, filed Mar. 7, 2008, entitled “Systems and Methods for Determining a Physiological Condition Using an Acoustic Monitor,” (hereinafter referred to as “the '883 application”), the disclosure of which is hereby incorporated by reference in its entirety. In other embodiments, the acoustic sensor 215 is a biological sound sensor such as those described in U.S. Pat. No. 6,661,161, which is incorporated by reference herein in its entirety. Other embodiments include other suitable acoustic sensors.


The attachment mechanism 204 in certain embodiments includes first and second portions 206, 208 which can include adhesive (e.g., in some embodiments, tape, glue, a suction device, etc.). The adhesive can be used to secure the sensor 215 to a patient's skin. Moreover, one or more biasing members 210 included in the first and/or second portions 206, 208 can beneficially bias the sensor subassembly 202 in tension against the patient's skin and reduce stress on the connection between the patient adhesive and the skin. A removable backing can be provided with the patient adhesive to protect the adhesive surface prior to affixing to a patient's skin.


The sensor cable 207 can be electrically coupled to the sensor subassembly 202 via a printed circuit board (“PCB”) (not shown) in the sensor subassembly 202. Through this contact, electrical signals are communicated from the multi-parameter sensor subassembly to the physiological monitor through the sensor cable 207 and the cable 211.


In various embodiments, not all of the components illustrated in FIG. 2 are included in the sensor system 200. For example, in various embodiments, one or more of the patient anchor 203 and the attachment subassembly 204 are not included. In one embodiment, for example, a bandage or tape is used instead of the attachment subassembly 204 to attach the sensor subassembly 202 to the measurement site. Moreover, such bandages or tapes can be a variety of different shapes including generally elongate, circular and oval, for example. In addition, the cable hub 220 need not be included in certain embodiments. For example, multiple cables from different sensors could connect to a monitor directly without using the cable hub 220.


Additional information relating to acoustic sensors compatible with embodiments described herein, including other embodiments of interfaces with the physiological monitor are included in applications incorporated by reference herein, such as the '883 application, for example.



FIGS. 3A and 3B illustrate example layouts of a physiological monitoring systems 300A, 300B. FIGS. 3A and 3B illustrate various information elements 360, 362, and 364. In certain embodiments, the physiological monitoring systems 300 of FIGS. 3A and 3B implement multi-stage calibration. For example, the information elements 360, 362, and 364 can store calibration information usable to perform multi-stage calibration in accordance with embodiments described herein. The information elements 360, 362, 364 may additionally include other types of information (e.g., cable management, patient context, and/or physiological information). Although not shown, the information elements 360, 362, and 364 may also be included in any of the splitter cables described herein. Moreover, decoupling circuitry may be included in the cables of FIGS. 3A and 3B.


Referring to FIG. 3A, a physiological monitoring system 300A includes a physiological monitor 310 that communicates with a sensor 350 through an instrument cable 314 and a sensor cable 312. An information element 360 is included in the sensor cable 312.


The physiological monitor 310 interfaces with the instrument cable 314 using a connector 319, which mates with a connector 331 of the instrument cable 314. The instrument cable 314 mates in turn with the sensor cable 312 through a connector 335 on the instrument cable 314 and a corresponding connector 337 on the sensor cable 312. The sensor cable 312 in turn connects to a sensor 350 through a connector 333 and a corresponding connector 351 on the sensor 350. In alternative embodiments, the sensor cable 312 may be a splitter cable.


In the embodiment shown, the information element 360 is located in the connector 337. Other placements for the information element 360 are also possible. For example, the information element 360 could be located anywhere in the sensor 350 or in the sensor cable 312, including in a sensor cable section 332 or the connector 333. In addition, the information element 360 could also be located in the instrument cable 314 instead, or two or more information elements 360 could be used, one or more in each cable 312, 314 (see, e.g., FIG. 3).


The information element 360 can include any one or more of a wide variety of types of information elements. In an embodiment, the information element 360 is a non-volatile information element, such as, for example, an erasable programmable read-only memory (“EPROM”). “EPROM” as used herein includes its broad ordinary meaning known to one of skill in the art, including those devices commonly referred to as “EEPROM “EPROM,” as well as any types of electronic devices capable of retaining their contents even when no power is applied and/or those types of devices that are reprogrammable. In an embodiment, the information element is an impedance value associated with the sensor, such as, for example, a resistive value, an impedance value, an inductive value, and/or a capacitive value or a combination of the foregoing. In addition, the cable's information element could be provided through an active circuit such as a transistor network, memory chip, flash device, or other identification device, including multi-contact single wire information elements or other devices, such as those commercially available from Dallas Semiconductor or the like. Moreover, the information element may be random access memory (RAM), read-only memory (ROM), or a combination of the same.


In an embodiment, the physiological monitor 310 communicates with the information element 360 via a serial transmission line 340. In one embodiment, the serial transmission line 340 is a multi-drop bus, although in alternative embodiments, the serial transmission line 340 is a 1-wire bus, a SCSI bus, or another form of bus. Once the physiological monitor 310 determines that it is connected to the sensor cable 312, it sends and receives signals to and from the information element 360 to access calibration information, cable management information and/or patient context information. Alternatively, the physiological monitor 310 does not access the information element 360 until requested to do so by a user (e.g., a clinician). In addition, the physiological monitor 310 may also automatically access the information element 360 or access the information element 360 in response to a user request.



FIG. 3B illustrates another embodiment of a monitoring system 300B. The monitoring system 300B preferably includes all the features of the monitoring system 300A and additionally includes an information element 362 in the instrument cable 314 and an information element 364 in the sensor 350. The information elements 362, 364 may have the same or different characteristics of the information element 360, including the same or different memory type, capacity, latency, or throughput.


In an embodiment, the serial transmission line 340 connects the physiological monitor 310 to the information element 360 in the sensor cable 312 as above. However, the serial transmission line 340 also connects to the information elements 362, 364. The physiological monitor 310 may therefore access the information elements 360, 362, 364 while running generally few transmission lines 340.


The information elements 362, 364 may have all or a portion of the functionality of the information element 360. In one embodiment, the same data is stored in each of the information elements 360, 362, 364, thereby providing data redundancy. Additionally, in such embodiments the instrument cable 314 may stay with the patient as the patient moves from one department to another, in place of or in addition to the sensor cable 312. Moreover, in one embodiment only the instrument cable 314 or the sensor assembly 350 has an information element 362 or 364, and the sensor cable 312 does not have an information element 360.


The placement of the information elements 362, 364 can be in any of a variety of locations. For example, the information element 362 may be located in either one or the connectors 331, 335 or in the instrument cable section 334. Likewise, the information element 364 of the sensor 350 may be located in the connector 351 or in another part of the sensor 350.


Although not shown, the sensor cable 312 and/or the instrument cable 314 may have multiple information elements in some embodiments. When multiple information elements are used, certain data may be stored on some information elements, and other data may be stored on others. For instance, calibration, cable management information, patient context information, physiological information, etc., or any combination thereof may be stored separate information elements.


Referring to FIG. 3B for the purposes of illustration, each of the components in the sensor path, including, for example, the sensor 350, the sensor cable 314 and the instrument cable 312 form one or more stages. Additionally, each stage can have a respective information element 364, 360, 362 associated with it.


One or more additional stages may be located in the monitor 310. For example, The monitor 310 can further include one or more components (e.g., front-end processing circuitry) and one or more information elements (not shown) storing calibration information related to those components. Example front end processing circuitry is described below with respect to FIG. 5. Further additional stages may be included, or one or more of the stages shown in FIG. 3B may not be included in certain embodiments.


The instrument cable 314 may include a splitter cable such as any of the splitter cables described herein. Additionally, in some embodiments, the sensor includes an integrated cable which connects to the sensor cable 312. Such a configuration is shown in FIG. 2, discussed above. For example, referring to FIG. 2, information elements storing calibration information may be included on one or more of the sensor assembly 201, the monitor cable 211 and the hub 220.


The monitor 310 includes at least one processor (not shown) such as any of those described herein which receives the signal detected by the sensor after it has gone through each of the stages. Thus, the signal or signals received by the processor has been modified according to the characteristic responses of each of the stages. The processor performs signal processing on the received signal to extract signals representative of one or more physiological parameters, such as any of the parameters described herein (e.g., respiratory rate, SpO2, etc.).


In certain embodiments, the system 300B is further configured for calibration of the multi-stage signal path. The information elements store calibration information related to behavioral characteristics of one or more of the stages such as the sensor 350, the sensor cable 312, the instrument cable 314, and/or front-end processing circuitry in the monitor. Using the calibration information, the monitor 310 is configured to adjust the processing of the received signal or signals so as to account for the specific behavioral characteristics of the stages. Thus, the system dynamically accesses predetermined response information related to the attached components and can produce accurate measurements generally regardless of the variable characteristics of those components.


For example, in some embodiments the calibration information from each information element corresponds to a characteristic response of a corresponding stage or portions of that stage. Alternatively, the calibration information may not be directly representative of the response and the processor instead derives the response from the calibration information.


In some embodiments, the processor performs the inverse of the response of one or more of the stages to calibrate the system, although other suitable computations can be employed. In some embodiments, the processor determines a transfer function associated with one or more of the stages or portions thereof and performs the inverse transfer function to reconstruct the signal.


A multi-stage calibration module running on the processor may perform the calibration process, for example. The calibration module in some embodiments operates on the signal received from the final stage in the signal path before other signal processing is performed on the signal. In another embodiment, the multi-stage calibration is performed substantially in parallel with other signal processing. In one embodiment, the calibration module reconstructs the original sensor signal. For example, the calibration module generates a signal substantially representative of the voltage or current signal output by the sensor, removing the effects of the other components in the sensor path.


In one embodiment, rather than computing and compensating for the response of each stage individually, the processor uses the calibration information from all of the stages to determine a single combined multi-stage response. The processor can then automatically calibrate the signal processing algorithm based on the combined response, such as by performing the inverse of the combined response or by performing some other suitable computation.


In certain embodiments, one or more of the systems 300A, 300B of FIGS. 3A and 3B are configured to calibrate the processing of the sensor signal in response to calibration information stored on one or more of the information elements 362, 360, 364 and/or one or more other information elements in the sensor path.


In some embodiments, the system 300B may be capable of performing targeted noise compensation by reducing the effect of noisy components in the signal path. For example, the system of some embodiments identifies certain components or portions thereof which are contributing a relatively high amount of noise and adjusts the processing of the sensor signal accordingly. For example, the system 300B may identify and/or compensate for relatively high noise stages by manipulating the responses (e.g., transfer functions) associated with the corresponding stages during signal processing. One or more of the components can have programmable operating values, and the system may adjust one or more of those programmable values to identify and/or compensate for relatively high noisy stages.


As described, other types of information in addition to calibration information can be stored on one or more of the information elements. For example, cable management information that may be stored on the information element 360 may include information on cable usage, sensor usage, and/or monitor usage. Cable usage data may include, for example, information on the time the cable has been in use, enabling the physiological monitor 310 to determine when the sensor cable 312 is near the end of its life. Sensor usage data may include, for example, information on what sensors have been attached to the sensor cable 312, for how long, and the like. Similarly, monitor usage data may include, for example, information on what monitors have been attached to the sensor cable 312, for how long, and the like. More detailed examples of cable management information are described below, with respect to FIG. 4.


Patient context information that may be stored on the information element 360 may include patient identification data and patient flow data. In one example embodiment, patient identification data includes at least the patient's name and one or more identification numbers. Patient flow data may include, for example, details regarding the departments the patient has stayed in, the length of time therein, and devices connected to the patient. More detailed examples of patient context information may also be found below, with respect to FIG. 4.


Advantageously, in certain embodiments, the physiological monitor 310 uses the cable management information in various embodiments to determine when to replace a cable in order to prevent cable failure. The physiological monitor 310 may also use the information element 360 to track sensor 350 and physiological monitor 310 use. Some implementations of the physiological monitor 310 enable the physiological monitor 310 to transmit some or all of the cable management information to a central nurses' station or to a clinician's end user device, such as is described in further detail with respect to FIG. 4. In some implementations, the physiological monitor 310 or a central nurses' station sends an alarm to the end user device that alerts the user to impending cable failure. For example, a clinician might receive an alarm notification on a personal digital assistant (PDA), pager, or the like, which enables the clinician to replace the cable before it fails. Patient context information, including identification information, may also be provided along with the alarm to help the clinician identify the cable with the patient.


Moreover, the physiological monitor 310 may transmit some or all of the cable management information and/or patient context information to a central server (see, e.g., FIG. 13). Inventory software on the central server can use this information to preemptively order new cables when cable inventory is low or at other times.


Different sensors 350 and physiological monitors 310 may be attached to the same sensor cable 312. Thus, the cable management information may also include a list of which sensors 350 and physiological monitors 310 have been attached to the cable 312, how long they were attached, and the like. The physiological monitor 310 may also provide this information to the central server to keep track of or journal this information. The cable management information is therefore used in some embodiments to derive patient monitoring metrics, which may be analyzed to monitor or improve hospital operations. A hospital may use these metrics, for example, to determine when to replace cables or to determine whether personnel are using the cables improperly or are damaging the cables through improper use.


The patient context information in some embodiments also enables the sensor cable 312 to be identified with a particular patient. As the sensor cable 312 of some embodiments may be transported with the patient when the patient is moved about the hospital, when the sensor cable 312 is attached to different monitors 350, the data stored in the information element 360 may be transferred to the new monitor 350. Thus, during the patient's stay at the hospital or at discharge, the information element 360 of certain embodiments has patient flow data that a hospital can use to monitor or improve operations. The flow data of multiple patients may be used, for instance, to determine the number of patients staying in a particular department at a given time and the equipment used during those patients' stay. Knowing this information, the hospital can adjust equipment inventories and staff assignments to more efficiently allocate hospital resources among the various departments.



FIG. 3C illustrates an embodiment of a circuit 300C for facilitating communication between a monitor and one or more information elements 390. The circuit 300C may be included in any of the cable or sensor assemblies described above, including in a splitter cable, a non-splitter cable, an instrument cable, a sensor cable, a sensor assembly, combinations of the same, and the like. In addition, the circuit 300C may be used in conjunction with the circuits 500B and 500C in a single cable, e.g., on the same circuit board, or in combination with multiple cables and/or sensor assemblies.


Advantageously, in certain embodiments, the circuit 300C provides electrical decoupling for communications lines 377, 379, 382, and 383, which provide communications between a monitor and one or more information elements. In addition, the circuit 300C may provide sensor connection status to a monitor via a sensor detect circuit 372.


A decoupling circuit 540d shown includes digital decoupling logic to electrically decouple one or more information elements and one or more sensors from the monitor. The decoupling circuit 540d includes transformers on a chip and associated logic that perform digital decoupling. In one embodiment, the decoupling circuit 540d is a ADuM130x series chip from Analog Devices. In other embodiments, optocouplers and/or other transformers are used.


Communications lines 382, 383 allow the monitor to transmit and receive data to and from one or more information elements 390. The line 382 is a monitor transmit line 382, and the line 383 is a monitor receive line 383. Each of these lines 382, 383 is electrically decoupled from the communications line 377 by the decoupling circuit 540d. The communication lines 377, 379 may be electrically coupled with the one or more information elements 390.


In an embodiment, the communications line 377 is a bus, such as a 1-wire bus. The communications line 377 may be used to both transmit and receive data to and from the monitor. The communications line 379 may be used to receive data from the monitor. A MOSFET switch 376 or the like is in communication with the depicted communications line 379, which selectively transmits signals to the one or more information elements 390.


The monitor receive line 383 is in communication with a power validation circuit 378, which determines whether the feedback power VFB described above with respect to FIG. 3C is high enough. If the feedback power VFB is too low, the data received from the information elements 390 may not be used because the data may be corrupt.


In the depicted embodiment, the power validation circuit 378 includes a comparator 389 that compares the feedback power VFB with a reference voltage. If the feedback power VFB is equal to or higher than the reference voltage, the comparator 389 might output a high voltage. This high voltage can be selectively overridden by a MOSFET switch 387 in response to communications received from the information elements 390. If the feedback power VFB is lower than the reference voltage, the comparator 389 might output a low voltage. The low voltage can override the MOSFET switch 387 such that communications from the information elements 390 are not sent to the monitor.


In the depicted embodiment, sensor connection status is provided to the monitor via the sensor detect circuit 372. The sensor detect circuit 372 includes a sensor detect line 375 in communication with a pull-up resistor 373. When a sensor 385 is not connected to the line 375, the line 375 may be pulled high. This high voltage may be inverted by a MOSFET switch 374 to provide a low signal to the monitor via sensor connect line 381. The switch 374 may be omitted in some embodiments.


In response to a sensor 385 being connected to the sensor detect line 375, a shorted line 386 (or low resistance line) in the sensor 385 can cause the line 375 to be pulled low. This low value can be inverted by the switch 374 to provide a high signal to the monitor. This signal can indicate that the sensor 385 is connected. Conversely, if the sensor 385 is disconnected, the line 375 may again be pulled high, resulting in a low output of the switch 374. As a result, the monitor may receive a rapid or near-immediate indication that the sensor 385 has been disconnected.


The sensor detect circuit 372 also includes passive elements in the depicted embodiment, such as a capacitor 391, to smooth or debounce contact oscillations from the sensor 385. Thus, the sensor detect circuit 372 can also be considered a debounce circuit. In other embodiments, the sensor detect circuit 372 can be replaced with other forms of debounce circuitry.


Advantageously, in certain embodiments, the sensor detect circuit 372 can be used instead of polling the one or more information elements 390 frequently to determine if the sensor 385 is connected. Alternatively, the polling cycle of the one or more information elements 390 may be reduced. Reducing or eliminating the polling cycle can reduce power consumption by the circuit 300C.


The sensor detect circuit 372 may be used to detect the connection of cables, such as a splitter cable, as well as or instead of detecting sensor connections. In some embodiments, a sensor detect line 375 may be provided for each sensor in a multi-sensor system, each cable, or the like. Moreover, the sensor detect circuit 372 may also be used with cables that do not have a decoupling circuit.



FIG. 4 illustrates a block diagram of example forms of data that can be stored on an information element 460. In the depicted embodiment, patient context information 420, cable management information 430, physiological information 440 and calibration information 450 are shown. The patient context information can include patient identification data 422 and patient flow data 424. Cable management information 430 can include cable usage data 432, sensor usage data 434, and instrument usage data 436. However, while the data is depicted in FIG. 4 as comprising discrete categories, data from one category may be included within another. Data from one or more categories also may not be included, or alternatively, additional data categories than that shown may be included.


The calibration information 450 may be related to the characteristics of the components attached to the system. For example, each information element may store information related to behavioral characteristics of the corresponding component (e.g., a sensor or cable) to which it is attached.


Such information can include electrical properties such as capacitances, impedances, resistances, and the like. The information element 460 may further store mechanical properties such as a mechanical sensitivity of a sensing element. For example, in an embodiment, an acoustic sensor assembly includes a piezoelectric membrane that vibrates in response to mechanical vibrations generated by the physiological sounds of a patient. The membrane generates a corresponding voltage signal. The mechanical sensitivity of such a device, or the mechanical properties of other mechanical components can be stored in the information element 460.


Additionally, frequency response characteristics such as cut-in and cut-off values can be stored. These cut-in and cut-off values can be mechanical values, such as for a piezoelectric membrane of an acoustic sensor, or electrical cut-in and cut-off values, such as for one or more circuit components. In addition to having their ordinary meaning, mechanical cut-in and cut-off frequencies may correspond to the lowest and highest frequency values, respectively, at which a particular component passes a signal from its input to its output. Saturation values and/or gain characteristics of certain components (e.g., circuit components) may also be included.


In addition to these specific examples and categories of calibration information, a wide variety of other calibration data may be used. Generally, any data related to characteristics of components in the sensor path may be stored.


In one embodiment patient identification data 422 can include a patient's name, a patient's unique hospital identification number, type of patient or body tissue, information about the patient's age, sex, medications, and medical history, and other information that can be useful for the accuracy of alarm settings and sensitivities and the like. In addition, the patient identification data 422 may also include an SpO2 fingerprint, determined by a pulse oximeter. In one such embodiment, the SpO2 fingerprint is determined by calculating a ratio of an infrared detected wavelength and a red detected wavelength. The SpO2 fingerprint can be used to detect if a sensor or cable is being improperly reused.


Patient flow data 424 can include a record of departments the patient has visited, length of stay (LOS) in those departments, overall LOS in the hospital, admittance date and time, discharge date and time, time stamps for events occurring in the hospital, and the like. Some or all of this information, in conjunction with the patient identification data, can constitute a patient flow profile.


Cable usage data 432 may include buyer or manufacturer information, cable type, serial number of the cable, date of purchase, time in use, and cable life monitoring functions (CLM), including near expiration percentage, update period, expiration limit, and an index of functions. In addition, the cable usage data 432 may include numerous read write parameters, such as the number of times the cable is connected to a monitoring system, the number of times the cable has been successfully calibrated, the total elapsed time connected to a monitor system, the number of times the cable has been connected to one or more sensors, the total time used to process patient vital parameters, the cumulative current, voltage, or power applied to the cable, the cumulative temperature of the cable, and the expiration status of the cable.


In an embodiment, the number of times the cable is placed on or removed from a patient is monitored and an indication is stored in the memory. The number of times a sensor connected to the cable is placed on or removed from a patient can be monitored by monitoring the number of probe off conditions sensed, or it can be monitored by placing a separate monitoring device on the cable or sensor to determine when a sensor clip is depressed, opened, removed, replaced, attached, or the like.


In an embodiment, the average operating temperature of the cable is monitored and an indication stored. This can be done, for example, through the use of bulk mass or through directly monitoring the temperature of the cable or the temperature of the cable's connectors. In an embodiment, the number of different monitors connected to the cable is tracked and an indication is stored in memory. In an embodiment, the number of times the cable is calibrated is monitored, and an indication is stored in memory. In an embodiment, the number of patients that use a cable is monitored and an indication is stored. This can be done by, for example, by storing sensed or manually entered information about the patient and comparing the information to new information obtained when the cable is powered up, disconnected and/or reconnected, or at other significant events or periodically to determine if the cable is connected to the same patient or a new patient. In an embodiment, a user is requested to enter information about the patient that is then stored in memory and used to determine the useful cable life. In an embodiment, a user is requested to enter information about cleaning and sterilization of the cable, and an indication is stored in the memory. Although described with respect to measuring certain parameters in certain ways, various other electrical or mechanical measurements can be used to determine any useful parameter in measuring the useful life of a cable.


Sensor usage data 434 can include some or all of the same information as the cable usage data but applied to sensors attached to the cable, and may also include information on the type or operation of the sensor, type or identification of a sensor buyer, sensor manufacturer information, sensor characteristics including the number of wavelengths capable of being emitted, emitter specifications, emitter drive requirements, demodulation data, calculation mode data, calibration data, software such as scripts, executable code, or the like, sensor electronic elements, sensor life data indicating whether some or all sensor components have expired and should be replaced, encryption information, monitor or algorithm upgrade instructions or data, or the like. In an embodiment, the sensor usage data 434 can also include emitter wavelength correction data.


Sensor usage data 434 can also include the number of emitting devices, the number of emission wavelengths, data relating to emission centroids, data relating to a change in emission characteristics based on varying temperature, history of the sensor temperature, current, or voltage, emitter specifications, emitter drive requirements, demodulation data, calculation mode data, the parameters it is intended to measure (e.g., HbCO, HbMet, etc.) calibration data, software such as scripts, executable code, or the like, sensor electronic elements, whether it is a disposable, reusable, or multi-site partially reusable, partially disposable sensor, whether it is an adhesive or non-adhesive sensor, whether it is reflectance or transmittance sensor, whether it is a finger, hand, foot, forehead, or ear sensor, whether it is a stereo sensor or a two-headed sensor, sensor life data indicating whether some or all sensor components have expired and should be replaced, encryption information, keys, indexes to keys or has functions, or the like monitor or algorithm upgrade instructions or data, and some or all of parameter equations.


Instrument usage data 436 can include buyer or manufacturer information, information on the type of monitors that the cable has connected to, number of monitors the cable has connected to, duration of cable connections to the monitors, duration of use of the monitor, trend history, alarm history, sensor life, an identification number for a specific monitor, and the like. In addition, the instrument usage data 436 may include all or a portion of all the cable and sensor usage data described above.


The physiological information 440 may include any of the physiological parameters described above, obtained from the sensors or monitors attached to the information element 460. In one implementation, the information element 460 enables the physiological information 440 to be transferred between physiological monitors. As a result, a historical view of the patient's physiological parameters may be provided to different monitors throughout the hospital. Thus, clinicians in different departments can observe the patient's physiological information obtained in a previous department, enabling clinicians to provide a higher quality of care.



FIG. 5 illustrates a functional block diagram of an acoustic signal processing system 500. The block diagram illustrates components which may be included on portions of various stages of a monitoring system having a multi-stage sensor path, for example. The processing system 500 includes an acoustic sensor 502 which can detect a physiological signal and produces a corresponding voltage signal. In one embodiment, the sensor 502 is an acoustic sensor such as one of the acoustic sensors described herein and is configured to measure at least one of a patient's respiratory rate, heart sounds, and related parameters.


The system 500 further includes front end circuitry 504 configured to condition the analog electrical signal output by the sensor 502 for processing. The front end circuitry 504 includes a pre-amplification circuit 506, one or more filters 508, a high gain stage 510, a low gain stage 512, and an analog to digital converter (ADC) 514. The system 500 further includes a digital signal processor (DSP) and a display 518.


The preamplification circuit 506 receives and amplifies the voltage signal from the sensor, such as by a predetermined gain. The one or more filters 508 modify the preamplified signal by, for example, smoothing or flattening the signal. In one embodiment, the one or more filters 508 include a high pass filter which passes high frequency signals and attenuates low frequency signals. The one or more filters 508 may include other types of filters, such as low pass or bandpass filters may be used instead of, or in addition to a high pass filter in some embodiments.


The output from the filter 508 is divided into two channels, for example, first and second channels 520, 522. In some embodiments, more than two channels may be used. For example, 3, 4, 8, 16, 32 or more channels may be used. The voltage signal is transmitted on both first and second channels 520, 522 to gain bank 509. The gain bank 509 in certain embodiments includes one or more gain stages. In the depicted embodiment, there are two gain stages 510, 512. A high gain stage 510 amplifies the voltage signal into a higher voltage signal. A low gain stage 512 in certain embodiments does not amplify or attenuates the voltage signal. In alternative embodiments, the low gain stage 512 may amplify the voltage signal with a lower gain than the gain in the high gain stage 510.


The amplified signal at both first and second channels 520, 522 then passes to an analog-to-digital converter (ADC) 514. The ADC 514 has two input channels to receive the separate output of both the high gain stage 510 and the low gain stage 512. The ADC bank 514 samples and converts analog voltage signals into digital signals. The digital signals then pass to the DSP 516 for processing. A display 518 then outputs a graphical display of one or more physiological parameters such as a respiratory rate, heart sounds, etc., based on the processed signal. In certain embodiments, a separate sampling module samples the analog voltage signal and sends the sampled signal to the ADC 514 for conversion to digital form. Additionally, in certain embodiments two ADCs 514 may be used in place of one ADC 514.


A variety of configurations are possible for the processing system 500. For example, one or more of the illustrated components may not be included in certain embodiments. In other embodiments, additional components may be used instead of or in addition to the illustrated components. Example compatible processing systems 500 are described in the '883 application and are incorporated by reference herein.


Example Multi-Stage Calibration System Implementation


As discussed, the various components of the acoustic processing system 500 may be dispersed throughout various stages of a monitoring system having a multi-stage sensor path. An example implementation of a multi-stage monitoring system capable of performing an example multi-stage calibration process will now be described with reference to FIGS. 2, 3 and 5. The example system includes a sensor path arrangement compatible with those depicted in FIGS. 2 and 3 implementing an acoustic processing system such as the processing system 500 of FIG. 5. This example implementation is provided for the purposes of illustration, and is not limiting.


Referring again to FIG. 2, the sensor assembly 201 including the sensor 215 and integrated sensor cable 217 form a first stage in the example implementation. The instrument cable 211 forms a second stage and includes preamplification circuitry, such as the preamplification circuitry 506 of FIG. 5. By placing the preamplification circuit in a component other than the sensor, such as the instrument cable 211, cost can be reduced. For example, in one embodiment, a disposable sensor is used, or the sensor 215 otherwise requires more frequent replacement than the reusable instrument cable 211. For example, the sensor 215 may become soiled or generally wear out more quickly than the instrument cable 211, due to repeated contact with the patient, relatively more fragile componentry, etc. Thus, it is advantageous to reduce the cost and complexity of constructing the sensor 215 by moving the preamplification circuit to the instrument cable 211.


Additionally, in order to amplify the sensed signal for processing before significant attenuation or other signal degradation occurs, it can be desirable to place the preamplification circuit generally as close to the sensor as possible. Thus, in one embodiment, the preamplification circuitry is located on the connector 209 of the instrument cable 211, which is adjacent to the sensor assembly 201 in an attached configuration. Thus, the preamplification circuitry in this embodiment is both relatively close to the sensor in the signal path and is on a separate component, achieving both performance benefit and cost savings. In other embodiments, the preamplification circuit resides on the sensor 215 or at some other location.


The hub 220 forms a third stage, and a front end module in the monitor (not shown) forms a fourth stage and includes the components of the front end circuitry other than the pre-amplification circuit. For example, the front end module includes one or more filters, high and low gain stages, and an ADC such as those of the system 500 of FIG. 5. In other embodiments, all of the front end circuitry is located in the monitor, some other stage, or is dispersed through the stages in some other manner. The monitor also houses a DSP and a display such as the DSP 516 and display 518 of FIG. 5.


Additionally, each of the four stages include at least one associated information element. While the information elements may be located in a variety of locations, in the example embodiment the information elements associated with stages one through four are located on the connector 205 of the integrated sensor cable 217, the connector 209 of the instrument cable, within the housing of the hub 220, and in the monitor, respectively.


In the example implementation, the information element associated with the example first (sensor) stage is a 1 Kbit EEPROM, although other types of information elements can be used. The information element stores data relating to the mechanical sensitivity of the piezoelectric sensing element, one or more mechanical cut-in and cut-off frequencies, and one or more capacitances associated with the sensor 215. In one embodiment, the mechanical sensitivity may be determined by comparing the amplitude of an acoustic input signal to the amplitude of the resulting voltage signal. In addition to having its ordinary meaning, mechanical cut-in and cut-off frequencies may correspond to the lowest and highest frequency values, respectively, of physiological sounds that the sensor 215 is capable of detecting to produce a corresponding voltage signal. The capacitance values may correspond to one or more of the output capacitance of the sensor 215, the capacitance of the integrated sensor cable 217, a combination thereof, or some other capacitance.


In one embodiment, the information element associated with the example second (instrument cable/preamplifier) stage is a 1 Kbit EEPROM and includes information relating to characteristics of the preamplifier 506 such as one or more of a differential gain value, input impedance, cut-in and/or cut-off frequencies, a minimum saturation value, and the like. In one embodiment, the cut-in frequency is not stored in the EEPROM but is instead computed (e.g., by the monitor) using the capacitance of the first stage and the input impedance of the second stage. Thus, by taking advantage of the information already stored in the previous stage, less memory space is used. As a result, smaller memory components or less memory components may be used, providing potential cost savings. In other embodiments, the cut-in frequency is stored on the information element.


The example third stage formed by the hub 220 includes a 20 Kbit EEPROM which stores information related to the hub 220. As discussed, the hub 220 can include electrical decoupling circuitry. In the example embodiment, the hub 220 includes decoupling circuitry having an optocoupler and/or transformer such as the decoupling circuitry described herein with respect to the example hub 1720 of FIG. 17.


The decoupling circuitry may exhibit some amount of phase change and/or non-linear behavior such as signal compression, for example. Information is stored in the information element which can be used to account for this behavior. For example, one or more coefficients are stored in the EEPROM which can be used to construct the curve of the non-linear response. Additional information related to the hub 220 is stored in the information element and can include, for example, a gain, cut-in and cut-off frequencies, output resistance, and minimum saturation level of the hub stage.


As discussed, the fourth stage in the example embodiment is located on the monitor and includes the front end circuitry other than preamplifier, which is stored in the instrument cable 211. The information element associated with the fourth stage can be a flash memory, for example, and is configured to store calibration data related to the properties of the front end circuitry components. For example, such information can include gain and frequency cut-off values for the high gain channel, gain and cut-off frequency values for the low gain channel, etc.


The fourth stage may also have a characteristic input gain value. In the example embodiment, this value is not stored by the information element but is instead computed (e.g., by the monitor) using the output resistance from the previous stage. Again, by taking advantage of stored information, less memory is used, providing cost savings. Alternatively, the input stage gain value may be stored on the information element.


A processor in the monitor downloads the calibration information from the information elements of the four stages and performs the multi-stage calibration based on the information. For example, the processor may acquire or generate a mathematical representation of the responses (e.g., transfer functions) associated with one or more of the stages or portions thereof. The processor may then perform an appropriate computation to generally remove or modify the effect of the four stages or portions thereof on the sensor signal. For example, the processor may perform the mathematical inverse (e.g., inverse transfer functions) of those responses. In general, any appropriate mathematical operation incorporating the calibration information may be used.


While a variety of types of calibration information have been described with respect to the above example embodiment, a wide variety of other kinds of information (e.g., quality control information, compatibility information, cable management information, patient context information, and/or physiological information, etc.) may be stored in other configurations. Additionally, other or additional types of components including different information elements, front end circuitry components, sensors, cables, etc., are contemplated. Moreover, while the example implementation involves a system incorporating an acoustic sensor, systems having other types of sensors (e.g., optical sensors such as pulse oximeter sensors) may also incorporate the multi-stage calibration described herein.


In the example implementation, physically separable components generally form separate stages. In other embodiments, stages may be delineated in some other manner, such as based on functionality rather than physical separability. Additionally, in some embodiments, one or more physically separable components do not include calibration information and the monitor does not factor in characteristics associated with that component in the adaptive processing.


In certain embodiments the monitoring system is a “restricted access” system, which generally only functions with quality-controlled components that are authorized or compatible, such as components or families of components from a specific manufacturer or licensed vendor. This restricted access functionality can ensure proper functioning and quality of the monitoring system, for example, providing safety benefits.


In such systems, each of the information elements may include authentication information indicating that the corresponding component is compatible with the system. The authentication information may include predetermined data such as a key or other information capable of identifying the respective component as a compatible with the system.


The monitoring device can be configured to read the authentication information and verify that each of the attached components is authorized or otherwise compatible with the system. If the components are compatible, the monitoring device enables physiological monitoring. On the other hand, if one or more of the components do not have the appropriate authentication information, the monitoring device disables the monitoring function. Such authentication information may be stored in combination with the calibration information discussed above.


In some embodiments, only select components in the system require authentication by the monitor. For example, in one embodiment, the sensor is the only device including authentication information.


Examples of restricted access technology compatible with embodiments described herein are provided in U.S. Pat. No. 7,843,729, titled “Pulse Oximeter Access Apparatus and Method,” the disclosure of which is hereby incorporated by reference in its entirety.



FIG. 6 illustrates a flowchart diagram of an example physiological monitoring process 600 incorporating multi-stage calibration. In one embodiment, the process 600 begins at step 602, where the process 600 determines whether a compatible multi-stage sensor path is appropriately connected to the monitor. The process 600 may enter step 602 when it receives an indication that a user would like to begin physiological monitoring, for example. In another embodiment, the process 600 may enter step 602 when it detects that one or more components have been connected to the monitor.


At step 602, for example, the process 600 may electrically ping or otherwise communicate with the components in the sensor path (e.g., sensors, cables, etc.) to determine whether a compatible sensor path configuration is connected to the monitor. In one embodiment, the process 600 downloads and verifies quality control and/or authentication information from each of the stages in the sensor path at step 602 to determine if the sensor path configuration is compatible. Generally, any of the types of information described herein can be advantageously used in the compatibility determination (e.g., quality control information, cable management information, patient context information, and/or physiological information). If one or more of the sensor path stages are not compatible or are not appropriately connected, the process 600 waits.


If the components of the multi-stage sensor path are appropriately connected, the process 600 of some embodiments obtains calibration information from information elements associated with one or more of the stages at step 604. For example, the process may download calibration information from one or more of a sensor, instrument cable, splitter cable, front-end circuitry, and/or some other component. In one embodiment, the process 600 downloads the information from the attached components serially, such as in the order in which they are connected. In other embodiments, the process 600 may receive the information in parallel from one or more of the stages, or in another suitable manner.


The process 600 continues to step 606, where the process 600 adjusts one or more signal processing parameters of the physiological monitor based on the calibration information. For example, the process 600 determines the characteristic response associated with one or more of the stages or portions thereof using the calibration information. In some embodiments, the process 600 then adjusts one or more parameters of a signal processing algorithm using the determined responses or other calibration information.


At step 608, the process 600 processes the detected signal according to the adjusted processing parameters. For example, the process 600 may perform multi-stage calibration by applying the inverse of one or more of the calculated sensor path stage responses as described herein, or by performing some other compatible operation. In general, any of the automatic calibration techniques described herein may be used, such as those described with respect to FIG. 2, 3B, or 5, for example. In other configurations, some other appropriate algorithm or technique is used.


In addition to the automatic calibration operation, the process 600 at step 608 may apply appropriate further processing to the signals to extract the physiological signal or signals. At step 610, the process 600 provides a graphical display of one or more physiological parameters based on the processed signal or signals. Until monitoring is discontinued, the process 600 of certain embodiments generally continues to process the signal and display the physiological parameter by repeating steps 608 and 610.


FURTHER COMPATIBLE EMBODIMENTS

Multiple sensors are often applied to a medical patient to provide physiological information about the patient to a physiological monitor. Some sensors, including certain optical and acoustic sensors, interface with the monitor using a cable having power, signal, and ground lines or wires. One or more these lines can pose an electric shock hazard when multiple sensors are attached to the patient. If an electrical potential exists in the ground line, for instance, a ground loop can form in the patient or in the ground line, allowing unwanted current to pass through the patient through the ground line. Power fluctuations or surges, such as from a defibrillator, can potentially harm the patient and damage the monitor or the sensors.


This disclosure describes decoupling circuitry that can be used to prevent or substantially prevent ground loops and other current loops from forming. Using decoupling circuitry in this manner can be referred to as providing sensor isolation, patient isolation, patient protection, sensor decoupling, or the like. Currently-available physiological monitors that connect to one sensor at a time using a single cable may not have this decoupling circuitry. Upgrading these monitors to receive two or more sensors can create the shock hazard described above unless protective circuitry is added to these monitors. For existing single-sensor monitors, adding this circuitry might require a costly upgrade of the monitors' internal components. For new single-sensor monitors, the decoupling circuitry could be added during manufacturing. But this approach would be cost-inefficient for buyers who wish to use only one sensor with the device.


Accordingly, in certain embodiments, the decoupling circuitry is provided in a medical cable assembly. The medical cable assembly includes, in some embodiments, a splitter cable that interfaces multiple physiological sensors with a single sensor port on a physiological monitor. Advantageously, in certain embodiments, the medical cable assembly allows multiple sensors to connect to a monitor while reducing the risk of electric shock to a patient.



FIGS. 7A and 7B illustrate embodiments of physiological monitoring systems 700A, 700B interfacing with multiple sensor assemblies 750. The physiological monitoring systems 700A, 700B each include a physiological monitor 710, a splitter cable 720, two cables 730, and two sensor assemblies 750. The physiological monitoring systems 700A, 700B may include all of the features of the physiological monitoring system 100 described above.


In the physiological monitoring system 700A of FIG. 7A, a patient decoupling circuit 740a is provided in one of the cables 730b. In the physiological monitoring system 700B of FIG. 7B, the patient decoupling circuit 740b is provided in the splitter cable 720b. These patient decoupling circuits 740a, 740b can reduce or prevent ground loops from forming in the patient and/or in the physiological monitoring system 700. Although not shown, a decoupling circuit could instead be provided in one or both of the sensor assemblies 750.


The physiological monitor 710 processes and outputs physiological information received from sensors included in the sensor assemblies 750a, 750b. The physiological monitor 710 of certain embodiments includes a power decoupling circuit 715, a processing board 717, and a connector 719. The power decoupling circuit 715 may be a transformer or the like that decouples power (e.g., AC electrical power) received from a power source (such as an electrical outlet) and the circuitry of the physiological monitor 710. The power decoupling circuit 715 prevents or substantially prevents current spikes from damaging the other components of the physiological monitor 710 or the patient. In embodiments where the physiological monitor 710 receives power from another source, such as batteries, the power decoupling circuit 715 may not be included.


The processor 717 of certain embodiments is a microprocessor, digital signal processor, a combination of the same, or the like. The processor 717 receives power from the power decoupling circuit 715. In some implementations, the processor 717 processes physiological signals received from the sensors 750 and outputs the processed signals to a display, storage device, or the like. In addition, the processor 717 may communicate with an information element (e.g., a memory device) included in a cable or sensor. Information elements are discussed in greater detail herein with respect to FIGS. 3 through 6 and 11 through 17.


The connector 719 includes a physical interface for connecting a cable assembly to the physiological monitor 710. In the embodiment shown in FIGS. 7A and 7B, a single connector 719 is provided. Additional connectors 719 may also be included in some implementations. One embodiment of a physiological monitor having additional connectors 719 is described below with respect to FIG. 8.


The splitter cable 720 is provided in some embodiments to enable the physiological monitor 710 having one connector 719 to interface with multiple sensors 750. The splitter cable 720 interfaces with the connector 719 through a monitor connector 721 in the splitter cable 720. In the depicted embodiment, where the splitter cable 720 interfaces with two sensors 750, cable sections 722 of the splitter cable 720, which branches into two sections generally forming a “Y” shape or the like. Thus, the splitter cable 720 can be a Y cable or the like. While the splitter cable 720 is shown forming a “Y” shape, other configurations and shapes of the splitter cable 720 may be used. For example, the splitter cable 720 could branch into more than two cable sections 722 to interface with more than two sensors 750.


The cable sections 722 are shown connected to the monitor connector 721 and two cable connectors 723. In some embodiments, the cable sections 722 branch into more than two parts and connect to more than two cable connectors 723. In addition, in some embodiments the splitter cable 720 couples directly to two or more sensors 750.


Some embodiments of the splitter cable 720 include one or more lines, conductors, or wires per cable connector 723. One line might be provided, for example, to interface with one or more electrocardiograph (ECG) sensors. Two or three lines might be provided per cable connector 723, for example, to interface with an optical or acoustic sensor. For instance, three lines might be provided, including a power line, a signal line, and a ground line (see FIGS. 4 and 5). The power line powers the sensor 750, the signal line receives signals from the sensor 750, and the ground line acts as an electrical return path for the power and/or signal lines. In some embodiments, one or more of the lines coming from one sensor 750a are placed at a predetermined distance from one or more of the lines coming from another sensor 750b to reduce cross-talk interference between the sensors 750. One or more electromagnetic shielding and/or insulating layers may also be provided to help reduce cross-talk. Lines from different sensors may merge into a shared line that connects electrically to the monitor 710, and some form of multiplexing might be used to allow the different sensors to communicate along the shared lines.


The cables 730a, 730b interface with the splitter cable 720 in the depicted embodiment through cable connectors 731. In certain embodiments, each cable 730 also includes a cable section 732 and a sensor connector 733 that connects to a sensor 750. The cable section 732 in some implementations includes one or more lines or wires for communicating with the sensor 750. For example, a power line, sensor line, and ground line may be provided that correspond to the power line, sensor line, and ground line in the example splitter cable 720 described above.


In an embodiment, one of the cables 730 includes the decoupling circuit 740a. In FIG. 7A, for example, the decoupling circuit 740a is shown in the cable section 732 of the cable 730b. The decoupling circuit 740a may also be placed in the cable connector 731 or the sensor connector 733, or in a combination of one or more of the connectors 731, 733 and/or the cable section 732. In another exemplary embodiment, FIG. 7B shows that the decoupling circuit 740b can be included in one of the cable sections 722 of the splitter cable 720b. The decoupling circuit 740b may also be placed in the monitor connector 721 or the sensor connector 723, or in a combination of the cable sections 722 and/or one or more of the connectors 721, 723.


Multiple decoupling circuits 740 may also be provided in one or more of the cables 730 and/or in the splitter cable 720 in other embodiments. In particular, in one embodiment when N cables 730 are provided (or one splitter cable 720 with N connectors 723), N−1 decoupling circuits 740 are provided in N−1 of the cables 730 or in the various sections of the splitter cable 720.


The decoupling circuit 740 of certain embodiments electrically decouples a sensor 750 from the physiological monitor 710. In addition, the decoupling circuit 740 can electrically decouple one sensor (e.g., the sensor 750b) from another sensor (e.g., the sensor 750a) in certain embodiments. The decoupling circuit 740 can be a transformer, an optocoupler, a DC-DC converter, a switched-mode converter, or the like or a combination of the foregoing. In addition, the decoupling circuit 740 can include one or more optical fibers. An optical fiber may be used in place of the signal line, for example. More detailed embodiments of the decoupling circuit 740 are described below with respect to FIGS. 9 and 10.


The sensors 750 connect to the sensor connectors 733 of the cables 730. In an embodiment, one of the sensors 750 is an optical sensor, such as a multiple wavelength oximetry sensor. The other sensor 750 in one embodiment is an acoustic sensor. In addition, the sensor 750 may be an acoustic sensor that also monitors ECG signals, such as is described in U.S. Provisional Application No. 60/893,853, titled “Multi-parameter Physiological Monitor,” and filed Mar. 8, 2007, the disclosure of which is hereby incorporated by reference in its entirety and U.S. application Ser. No. 12/044,883, titled “SYSTEMS AND METHODS FOR DETERMINING A PHYSIOLOGICAL CONDITION USING AN ACOUSTIC MONITOR,” and filed Mar. 7, 2008. Many other types of sensors 250 can also be used to monitor one or more physiological parameters.



FIG. 8 illustrates another embodiment of a physiological monitoring system 800 having multiple cables 730. The physiological monitoring system 800 may have certain of the features of the physiological monitoring systems 100, 700 described above. For example, like the physiological monitoring system 700 described above, the physiological monitoring system 800 includes a physiological monitor 810, two cables 730, and two sensors 750. In the physiological monitoring system 800, a decoupling circuit 740 is provided in one of the cables 730b.


Like the physiological monitor 710, the physiological monitor 810 includes a power decoupling circuit 715 and a processor 717. Unlike the physiological monitor 710, however, the physiological monitor 810 includes two connectors 819 for interfacing directly with two cables without using a splitter cable. To save costs for users who will use only one sensor 750 with the physiological monitor 810, a decoupling circuit 740 is not provided in the physiological monitor 810. Instead, the decoupling circuit 740 can be provided in a separate cable 730b that can be used with the physiological monitor 810.


For example, a user might use one cable 730a and sensor 750a at a time with the physiological monitor 810. Since only one sensor 750a is being used, ground or other current loops are less likely to form in the patient. If the user later wishes to use additional sensors 750, the user can obtain a cable 730b having the decoupling circuit 740. Using the cable 730b can beneficially allow the user to continue using the physiological monitor 810 without performing an upgrade to the physiological monitor's 810 internal components.



FIG. 9 illustrates another embodiment of a physiological monitoring system 900 having multiple cables 930. The physiological monitoring system 900 may have certain of the features of the physiological monitoring systems 100, 700, 300 described above. For example, like the physiological monitoring systems described above, the physiological monitoring system 900 includes a physiological monitor 910, two cables 930, and two sensors 950. The features described with respect to FIG. 9 may also be applied to a monitoring system having a splitter cable instead of multiple cables.


In the depicted embodiment, the cables 930 are shown connected to the physiological monitor 910 and to the sensors 950. Connectors 919 in the physiological monitor 910 couple with connectors 931 of the cables 930, and connectors 933 of the cables couple with connectors 951 of the sensors 950. A cable section 932 extends between the connectors 931, 933 of each cable.


The cable 930a includes a power line 962a, a ground line 964a, and a signal line 966a extending from the connector 931 to the connector 933. These lines form electrical connections with corresponding power, ground, and signal lines in the connector 919a of the physiological monitor 910 and in the connector 951a of the sensor 950a. Likewise, the cable 930b includes a power line 962b, a ground line 964b, and a signal line 966b. These lines form electrical connections with corresponding power, ground, and signal lines in the connector 919b of the physiological monitor 910. In addition, these lines extend from the connector 931 to a decoupling circuit 940. A power line 972, ground line 974, and signal line 976 extend from the decoupling circuit 940 to the connector 931 to form electrical connections with corresponding power, signal, and ground lines in the connector 951b of the sensor 950b. The cable section 932 can also include one or more electrical insulation and shielding layers, materials, or fillers. Although not shown, one or more of the cables 930a, 930b may also include one or more communications lines for communicating with information elements.


In the depicted embodiment, the ground line 964a is connected to the ground line 964b in the physiological monitor 910 through line 964c. When both sensors 950 are placed on a patient, the ground lines 964a and 979b may also be in electrical communication through the patient, as illustrated by the dashed line 984. If the decoupling circuit 940 were not present in one of the cables 930, a ground loop might be formed along the lines 964a, 964b, 964c, 974, and 984 (illustrated with bold lines) due to, for example, a difference in electrical potential in the lines 964a, 964b, 964c, and 974. While not shown in bold, current loops might also form in some cases among the power lines 962a, 962b, 972 or the signal lines 966a, 966b, 976.


Advantageously, in certain embodiments, the decoupling circuit 940 reduces the risk of a ground or other loop forming by decoupling one or more of the power lines 962b, 972, the signal lines 964b, 974, or the ground lines 964b, 974. More detailed embodiments illustrating how the decoupling circuit 940 could decouple one or more lines is described below with respect to FIGS. 10A through 10C and FIG. 3C.


While only one decoupling circuit is shown, in other embodiments, multiple decoupling circuits may be provided in one cable 930. For instance, a first decoupling circuit could be connected to the power line 962b and the ground line 966b, and a second decoupling circuit could be connected to the signal line 964b and to the ground line 966b. In addition, in certain embodiments, there may be a decoupling circuit in each cable 930a, 930b.



FIG. 10A illustrates a more detailed embodiment of a decoupling circuit 1040a suitable for use with any of the embodiments discussed herein. The decoupling circuit 1040a may include all the features of the decoupling circuits 740, 840, and 940 described above. For example, the decoupling circuit 1040a may be included in a medical cable assembly, such as a splitter cable, medical cable, or the like, or in a sensor assembly. The decoupling circuit 1040a can decouple electrical signals and prevent or reduce ground or other conducting loops from forming and can protect against current surges in a multi-sensor physiological monitoring system.


The decoupling circuit 1040a is shown within dashed lines. The decoupling circuit 1040a of various embodiments receives a signal line 1062a, a power line 1066a, and a ground line 1064a. These lines can be connected to a physiological monitor (not shown). In addition, the decoupling circuit 1040a receives a signal line 1072a, a power line 1076a, and a ground line 1074a, which may be connected to a sensor (not shown).


In an embodiment, the power line 1066a provides power from a physiological monitor to the decoupling circuit 1040a, which provides the power to the sensor through the power line 1076a. The signal line 1072a provides a physiological signal from the sensor to the decoupling circuit 1040a, which provides the physiological signal to the monitor through the signal line 1062a. The ground lines 1064a and 1074a act as return paths for their respective signal and power lines 1062a, 1066a, 1072a, 1076a.


The decoupling circuit 1040a, in some implementations, includes an optocoupler 1042a and a transformer 1044a. The optocoupler 1042a receives physiological signals from the sensor line 1072a and provides the signals to the sensor line 1062a optically using, for example, a photodiode 1046a and a phototransistor 1048a. Because the signals are transmitted optically, in certain embodiments there is no electrical contact between the signal lines 1062a, 1072a. Similarly, the transformer 1044a provides power from the power line 1066a to the power line 1076a without electrical contact between the lines 1066a, 1076a. Through mutual inductance, electromagnetic energy is transferred from one winding 1050a of the transformer 1044a to another winding 1052a. Because the signals are transmitted using mutual inductance, there is no electrical contact between the power lines 1066a, 1076a.


In certain embodiments, because the power lines 1066a, 1076a and signal lines 1062a, 1072a are electrically decoupled, the ground lines 1064a, 1074a can also be electrically decoupled. As shown, a ground line 1043a of the optocoupler 1042a on the monitor side connects to the ground line 1064a, and a ground line 1053a of the optocoupler 1042a on the sensor side connects to the ground line 1074a. As a result, the risk of ground loops forming in the patient may be reduced or eliminated.


Many other configurations of the decoupling circuit 1040a may be employed. For instance, a second optocoupler 1042a may be used in place of the transformer 1044a, or a second transformer 1044a may be used in place of the optocoupler 1042a. In addition, some forms of DC-DC converters or switched mode converters may be used in place of either the optocoupler 1042a or the transformer 1044a. Alternatively, one or more optical fibers may be used.


Moreover, one or more optical fibers can be used instead of the optocoupler 1042a or the transformer 1044a. Because the optical fibers transmit optical, rather than electrical signals, using optical fibers in certain embodiments beneficially reduces the likelihood of ground loops forming in the patient. In one example embodiment, the optocoupler 1042a in FIG. 10A is replaced with an optical fiber, but the transformer 1044a is still included in the decoupling circuit 1040a. The optical fiber allows signals to be transmitted through the signal line while preventing current from passing through the signal line. In addition, if optical fibers are used for the signal lines of multiple sensors, the optical fibers can also reduce cross-talk interference among the signal lines.



FIG. 10B illustrates an embodiment of a circuit 1000B that includes a decoupling circuit 1040b. The decoupling circuit 1040b may include all the features of the decoupling circuits 240, 340, and 440 described above. For example, the decoupling circuit 1040b may be included in a medical cable assembly, such as a splitter cable, medical cable, or the like, or in a sensor assembly.


The decoupling circuit 1040b is shown decoupling a signal line 1062b connected to a monitor from a signal line 1072b connected to a sensor. In the depicted embodiment, the decoupling circuit 1040b is an analog optocoupler. The decoupling circuit 1040b includes a transmitting photodiode 1041 and two receiving photodiodes 1045a, 1045b for feedback control.


The transmitting photodiode 1041 receives physiological signals from the signal line 1072b via a feedback circuit 1057 (described below). The transmitting photodiode 1041 transmits the physiological signals to both of the receiving photodiodes 1045a, 1045b. The receiving photodiode 1045b transmits the signals it receives from the transmitting photodiode 1041 to the monitor via signal line 1062b. The receiving photodiode 1045a transmits the signals it receives to a feedback circuit 1057.


Many diodes are inherently unstable due to nonlinearity and drift characteristics of the diodes. As a result of such instability, the signal produced by the transmitting photodiode 1041 may not correspond to the signal provided by the signal line 1072b from the sensor. The receiving diode 1045a can therefore be used as a feedback diode to provide a received signal to the feedback circuit 1057.


The feedback circuit 1057 can include an amplifier or the like that adjusts its output provided to the transmitting photodiode 1041 based at least partly on a difference between the signal of the transmitting photodiode 1041 and the receiving diode 1045a. Thus, the feedback circuit 1057 can correct for errors in the transmitted signal via feedback from the feedback or receiving diode 1045a.



FIG. 10C illustrates another embodiment of a circuit 1000C that includes a decoupling circuit 1040c. The decoupling circuit 1040c may include all the features of the decoupling circuits 740, 840, and 940 described above. For example, the decoupling circuit 1040c may be included in a medical cable assembly, such as a splitter cable, medical cable, or the like, or in a sensor assembly.


The decoupling circuit 1040c is shown decoupling a power line 1066c connected to a monitor from a power line 1076c connected to a sensor. The decoupling circuit 1040c can be used together with the decoupling circuit 1040b of FIG. 10B in some embodiments. For example, the decoupling circuits 1040b, 1040c may be provided on the same circuit board. Like the decoupling circuit 1040b, the decoupling circuit 1040c uses feedback to dynamically correct or control the output of the decoupling circuit 1040c.


The decoupling circuit 1040c in the depicted embodiment is a flyback transformer having two primary windings 1050c, 1051c and one secondary winding 1052c. The primary winding 1050c receives power (VIN) from the power line 1066c. A switched mode power supply 1060 also receives power (VIN) from the power line 1066c. In an embodiment, the switched mode power supply 1060 is a DC-DC converter or the like. A switch pin 1062 of the power supply 1060 can be enabled or otherwise actuated to allow power (VIN) to cycle through the primary winding 1050c. The switch pin 1062 may cause the power to be switched according to a predetermined duty cycle. Feedback may be used, as described below, to maintain a stable or relatively stable duty cycle.


As the primary winding 1050c is being energized, the primary winding 1050c may store energy in itself and in a core 1063 of the transformer. Through inductive coupling, this energy may be released into the secondary winding 1052c and into the primary winding 1051c. The polarity of the windings 1052c, 1051c (as indicated by the dots on the windings) may be the same to facilitate the transfer of energy. Likewise, the polarity of the windings 1052c, 1051c may differ from the polarity of the winding 1050c.


Like the feedback receiving photodiode 1045a described above, the primary winding 1051c acts as a flyback winding in certain embodiments to transmit the received power as a feedback signal. A rectifier 1065 rectifies the power received from the primary winding 1051c and provides a feedback power VFB to a feedback pin 1066 of the power supply 1060. The power supply 1060 may then use the difference between the received feedback power VFB and the transmitted power VIN to adjust VIN to compensate for any error in the transmitted power. For example, the power supply 1060 can adjust the duty cycle described above based at least partly on the error, e.g., by increasing the duty cycle if the VFB is low and vice versa. This flyback operation can advantageously maintain a stable or substantially stable power duty cycle despite varying load conditions on the decoupling circuit 1040c.


The secondary winding 1050c can provide an output to a linear power supply 1070, which may rectify the received power, among other functions. The linear power supply 1070 may provide the power to the power line 1076c for transmission to the sensor.



FIGS. 11A and 11B illustrate an example splitter cable 1120. FIG. 11A depicts a side view of the splitter cable 1120 while FIG. 11B depicts a bottom view of the splitter cable 1120. The splitter cable 1120 includes a housing 1107 that includes a circuit board 1140 having a decoupling circuit, show in phantom. The housing 1107 further includes wires 1142, also shown in phantom, in communication with the circuit board 1140 and with first cable sections 1130a, 1130b and a second cable section 1122 of the splitter cable 1120. The housing 1107 is also shown connected to the second cable section 1122, which in turn connects to a connector 1121. In an embodiment, the connector 1121 is used to connect the splitter cable 1120 to a physiological monitor.


The housing 1107 of the splitter cable 1120 further connects to one of the first cable sections 1130a through a connector 1131. Another one of the first cable sections 1130b is integrally coupled to the housing 1107 of the splitter cable 1120 in the depicted embodiment. In one implementation, the splitter cable 1120 and the cable 1130b are used to obtain physiological information from a single sensor, and the cable 1130a may be added to the splitter cable 1120 to obtain physiological information from an additional sensor. It should be noted that in an alternative embodiment, the first cable section 1130b is not integrally attached to the housing 1107 but instead attaches to the housing using a second connector. Or, both of the first cable sections 1130 could be integral to the housing 1107.


The circuit board 1140 interfaces with both first cable sections 1130a, 1130b and with the second cable section 1122. The circuit board 1140 may include, for example, one or more integrated circuits or discrete circuit components that together are implemented as a decoupling circuit. In addition, the circuit board 1140 can include one or more information elements for storing various forms of data.


Turning to FIG. 12, additional embodiments of cable assemblies 1230 will be described. As explained above with respect to FIG. 1, cable assemblies having two separate cables may be provided in some embodiments. These separate cables can include a sensor cable 1212 and an instrument cable 1214. In one embodiment, the sensor cable 1212 is a short, lightweight cable, adapted to facilitate comfortable attachment of sensors to a medical patient. In certain embodiments, the instrument cable 1214 is a heavier, sturdier cable, acting as a durable interface between the sensor cable 1212 and a monitor. Sensor cables 1212 and instrument cables 1214 may be periodically replaced. Periodic replacement is advantageous in certain embodiments for a wide variety of reasons. For example, the cable can become soiled or damaged, causing cable failure, inaccurate results, or patient cross-contamination.


In addition, one or more decoupling circuits or information elements (see FIGS. 3 and 15) may be incorporated into the cable assembly 1230 in certain embodiments. The information elements may store cable management information related to usage of the cable assembly and devices connected to the cable assembly. The information elements may also store patient context information related to patient identification and patient movement (flow) among hospital departments, thereby tracking the patient's progress throughout the hospital. Examples of patient context information are described more fully in U.S. patent application Ser. No. 11/633,656, titled “Physiological Alarm Notification System,” filed Dec. 4, 2006, which is hereby incorporated by reference in its entirety. Moreover, the information elements can store physiological information in some implementations. The information elements may further store calibration information related to the particular components presently attached to the system. For example, each information element may store information related to behavioral characteristics of the stage to which it is attached (e.g., a sensor, cable, etc.). The monitoring device may use such information to automatically calibrate a multi-stage sensor path, for example. Example calibration information is described herein, with respect to FIGS. 2 through 6, for example.


Referring again to FIG. 12, a sensor cable 1212 is shown connected to a sensor assembly 1250. The sensor cable 1212 may include a flexible cable section 1232 having an elongated shape, a connector 1251 for interfacing with a sensor assembly 1250, and a connector 1237 for interfacing with an instrument cable 1214. The flexible nature of the cable section 1232 in one embodiment is provided to enable greater patient comfort, as the patient can move more easily with a flexible sensor cable 1212 attached.


The depicted example instrument cable 1214 includes a stiff or relatively rigid, durable cable section 1234 having an elongated shape, a connector 1235 for interfacing with the sensor cable 1212, and a connector 1231 for interfacing with a physiological monitor. As the instrument cable 1214 of various embodiments is not connected directly to the patient, the instrument cable section 1234 may be less flexible (and more durable) than the sensor cable section 1232, thereby extending the life of the instrument cable 1214.


Decoupling circuitry and/or information elements may be included within the sensor cable 1212, the instrument cable 1214, or both. The decoupling circuits and/or information elements may be placed in any of the connectors 1237, 1251, 1235, or 1231 or in either cable section 1232, 1234. In other embodiments, one or more information elements may be included in any of the splitter cables described above. In alternative embodiments, the sensor cable 1212 can be a splitter cable.



FIG. 13 illustrates an embodiment of a physiological monitoring system 1300 which may be used in a hospital, nursing home, or other location where medical services are administered (collectively “hospital”). Certain aspects of the physiological monitoring system 1300 are described in more detail in U.S. patent application Ser. No. 11/633,656, titled “Physiological Alarm Notification System,” filed Dec. 4, 2006, which is hereby incorporated by reference in its entirety.


The physiological monitoring system 1300 of certain embodiments includes patient monitoring devices 1302. The patient monitoring devices 1302 of various embodiments include sensors 1350, one or more physiological monitors 1310, cables 1330 attaching the sensors 1350 to the monitors 1310, and a network interface module 1306 connected to one or more physiological monitors 1310. Each patient monitoring device 1302 in some embodiments is part of a network 1320 of patient monitoring devices 1302. As such, the patient monitoring devices 1302 in these embodiments can communicate physiological information and alarms over a hospital wireless network (WLAN) 1326 or the Internet 1350 to clinicians carrying end user devices 1328, 1352.


The network interface module 1302 of certain embodiments transmits physiological information on demand or in the event of an alarm to the end-user devices 1328, 1352 and/or transmits the alarm to a central nurses' station. Alternatively, the network interface module 1302 transmits information and alarms to a server 1336. The server 1336 is a computing device, such as an appliance server housed in a data closet or a workstation located at a central nurses' station. The server 1336 passes the information or alarms to the end user devices 1328, 1352 or to the central nurse's station. The alarms may be triggered when certain physiological parameters exceed safe thresholds, thereby enabling clinicians to respond rapidly to possible life-threatening situations. Situations giving rise to an alarm might include, for example, decreased heart rate, respiratory rate, low SpO2 levels, or any other physiological parameter in an abnormal range.


The network interface module 1302 in one embodiment also performs cable management by generating an alarm when one of the cables 1330 is nearing the end of its life. The network interface module 1302 determines whether the cable's 1330 life is close to expiring by, for example, analyzing some or all of the data described above with respect to FIG. 4. In one embodiment, if the network interface module 1302 determines that the cable life is close to expiration, the network interface module 1302 provides an expiration message as an alarm.


In one embodiment, the server 1336 receives this expiration message. The server 1336 then checks an inventory stored in a database 1338 to see if a replacement cable is available. If there is no replacement cable in the inventory, the server may forward the message to a supplier 1370 over the Internet 1350 (or through a WAN, leased line or the like). In an embodiment, the server 1336 transmits an email message to a supplier 1370 that indicates the cable location, cable condition, and/or other cable usage data. The supplier 1370 in one embodiment is a cable seller. Upon receiving the message, the supplier 1370 may automatically ship a new cable to the hospital. Consequently, cable 1330 inventories are able to be maintained with minimal or no user intervention in this implementation, and cables 1330 may be replaced preemptively, before cable failure.


In additional embodiments, the network interface module 1306 may monitor sensor utilization, such as the number of sensors used during the patient's stay, the types of sensors, and the length of time in use before replacement. Such data can be used by the hospital to preemptively plan restocking and set department par inventory levels. In addition, a supplier can use this data to restock the hospital or implement a just in time inventory control program. Moreover, such information can be used by the supplier to improve overall cable reliability and for the hospital to better plan and manage consumables.


The network interface module 1306 of various implementations also performs context management. In one embodiment, context management includes associating context information with physiological information to form a contextual data package. As described above, context information may include patient identification data and patient flow data. In addition, context information may include context information related to usage of the network interface module 1306 and context information related to the network. For example, this additional context information may include an identification number of the network interface module 1306, time stamps for events occurring in the physiological monitoring system 1300, environmental conditions such as changes to the state of the network and usage statistics of the network interface module 1306, and identification information corresponding to the network (e.g., whether the network connection is WiFi or Ethernet).


The network interface module 1306 receives context information in one embodiment by a nurse entering the information in the network interface module 1306 or from the server 1336. The network interface module 1306 transmits or communicates the contextual data package to clinicians during an alarm, upon clinician request, or on a scheduled basis. In addition, the network interface module 1306 may transmit a continuous stream of context information to clinicians.


The server 1336 receives contextual data packages from a plurality of network interface modules 1306 and stores the contextual data package in a storage device 1338. In certain embodiments, this storage device 1338 therefore archives long-term patient data. This patient data may be maintained even after the patient is discharged. Thus, context information may be stored for later analysis to, for example, develop patient care metrics and improve hospital operations. The patient data could be deleted after the care metrics are developed to protect patient privacy.


Although the functions of cable management and context management have been described as being performed by the network interface module 1306, in certain embodiments, some or all of these functions are instead performed by the physiological monitor 1310. In addition, the physiological monitor 1310 and the network interface module 1306 may both perform cable management and/or context management functions.



FIG. 14 illustrates an embodiment of a usage tracking method 1400 for tracking the life of a medical cable. In one implementation, the usage tracking method 1400 is performed by the network interface module and/or one of the physiological monitors described above. More generally, the usage tracking method 1400 may be implemented by a machine having one or more processors. Advantageously, in certain embodiments, the usage tracking method 1400 facilitates replacing a cable prior to failure of that cable.


The usage tracking method 1400 begins by obtaining sensor parameters from a sensor at block 1402. At block 1404, cable usage information stored in an information element is tracked. The cable usage information can be tracked by at the same time or substantially the same time as obtaining sensor parameters from the sensor. Alternatively, the cable usage information may be tracked by determining cable usage at the start or end of monitoring (e.g., obtaining sensor parameters), or periodically throughout monitoring. In addition, the cable usage information may be tracked even if the block 1402 were not performed, e.g., when the monitor is not currently obtaining parameters from the sensor.


At decision block 1406, it is determined whether the cable's life is close to expiring (or whether the cable has in fact expired). This determination may be made using the data described above with respect to FIG. 4. In addition, the this determination may be made using sensor life functions applied analogously to the life of the cable.


If it is determined that the cable life is close to expiration (or has expired), an expiration message is provided at block 1408. In one embodiment, this message is provided as an alarm on the monitor or at a central nurses' station. The message may also be provided to a clinician's end user device, which may be located in the hospital or at a remote location. Moreover, the message may be provided to a server, which forwards the message to a supplier, which ships a new cable. In an embodiment, the message is an email that indicates the cable location, cable condition, and/or other cable usage data. If, however, it is determined that the cable life is not close to expiration (or is not expired), the usage tracking method 1400 loops back to block 1402 to continue monitoring. In effect, the usage tracking method 1400 may continue monitoring and/or tracking cable usage information until the cable is close to expiration or has expired.



FIG. 15 illustrates an embodiment of a cable inventory method 1500 for controlling cable inventory. The cable inventory method 1500 may be performed by a server, such as the server 1038 described above. More generally, the cable inventory method 1500 may be implemented by a machine having one or more processors. In one embodiment, the method 1500 is performed in response to the method 1400 providing an expiration message at step 1408.


At block 1502, an expiration message is received from a monitor, indicating that a cable is close to expiration or has expired. At block 1504, an inventory is checked for a replacement cable. This inventory may be a hospital inventory, a record of which may be maintained in a hospital database or the like.


If it is determined at decision block 1506 that there is no replacement cable in the inventory, a new cable is ordered automatically to order a at block 1508. In an embodiment, this block 1508 is performed by electronically contacting a supplier to order the cable, for example, by sending a request over a network such as the Internet. Consequently, in certain embodiments, the cable inventory method 1500 enables the cable to be replaced preemptively, before cable failure. If, however, there is a replacement cable in inventory, the cable inventory method 1500 ends. However, in alternative embodiments, the cable inventory method 1500 orders a replacement cable regardless of the inventory, such that a predetermined level of cable inventory is maintained.


In additional embodiments, the cable inventory method 1500 may monitor sensor utilization, such as the number of sensors used during the patient's stay, the types of sensors, and the length of time in use before replacement. Such data can be used by the hospital to preemptively plan restocking and set department par inventory levels. In addition, a supplier can use this data to restock the hospital or implement a just-in-time program. Moreover, such information can be used by the supplier to improve overall cable reliability, and for the hospital to better plan and manage consumables.



FIG. 16 illustrates an example context management method 1600 for managing patient context. In an embodiment, the context management method 1600 is performed by a physiological monitor, such as any of the monitors described above. More generally, certain blocks of the context management method 1600 may be implemented by a machine having one or more processors. The context management method 1600, in certain embodiments, advantageously enables a patient to be assigned a cable with a unique identifier upon the first connection of the cable to the patient or to a monitor.


At block 1600, a cable is connected to a monitor, for example, by a clinician such as a nurse. Thereafter, a temporary patient ID is assigned to the cable at block 1604. The temporary ID may be automatically assigned when power is provided to the information element in the cable, or a prompt may be provided to a clinician, who then assigns the ID. In addition, the temporary ID may also be previous stored on the cable. The temporary patient ID enables the cable to be identified as uniquely relating to the patient, prior to the patient's identification information being provided to the cable. The temporary patient ID may be stored in the information element of the cable.


At block 1606, patient flow data is stored in the information element. The patient flow data may include flow data described above with respect to FIG. 4. For example, the patient flow data may include information regarding connected devices, a department ID associated with the cable, and time spent by the cable in a department. By storing patient flow data, the context management method 1600 can enable the flow of the patient may be monitored upon connection of the cable to a monitor. Thus, even if the nurse neglects to identify the cable with the patient, the cable can have data indicating when it is being used on the same or a different patient.


At decision block 1608 it is determined whether a real patient ID has been provided. If so, then the temporary ID is replaced with the real patient ID at block 1610. The real patient ID may include any of the patient identification information described above, with respect to FIG. 4. If, however, it is determined that a real patient ID has not been provided, the context management method 1600 loops back to block 1606 to continue storing patient flow data in the information element.



FIG. 17 illustrates another example context management method 1700 for managing patient context. In an embodiment, the context management method 1700 is performed by one or more monitors, such as any of the monitors described above. More generally, certain blocks of the context management method 1700 may be implemented by a machine having one or more processors.


At block 1702, a cable is connected to a monitor. In one embodiment, this block is performed by a clinician, such as a nurse. Patient flow data is then stored in an information element at block 1704. The patient flow data may include the flow data described above with respect to FIG. 4.


At decision block 1706, it is determined whether the cable has been connected to a new monitor. If it has, patient flow data is transferred from the cable to the new monitor at block 1708. In an embodiment, the new monitor determines whether the cable has been connected to the new monitor. Alternatively, the cable makes this determination. Transferring the patient flow data to the new monitor provides, in certain embodiments, the advantage of enabling the monitor to know where the patient has been in the hospital and for how long. If a new monitor has not been connected, the context management method 1700 ends.



FIG. 18 illustrates a front elevation view of an embodiment of a coextruded cable 1800. The coextruded cable 1800 can be used as a cable or cable section in place of any of the cables mentioned herein. The coextruded cable 1800 can advantageously reduce noise due to a triboelectric effect.


Noise can adversely affect acoustic signals detected by any of the acoustic sensors described herein by corrupting a waveform detected by an acoustic or other sensor. Once source of noise is triboelectric noise, which can be present when a cable is squeezed, bringing conductors in the cable closer together. The closer the conductors are, the greater a capacitance can form between the conductors and/or between the conductors and shielding. This capacitance can be a source of triboelectric noise.


The example coextruded cable 1800 shown includes features that can reduce the amount of triboelectric noise generated by squeezing, rubbing, or other touching of the cable 1800. The cable 1800 includes an outer jacket 1810, which encompasses an outer shielding layer 1812. The outer shielding layer 1812 can reduce ambient noise from reaching conductors 1820 that extend through the cable 1800. Insulation 1822 surrounds each conductor 1820.


For ease of illustration, the coextruded cable 1800 is shown having two conductors 1820. However, the features of the coextruded cable 1800 can be extended to more than two conductors in certain embodiments. For example, more than two conductors can be surrounded by the insulation 1822, or each of two or more conductors can be individually surrounded by insulation. Further, a group of acoustic sensor-related conductors can be surrounded by insulation, and a group of optical sensor-related conductors can be surrounded by separate insulation.


Although not shown, the insulation 1822 can be shielded as well. Thus, in one embodiment, some or all acoustic sensor-related conductors can be shielded by a separate, inner shielding layer from the outer shielding layer 1812. Similarly, some or all optical sensor-related conductors can be shielding by a separate, inner shielding layer from the outer shielding layer 1812. One or both of the acoustic and optical sensor-related sets of conductors can include their own inner layer of shielding to reduce crosstalk between the acoustic and optical sensor-related conductors. Reducing crosstalk can be particularly beneficial for reducing noise on a communications line or lines in the cable 1800 (such as the serial transmission line 340 of FIGS. 3A, 3B).


Filling or substantially filling the space between the insulation 1822 and the shielding layer 1812 is a coextruded material 1830. The coextruded material 1830 can be conductive PVC or the like that reduces space between the conductors 1820, so that the cable 1800 does not compress the conductors 1822 together as easily. The cable 1800 can still be flexible or relatively flexible, however. Because the cable 1800 may compress less than other cables, less triboelectric noise may be generated. In addition, the conductive property of the conductive material 1830 can dissipate charge that builds up from the triboelectric capacitance occurring between the conductors 1820 and/or between the conductors 1820 and the shielding 1812. This dissipative property of the material 1830 can further reduce noise.


Moreover, in certain embodiments, the outer jacket 1810 of the cable 1800 can be coated or can be composed of a glossy material that has a reduced coefficient of friction. Accordingly, materials that rub, brush against, or otherwise contact the outer jacket 1810 can slide smoothly off, thereby further reducing triboelectric noise.


Many other configurations of the cable 1800 are possible. For example, in one embodiment, the cable 1600 can include a flexible or “flex” circuit having conductive traces disposed on a substrate. Acoustic and/or optical sensor-related conductors can be disposed in the flex circuit (or in separate flex circuits). Further, the decoupling circuitry described above can also be included in the flex circuit or circuits. The flex circuit can be used as a sensor cable (see above), an instrument cable (see above), as a hub cable (see below), portions of the same, or any combination of the same. Some examples of flex circuits that can be employed with any of the sensors, circuits, and cables described herein are described in U.S. Pat. No. 6,986,764, filed May 2, 2002, titled “Flex Circuit Shielded Optical Sensor,” and U.S. Pat. No. 7,377,794, filed Mar. 1, 2006, titled “Multiple Wavelength Sensor Interconnect,” the disclosures of which are both hereby incorporated by reference in their entirety.



FIG. 19 illustrates example internal components of an example hub 1920 or splitter cable. The hub 1920 shown is an example implementation of the hub 220 of FIG. 2 and can be used in place of any of the splitter cables described herein. Advantageously, in certain embodiments, the hub 1920 includes localized shielding 1942 to reduce the effects of electromagnetic noise on one or more physiological signals.


The hub 1920 includes connectors 1910, 1912 that connect to sensor or patient cables (see, e.g., FIG. 2). For purposes of illustration, the connector 1910 can be connected to an optical sensor via a cable, and the connector 1912 can be connected to an acoustic sensor via a cable. Other physiological sensors can be connected via cables to the connectors 1910, 1912.


The connectors 1910, 1912 can be soldered to a printed circuit board (PCB) 1930 housed within the hub 1920. The PCB 1930 includes front-end signal conditioning circuitry 1940, 1950, which can filter and condition optical signals and acoustic signals, respectively. The optical signal conditioning circuitry 1940 is disposed on a first area 1931 of the PCB 1930, and the acoustic signal conditioning circuitry 1950 is disposed on a second area 1932 of the PCB 1930. An electrical decoupling region 1933, which may be a nonconductive portion of the PCB 1930, separates the two areas 1931, 1932 of the PCB 1930 electrically. In other embodiments, the two areas 1931, 1932 are separate PCBs. For example, one of the areas 1931, 1932 can be a daughter board attachable to the other area. Decoupling circuitry 1956 electrically decouples the two areas 1931, 1932. The decoupling circuitry 1956 can include any of the decoupling features described above. For example, the decoupling circuitry 1956 can include a transformer 1954 for decoupling power signals and an optocoupler 1952 for decoupling physiological signals. The decoupling circuitry 1956 is shown coupled to the acoustic signal conditioning circuitry 1950 in the depicted embodiment. In other embodiments, the decoupling circuitry 1956 is coupled with the optical signal conditioning circuitry 1940. Decoupling circuitry can also be applied separately to both the optical and acoustic signal conditioning circuitry 1940, 1950.


Due to regulations on winding insulation, to increase power efficiency of the transformer 1954, and possibly other factors, the transformer 1954 can be physically large relative to the size of other components in the hub 1920. As a result, the hub 1920 can be relatively large. The size of the hub 1920 can be reduced in certain embodiments by incorporating the decoupling circuitry in a patient monitor (not shown) attached to the hub 1920. However, if the hub 1920 is used with existing monitors that do not have decoupling circuitry, there may be little or no available space inside the monitor to fit a power-efficient transformer 1954. Thus, including the transformer 1954 in the hub 1920 can be advantageous to avoid making expensive modifications to an existing patient monitor.


A schematic view of a cable 1922 is also shown. The cable 1922 is attached to the hub 1920. The cable 1922 can be permanently attached to the hub 1920 or can be selectively detachable from the hub 1920. The cable 1922 includes various example conductors 1961, 1965, 1967, and 1969 in the depicted embodiment. Certain of the conductors 1961, 1965, 1967, and 1969 can be used for power transmission, signal acquisition, and grounding, among other potential uses.


One of the conductors 1969 is shown as a first ground (G1) and is electrically coupled with the optical signal conditioning circuitry 1940. Another of the conductors 1961 is shown as a second ground (G2) and is electrically coupled with the decoupling circuit 1952 (and, optionally, the decoupling circuit 1954 as well). The first and second grounds 1969, 1961 are therefore separated for optical and acoustic signals, respectively, in the depicted embodiment. Providing separate ground lines for the optical and acoustic signals can beneficially reduce crosstalk between these signals. The ground lines 1969, 1961 can be connected together at the end of the cable 1922 (e.g., in a monitor connector) or in a patient monitor (e.g., on a processing board).


To reduce noise, various components of the hub 1920 (e.g., including the PCB 1930) can be enclosed in an electromagnetic shield. The electromagnetic shield can be tied to ground conductors in the hub 1920, including the conductors 1961, 1969, and ground conductors in the acoustic signal conditioning circuitry 1950. However, doing so can cause the ground lines 1961, 1969 to come in electrical communication with both electrically-decoupled areas 1931, 1932 of the PCB 1930. As a result, patient isolation or decoupling would be broken, causing potentially unsafe conditions.


Advantageously, in certain embodiments, shielding can be provided locally within the hub 1920 instead of over all or substantially all of the components in the hub 1920. For instance, a local shield can enclose or at least partially enclose the acoustic circuitry 1950 and/or connector 1912. Alternatively, a local shield can enclose or at least partially enclose the optical circuitry 1940 and/or connector 1910. Advantageously, in certain embodiments, substantial noise-reduction benefit can be achieved by locally shielding one of the optical and acoustic circuitry 1940, 1950 with a local shield 1942. The local shield 1942 can beneficially shield solder joints of the connector 1910 and/or components 1940 as well. The shield can include a metal box, grate, perforated box, conductive glass, combinations of the same, or the like.


In other embodiments, a first local shield is disposed about the optical circuitry 1940 and a second local shield is disposed about the acoustic circuitry 1950. Each of these shields can be tied to different grounds or common potentials by virtue of the decoupling circuitry 1952, 1954.


Although the hub 1920 is illustrated with respect to optic and acoustic signals, more generally, the hub 1920 can interface with any type of physiological signals. Further, some or all of the features of the hub 1920 can be used in certain applications outside of the medical field where cables are joined together in a single hub. Moreover, the features of the hub 1920 can be extended to more than two sensor cables. Such a hub can optionally include decoupling circuitry for some or all of the sensor cables that interface with the hub.


In some embodiments, one or more of the steps are performed substantially in parallel, in an overlapping manner, or in another order. For example, some of the calibration information may change during operation (e.g., due to changes in operating temperatures and the like). In such situations, the process 1900 can periodically or continually perform steps 1904 and 1906 to obtain, and automatically adjust to, the most up to date calibration information, providing improved calibration and measurement accuracy. The process 1900 may further continually or periodically perform step 1902 (e.g., during processing), thereby detecting sensor path disconnection or changes during use.


Those of skill in the art will understand that information and signals can be represented using any of a variety of different technologies and techniques. For example, data, instructions, commands, information, signals, bits, symbols, and chips that can be referenced throughout the above description can be represented by voltages, currents, electromagnetic waves, magnetic fields or particles, optical fields or particles, or any combination thereof.


Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or states. Thus, such conditional language is not generally intended to imply that features, elements and/or states are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or states are included or are to be performed in any particular embodiment.


Depending on the embodiment, certain acts, events, or functions of any of the methods described herein can be performed in a different sequence, can be added, merged, or left out all together (e.g., not all described acts or events are necessary for the practice of the method). Moreover, in certain embodiments, acts or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors or processor cores, rather than sequentially.


Those of skill will further appreciate that the various illustrative logical blocks, modules, circuits, and algorithm steps described in connection with the embodiments disclosed herein may be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, circuits, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. Skilled artisans can implement the described functionality in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of this disclosure.


The various illustrative logical blocks, modules, and circuits described in connection with the embodiments disclosed herein can be implemented or performed with a machine, such as a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor can be a microprocessor, processor, controller, microcontroller, state machine, etc. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. In addition, the term “processing” is a broad term meant to encompass several meanings including, for example, implementing program code, executing instructions, manipulating signals, filtering, performing arithmetic operations, and the like.


The steps of a method or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, a DVD, or any other form of storage medium known in the art. A computer-readable storage medium is coupled to the processor such that the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium may be integral to the processor. The processor and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor and the storage medium can reside as discrete components in a user terminal.


The modules can include, but are not limited to, any of the following: software or hardware components such as software object-oriented software components, class components and task components, processes, methods, functions, attributes, procedures, subroutines, segments of program code, drivers, firmware, microcode, circuitry, data, databases, data structures, tables, arrays, and/or variables.


In addition, although certain inventions have been disclosed in the context of certain embodiments, it will be understood by those skilled in the art that the inventions disclosed herein extend beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the inventions and obvious modifications and equivalents thereof. In particular, while the system and methods have been described in the context of certain embodiments, the skilled artisan will appreciate, in view of the present disclosure, that certain advantages, features and aspects of the acoustic signal processing system, device, and method may be realized in a variety of other applications and software systems. Additionally, it is contemplated that various aspects and features of the inventions disclosed herein can be practiced separately, combined together, or substituted for one another, and that a variety of combination and subcombinations of the features and aspects can be made and still fall within the scope of the inventions disclosed herein. Furthermore, the systems described above need not include all of the modules and functions described in certain embodiments. Thus, it is intended that the scope of the inventions disclosed herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by the claims that follow.

Claims
  • 1. A multi-stage physiological monitoring system comprising: a first stage comprising a physiological sensor and a sensor cable, wherein the sensor cable comprises a first connector;a second stage comprising an instrument cable, wherein the instrument cable comprises at least a second connector configured to removably couple with the first connector of the sensor cable, and wherein the second connector comprises preamplification circuitry; anda third stage comprising a splitter cable, wherein the splitter cable comprises: a monitor connector configured to removably connect to a sensor port of a monitor;at least first and second sensor connectors each configured to separately and simultaneously removably connect to respective sensor cables and/or instrument cables, wherein at least one of the first or second sensor connectors is configured to removably connect to the second stage; andone or more decoupling circuits configured to electrically decouple, from each other, physiological sensors connected, via sensor cables and/or instrument cables, to the at least first and second sensor connectors.
  • 2. The multi-stage physiological monitoring system of claim 1 further comprising: a monitor comprising: a sensor port configured to removably connect to the monitor connector of the splitter cable; andone or more hardware processors configured to: receive, via the sensor port, at least a signal indicative of physiological information associated with a patient; anddetermine a physiological parameter of the patient based on the signal.
  • 3. The multi-stage physiological monitoring system of claim 1 further comprising: electronic memories provided in each of at least the first stage and the second stage, wherein the electronic memories store calibration information.
  • 4. The multi-stage physiological monitoring system of claim 3, wherein the calibration information includes at least a first characteristic associated with the first stage and a second characteristic associated with the second stage.
  • 5. The multi-stage physiological monitoring system of claim 3 further comprising: a monitor comprising: a sensor port configured to removably connect to a monitor connector of the instrument cable; andone or more hardware processors configured to: receive, via the sensor port, one or more signals including at least a signal indicative of physiological information associated with a patient and a signal including calibration information;adjust one or more signal processing parameters of a signal processing algorithm of the one or more hardware processors, based on the calibration information, to compensate for variations in components of one or more stages of the multi-stage physiological monitoring system;based on the adjusted one or more signal processing parameters, generate a modified version of the signal indicative of physiological information associated with the patient; anddetermine a physiological parameter of the patient based on the modified version of the signal.
  • 6. The multi-stage physiological monitoring system of claim 5, wherein the monitor further comprises: a front end processor configured to condition the received signal for processing by said one or more hardware processors, wherein said one or more hardware processors are further configured to adjust the one or more signal processing parameters of the signal processor based on calibration information associated with the front end processor.
  • 7. The multi-stage physiological monitoring system of claim 5, wherein adjusting the one or more signal processing parameters comprises calculating, based on a first characteristic associated with the first stage, and a second characteristic associated with the second stage, an inverse of a transfer function associated with each of at least the first stage and the second stage.
  • 8. The multi-stage physiological monitoring system of claim 7, wherein generating a modified version of the signal comprises applying the inverse transfer function to the signal.
  • 9. The multi-stage physiological monitoring system of claim 5, wherein the one or more hardware processors are further configured to automatically adjust the one or more signal processing parameters when a stage of the multi-stage physiological monitoring system is replaced.
  • 10. The multi-stage physiological monitoring system of claim 3, wherein the calibration information includes a cut-off frequency associated with at least one of the first stage or the second stage.
  • 11. The multi-stage physiological monitoring system of claim 3, wherein the calibration information includes a cut-off frequency associated with each of the first stage and the second stage.
  • 12. The multi-stage physiological monitoring system of claim 3, wherein the calibration information includes process variable characteristics associated with at least one of the first stage or the second stage.
  • 13. The multi-stage physiological monitoring system of claim 3, wherein the calibration information includes a design variable characteristic associated with at least one of the first stage or the second stage.
  • 14. The multi-stage physiological monitoring system of claim 3, wherein the calibration information includes at least one of a sensitivity, a mechanical cut-in frequency, a mechanical cut-off frequency, a capacitance, a gain, an input impedance, an output impedance, a minimum saturation level, a resistance, a linear curve, a non-linear curve, a response, or a transfer function.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/911,770, filed Jun. 25, 2020, and titled “CALIBRATION FOR MULTI-STAGE PHYSIOLOGICAL MONITORS,” which application is a continuation of U.S. patent application Ser. No. 14/321,638, filed Jul. 1, 2014, and titled “Calibration For Multi-Stage Physiological Monitors,” which application is a continuation of U.S. patent application Ser. No. 12/960,325, filed Dec. 3, 2010, and titled “Calibration For Multi-Stage Physiological Monitors,” which application claims priority from U.S. Provisional Patent Application No. 61/266,984, filed Dec. 4, 2009, and titled “Automatic Calibration for Multi-Stage Physiological Monitors.” The disclosures of all of the above-referenced applications are hereby incorporated by reference herein in their entireties and for all purposes. Additionally, this application relates to the following U.S. patent applications, the disclosures of which are incorporated in their entirety by reference herein: FilingApp. No.DateTitle60/893853Mar. 08, 2007MULTI-PARAMETERPHYSIOLOGICAL MONITOR60/893850Mar. 08, 2007BACKWARD COMPATIBLEPHYSIOLOGICAL SENSOR WITHINFORMATION ELEMENT60/893858Mar. 08, 2007MULTI-PARAMETER SENSOR FOR PHYSIOLOGICALMONITORING60/893856Mar. 08, 2007PHYSIOLOGICAL MONITORWITH FAST GAIN ADJUSTDATA ACQUISITION12/044883Mar. 08, 2008SYSTEMS AND METHODS FOR DETERMINING A PHYSIOLOGICALbCONDITIONUSING AN ACOUSTICMONITOR61/252083Oct. 15, 2009DISPLAYING PHYSIOLOGICALINFORMATION12/904836Oct. 14, 2010BIDIRECTIONAL PHYSIOLOGICALINFORMATION DISPLAY12/904823Oct. 14, 2010BIDIRECTIONAL PHYSIOLOGICALINFORMATION DISPLAY61/141584Dec. 30, 2008ACOUSTIC SENSOR ASSEMBLY61/252076Oct. 15, 2009ACOUSTIC SENSOR ASSEMBLY12/643939Dec. 21, 2009ACOUSTIC SENSOR ASSEMBLY61/313645Mar. 12, 2010ACOUSTIC RESPIRATORYMONITORING SENSOR HAVINGMULTIPLE SENSING ELEMENTS12/904931Oct. 14, 2010ACOUSTIC RESPIRATORYMONITORING SENSOR HAVINGMULTIPLE SENSING ELEMENTS12/904890Oct. 14, 2010ACOUSTIC RESPIRATORYMONITORING SENSOR HAVINGMULTIPLE SENSING ELEMENTS12/904938Oct. 14, 2010ACOUSTIC RESPIRATORYMONITORING SENSOR HAVINGMULTIPLE SENSING ELEMENTS12/904907Oct. 14, 2010ACOUSTIC PATIENT SENSOR61/252062Oct. 15, 2009PULSE OXIMETRY SYSTEM WITH LOW NOISE CABLE HUB61/265730Dec. 01, 2009PULSE OXIMETRY SYSTEMWITH ACOUSTIC SENSOR12/904775Oct. 14, 2010PULSE OXIMETRY SYSTEMWITH LOW NOISE CABLE HUB12/905036Oct. 14, 2010PHYSIOLOGICAL ACOUSTICMONITORING SYSTEM61/331087May 04, 2010ACOUSTIC RESPIRATION 61/391098Oct. 08, 2010DISPLAY ACOUSTIC MONITOR

US Referenced Citations (1951)
Number Name Date Kind
3316395 Lavin Apr 1967 A
3316396 Trott et al. Apr 1967 A
3682161 Alibert Aug 1972 A
3699389 Holsinger Oct 1972 A
3808502 Babilius Apr 1974 A
3910701 Henderson et al. Oct 1975 A
3951230 Littmann Apr 1976 A
3998550 Konishi et al. Dec 1976 A
4014321 March Mar 1977 A
4051522 Healy et al. Sep 1977 A
4127749 Atoji et al. Nov 1978 A
4134678 Brown et al. Jan 1979 A
4157708 Imura Jun 1979 A
4163290 Sutherlin et al. Jul 1979 A
4167331 Nielsen Sep 1979 A
4266554 Hamaguri May 1981 A
4267844 Yamanishi May 1981 A
4295475 Torzala Oct 1981 A
4305059 Benton Dec 1981 A
4326143 Guth et al. Apr 1982 A
4331161 Patel May 1982 A
4399824 Davidson Aug 1983 A
4446871 Imura May 1984 A
4491725 Pritchard Jan 1985 A
4531527 Reinhold, Jr. et al. Jul 1985 A
4537200 Widrow Aug 1985 A
4561440 Kubo et al. Dec 1985 A
4578613 Posthuma de Boer et al. Mar 1986 A
4586513 Hamaguri May 1986 A
4603700 Nichols et al. Aug 1986 A
4621643 New, Jr. et al. Nov 1986 A
4634917 Dvorsky et al. Jan 1987 A
4653498 New, Jr. et al. Mar 1987 A
4655225 Dahne et al. Apr 1987 A
4669475 Turner Jun 1987 A
4685464 Goldberger et al. Aug 1987 A
4694833 Hamaguri Sep 1987 A
4695955 Faisandier Sep 1987 A
4700708 New, Jr. et al. Oct 1987 A
4714341 Hamaguri et al. Dec 1987 A
4770179 New, Jr. et al. Sep 1988 A
4773422 Isaacson et al. Sep 1988 A
4781195 Martin Nov 1988 A
4800885 Johnson Jan 1989 A
4805623 Jobsis Feb 1989 A
4822997 Fuller et al. Apr 1989 A
4827943 Bornn et al. May 1989 A
4832484 Aoyagi et al. May 1989 A
4846183 Martin Jul 1989 A
4854328 Pollack Aug 1989 A
4863265 Flower et al. Sep 1989 A
4867571 Frick et al. Sep 1989 A
4868476 Respaut Sep 1989 A
4869254 Stone et al. Sep 1989 A
4884809 Rowan Dec 1989 A
4890306 Noda Dec 1989 A
4907876 Suzuki et al. Mar 1990 A
4911167 Corenman et al. Mar 1990 A
4924846 Peacock et al. May 1990 A
4928692 Goodman et al. May 1990 A
4934372 Coenman et al. Jun 1990 A
4938218 Goodman et al. Jul 1990 A
4942877 Sakai et al. Jul 1990 A
4955379 Hall Sep 1990 A
4960126 Conlon et al. Oct 1990 A
4960128 Gordon et al. Oct 1990 A
4964010 Miyasaka et al. Oct 1990 A
4964408 Hink et al. Oct 1990 A
4967571 Sporri Nov 1990 A
4975581 Robinson et al. Dec 1990 A
4975647 Downer et al. Dec 1990 A
4982738 Griebel Jan 1991 A
4986665 Yamanishi et al. Jan 1991 A
4995402 Smith et al. Feb 1991 A
4996975 Nakamura Mar 1991 A
4997769 Lundsgaard Mar 1991 A
5003979 Merickel et al. Apr 1991 A
5025791 Niwa Jun 1991 A
RE33643 Isaacson et al. Jul 1991 E
5027825 Phelps, Sr. et al. Jul 1991 A
5028787 Rosenthal et al. Jul 1991 A
5033032 Houghtaling Jul 1991 A
5033472 Sato et al. Jul 1991 A
5033474 Varelis Jul 1991 A
5035247 Heimann Jul 1991 A
5041187 Hink et al. Aug 1991 A
5054495 Uemura et al. Oct 1991 A
5058588 Kaestle Oct 1991 A
5069213 Hink et al. Dec 1991 A
5077476 Rosenthal Dec 1991 A
5078136 Stone et al. Jan 1992 A
5086776 Fowler, Jr. et al. Feb 1992 A
5101825 Gravenstein et al. Apr 1992 A
5105821 Reyes Apr 1992 A
5137023 Mendelson et al. Aug 1992 A
5143078 Mather et al. Sep 1992 A
5155697 Bunsen Oct 1992 A
5162725 Hodson et al. Nov 1992 A
5163438 Gordon et al. Nov 1992 A
5188108 Secker Feb 1993 A
5189609 Tivig et al. Feb 1993 A
5190040 Aoyagi Mar 1993 A
5203329 Takatani et al. Apr 1993 A
5209230 Swedlow et al. May 1993 A
5226053 Cho et al. Jul 1993 A
5226417 Swedlow et al. Jul 1993 A
5246002 Prosser Sep 1993 A
5247931 Norwood Sep 1993 A
5259381 Cheung et al. Nov 1993 A
5267562 Ukawa et al. Dec 1993 A
5267563 Swedlow et al. Dec 1993 A
5278627 Aoyagi et al. Jan 1994 A
5297548 Pologe Mar 1994 A
5309918 Schraag May 1994 A
5313940 Fuse et al. May 1994 A
5319355 Russek Jun 1994 A
5331549 Crawford, Jr. Jul 1994 A
5335659 Pologe Aug 1994 A
5337744 Branigan Aug 1994 A
5337745 Benaron Aug 1994 A
5341805 Stavridi et al. Aug 1994 A
5348004 Hollub Sep 1994 A
5351685 Potratz Oct 1994 A
5355129 Baumann Oct 1994 A
5355880 Thomas et al. Oct 1994 A
5355882 Ukawa et al. Oct 1994 A
5361758 Hall et al. Nov 1994 A
5368041 Shambroom Nov 1994 A
5368224 Richardson et al. Nov 1994 A
D353195 Savage et al. Dec 1994 S
D353196 Savage et al. Dec 1994 S
5370114 Wong et al. Dec 1994 A
5372136 Steuer et al. Dec 1994 A
5377302 Tsiang Dec 1994 A
5377676 Vari et al. Jan 1995 A
5383874 Jackson et al. Jan 1995 A
5385143 Aoyagi Jan 1995 A
5387122 Goldberger et al. Feb 1995 A
5392777 Swedlow et al. Feb 1995 A
5400267 Denen et al. Mar 1995 A
5413101 Sugiura May 1995 A
D359546 Savage et al. Jun 1995 S
5421329 Casciani et al. Jun 1995 A
5424545 Block et al. Jun 1995 A
5425362 Siker et al. Jun 1995 A
5425375 Chin et al. Jun 1995 A
5427093 Ogawa et al. Jun 1995 A
5429128 Cadell et al. Jul 1995 A
5431170 Mathews Jul 1995 A
5435309 Thomas et al. Jul 1995 A
5436499 Namavar et al. Jul 1995 A
D361840 Savage et al. Aug 1995 S
D362063 Savage et al. Sep 1995 S
5448996 Bellin et al. Sep 1995 A
5452717 Branigan et al. Sep 1995 A
D363120 Savage et al. Oct 1995 S
5456252 Vari et al. Oct 1995 A
5469845 DeLonzor et al. Nov 1995 A
RE35122 Corenman et al. Dec 1995 E
5479934 Imran Jan 1996 A
5482036 Diab et al. Jan 1996 A
5487386 Wakabayashi et al. Jan 1996 A
5490505 Diab et al. Feb 1996 A
5490523 Isaacson et al. Feb 1996 A
5494032 Robinson et al. Feb 1996 A
5494043 O'Sullivan et al. Feb 1996 A
5503148 Pologe et al. Apr 1996 A
5520177 Ogawa et al. May 1996 A
5528519 Ohkura et al. Jun 1996 A
5533507 Potratz Jul 1996 A
5533511 Kaspari et al. Jul 1996 A
5534851 Russek Jul 1996 A
5539831 Harley Jul 1996 A
5551423 Sugiura Sep 1996 A
5553615 Carim et al. Sep 1996 A
5555882 Richardson et al. Sep 1996 A
5561275 Savage et al. Oct 1996 A
5562002 Lalin Oct 1996 A
5575284 Athan et al. Nov 1996 A
5577500 Potratz Nov 1996 A
5584299 Sakai et al. Dec 1996 A
5588427 Tien Dec 1996 A
5590649 Caro et al. Jan 1997 A
5590652 Inai Jan 1997 A
5595176 Yamaura Jan 1997 A
5596992 Haaland et al. Jan 1997 A
5602924 Durand et al. Feb 1997 A
5603323 Pflugrath et al. Feb 1997 A
5603623 Nishikawa et al. Feb 1997 A
5615672 Braig et al. Apr 1997 A
5617857 Chader et al. Apr 1997 A
5630413 Thomas et al. May 1997 A
5632272 Diab et al. May 1997 A
5638816 Kiani-Azarbayjany et al. Jun 1997 A
5638818 Diab et al. Jun 1997 A
5645059 Fein et al. Jul 1997 A
5645060 Yorkey Jul 1997 A
5645440 Tobler et al. Jul 1997 A
5651780 Jackson et al. Jul 1997 A
5658248 Klein et al. Aug 1997 A
5660567 Nierlich et al. Aug 1997 A
5662106 Swedlow et al. Sep 1997 A
5671914 Kalkhoran et al. Sep 1997 A
5676139 Goldberger et al. Oct 1997 A
5676141 Hollub Oct 1997 A
5678544 DeLonzor et al. Oct 1997 A
5685299 Diab et al. Nov 1997 A
5685301 Klomhaus Nov 1997 A
5687719 Sato et al. Nov 1997 A
5687722 Tien et al. Nov 1997 A
5690104 Kanemoto et al. Nov 1997 A
5692503 Kunstner Dec 1997 A
5697371 Aoyagi et al. Dec 1997 A
5701894 Cherry et al. Dec 1997 A
5713355 Richardson et al. Feb 1998 A
5719589 Norman et al. Feb 1998 A
5720284 Aoyagi et al. Feb 1998 A
5720293 Quinn et al. Feb 1998 A
5724983 Selker et al. Mar 1998 A
5726440 Kalkhoran et al. Mar 1998 A
5730125 Prutchi et al. Mar 1998 A
D393830 Tobler et al. Apr 1998 S
5738106 Yamamori et al. Apr 1998 A
5742718 Harman et al. Apr 1998 A
5743262 Lepper, Jr. et al. Apr 1998 A
5743263 Baker, Jr. Apr 1998 A
5746206 Mannheimer May 1998 A
5746697 Swedlow et al. May 1998 A
5747806 Khalil et al. May 1998 A
5750994 Schlager May 1998 A
5752914 DeLonzor et al. May 1998 A
5755226 Carim et al. May 1998 A
5758644 Diab et al. Jun 1998 A
5760910 Lepper, Jr. et al. Jun 1998 A
5769785 Diab et al. Jun 1998 A
5772587 Gratton et al. Jun 1998 A
5779630 Fein et al. Jul 1998 A
5782237 Casciani et al. Jul 1998 A
5782756 Mannheimer Jul 1998 A
5782757 Diab et al. Jul 1998 A
5785659 Caro et al. Jul 1998 A
5786592 Hok Jul 1998 A
5790729 Pologe et al. Aug 1998 A
5791347 Flaherty et al. Aug 1998 A
5792052 Isaacson et al. Aug 1998 A
5793485 Gourley Aug 1998 A
5800348 Kaestle Sep 1998 A
5800349 Isaacson et al. Sep 1998 A
5803910 Potratz Sep 1998 A
5807246 Sakaguchi et al. Sep 1998 A
5807247 Merchant et al. Sep 1998 A
5810723 Aldrich Sep 1998 A
5810724 Gronvall Sep 1998 A
5810734 Caro et al. Sep 1998 A
5817010 Hibl Oct 1998 A
5818985 Merchant et al. Oct 1998 A
5819007 Elghazzawi Oct 1998 A
5823950 Diab et al. Oct 1998 A
5823952 Levinson et al. Oct 1998 A
5825895 Grasfield et al. Oct 1998 A
5827182 Raley et al. Oct 1998 A
5830121 Enomoto et al. Nov 1998 A
5830131 Caro et al. Nov 1998 A
5830137 Scharf Nov 1998 A
5833602 Osemwota Nov 1998 A
5833618 Caro et al. Nov 1998 A
5839439 Nierlich et al. Nov 1998 A
RE36000 Swedlow et al. Dec 1998 E
5842979 Jarman Dec 1998 A
5850443 Van Oorschot et al. Dec 1998 A
5851178 Aronow Dec 1998 A
5851179 Ritson et al. Dec 1998 A
5853364 Baker, Jr. et al. Dec 1998 A
5857462 Thomas et al. Jan 1999 A
5860099 Milios et al. Jan 1999 A
5860919 Kiani-Azarbayjany et al. Jan 1999 A
5865736 Baker, Jr. et al. Feb 1999 A
5876348 Sugo et al. Mar 1999 A
5885213 Richardson et al. Mar 1999 A
5890929 Mills et al. Apr 1999 A
5891022 Pologe Apr 1999 A
5891024 Jarman et al. Apr 1999 A
5900632 Sterling et al. May 1999 A
5904654 Wohltmann et al. May 1999 A
5910108 Solenberger Jun 1999 A
5916154 Hobbs et al. Jun 1999 A
5919133 Taylor et al. Jul 1999 A
5919134 Diab Jul 1999 A
5921921 Potratz et al. Jul 1999 A
5924979 Swedlow et al. Jul 1999 A
5928156 Krumbiegel et al. Jul 1999 A
5934277 Mortz Aug 1999 A
5934925 Tobler et al. Aug 1999 A
5939609 Knapp et al. Aug 1999 A
5940182 Lepper, Jr. et al. Aug 1999 A
5954644 Dettling et al. Sep 1999 A
5976466 Ratner et al. Nov 1999 A
5978691 Mills Nov 1999 A
5983122 Jarman et al. Nov 1999 A
5987343 Kinast Nov 1999 A
5991355 Dahlke Nov 1999 A
5995855 Kiani et al. Nov 1999 A
5995856 Mannheimer et al. Nov 1999 A
5995859 Takahashi Nov 1999 A
5997343 Mills et al. Dec 1999 A
5999841 Aoyagi et al. Dec 1999 A
6002952 Diab et al. Dec 1999 A
6006119 Soller et al. Dec 1999 A
6010937 Karam et al. Jan 2000 A
6011986 Diab et al. Jan 2000 A
6014576 Raley Jan 2000 A
6018673 Chin et al. Jan 2000 A
6018674 Aronow Jan 2000 A
6023541 Merchant et al. Feb 2000 A
6027452 Flaherty et al. Feb 2000 A
6029665 Berthon-Jones Feb 2000 A
6035223 Baker, Jr. Mar 2000 A
6036642 Diab et al. Mar 2000 A
6040578 Malin et al. Mar 2000 A
6045509 Caro et al. Apr 2000 A
6064898 Aldrich May 2000 A
6064910 Andersson et al. May 2000 A
6066204 Haven May 2000 A
6067462 Diab et al. May 2000 A
6068594 Schloemer et al. May 2000 A
6073037 Alam et al. Jun 2000 A
6081735 Diab et al. Jun 2000 A
6083156 Lisiecki Jul 2000 A
6083172 Baker, Jr. et al. Jul 2000 A
6088607 Diab et al. Jul 2000 A
6094592 Yorkey et al. Jul 2000 A
6104938 Huiku et al. Aug 2000 A
6106481 Cohen Aug 2000 A
6110522 Lepper, Jr. et al. Aug 2000 A
6112107 Hannula Aug 2000 A
6115673 Malin et al. Sep 2000 A
6122042 Wunderman et al. Sep 2000 A
6124597 Shehada et al. Sep 2000 A
6128521 Marro et al. Oct 2000 A
6129675 Jay Oct 2000 A
6132363 Freed et al. Oct 2000 A
6138675 Berthon-Jones Oct 2000 A
6144868 Parker Nov 2000 A
6149588 Noda et al. Nov 2000 A
6151516 Kiani-Azarbayjany et al. Nov 2000 A
6151518 Hayashi Nov 2000 A
6152754 Gerhardt et al. Nov 2000 A
6154667 Miura et al. Nov 2000 A
6157041 Thomas et al. Dec 2000 A
6157850 Diab et al. Dec 2000 A
6163715 Larsen et al. Dec 2000 A
6165005 Mills et al. Dec 2000 A
6165173 Kamdar et al. Dec 2000 A
6168568 Gavriely Jan 2001 B1
6174283 Nevo et al. Jan 2001 B1
6175752 Say et al. Jan 2001 B1
6184521 Coffin, IV et al. Feb 2001 B1
6188470 Grace Feb 2001 B1
6192261 Gratton et al. Feb 2001 B1
6206830 Diab et al. Mar 2001 B1
6226539 Potratz May 2001 B1
6229856 Diab et al. May 2001 B1
6230035 Aoyagi et al. May 2001 B1
6232609 Snyder et al. May 2001 B1
6236872 Diab et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6241683 Macklem et al. Jun 2001 B1
6248083 Smith et al. Jun 2001 B1
6253097 Aronow et al. Jun 2001 B1
6254551 Varis Jul 2001 B1
6255708 Sudharsanan et al. Jul 2001 B1
6256523 Diab et al. Jul 2001 B1
6262698 Blum Jul 2001 B1
6263222 Diab et al. Jul 2001 B1
6266551 Osadchy et al. Jul 2001 B1
6272363 Casciani et al. Aug 2001 B1
6278522 Lepper, Jr. et al. Aug 2001 B1
6280213 Tobler et al. Aug 2001 B1
6280381 Malin et al. Aug 2001 B1
6285895 Ristolainen et al. Sep 2001 B1
6285896 Tobler et al. Sep 2001 B1
6295330 Skog et al. Sep 2001 B1
6298252 Kovach et al. Oct 2001 B1
6298255 Cordero et al. Oct 2001 B1
6301493 Marro et al. Oct 2001 B1
6304675 Osbourn et al. Oct 2001 B1
6304767 Soller et al. Oct 2001 B1
6308089 von der Ruhr et al. Oct 2001 B1
6317627 Ennen et al. Nov 2001 B1
6321100 Parker Nov 2001 B1
6325761 Jay Dec 2001 B1
6330468 Scharf Dec 2001 B1
6334065 Al-Ali et al. Dec 2001 B1
6336900 Alleckson et al. Jan 2002 B1
6337798 Hailey et al. Jan 2002 B1
6339715 Bahr et al. Jan 2002 B1
6341257 Haaland Jan 2002 B1
6343224 Parker Jan 2002 B1
6349228 Kiani et al. Feb 2002 B1
6351658 Middleman et al. Feb 2002 B1
6356774 Bernstein et al. Mar 2002 B1
6360113 Dettling Mar 2002 B1
6360114 Diab et al. Mar 2002 B1
6363269 Hanna et al. Mar 2002 B1
6368283 Xu et al. Apr 2002 B1
6371921 Caro et al. Apr 2002 B1
6371923 Roteliuk et al. Apr 2002 B1
6374129 Chin et al. Apr 2002 B1
6377828 Chaiken et al. Apr 2002 B1
6377829 Al-Ali Apr 2002 B1
6388240 Schulz et al. May 2002 B2
6393310 Kuenstner May 2002 B1
6397091 Diab et al. May 2002 B2
6397092 Norris et al. May 2002 B1
6397093 Aldrich May 2002 B1
6402690 Rhee et al. Jun 2002 B1
6408198 Hanna et al. Jun 2002 B1
6411373 Garside et al. Jun 2002 B1
6411833 Baker, Jr. et al. Jun 2002 B1
6415166 Van Hoy et al. Jul 2002 B1
6415167 Blank et al. Jul 2002 B1
6415233 Haaland Jul 2002 B1
6415236 Kobayashi et al. Jul 2002 B2
6421549 Jacques Jul 2002 B1
6430437 Marro Aug 2002 B1
6430525 Weber et al. Aug 2002 B1
6434408 Heckel Aug 2002 B1
6441388 Thomas et al. Aug 2002 B1
6443907 Mansy et al. Sep 2002 B1
6453184 Hyogo et al. Sep 2002 B1
6455340 Chua et al. Sep 2002 B1
6463310 Swedlow et al. Oct 2002 B1
6463311 Diab Oct 2002 B1
6466824 Struble Oct 2002 B1
6470199 Kopotic et al. Oct 2002 B1
6480729 Stone Nov 2002 B2
6486588 Doron et al. Nov 2002 B2
6487429 Hockersmith et al. Nov 2002 B2
6490466 Fein et al. Dec 2002 B1
6490684 Fenstemaker et al. Dec 2002 B1
6491647 Bridger et al. Dec 2002 B1
6497659 Rafert Dec 2002 B1
6498942 Esenaliev et al. Dec 2002 B1
6501974 Huiku Dec 2002 B2
6501975 Diab et al. Dec 2002 B2
6504943 Sweatt et al. Jan 2003 B1
6505059 Kollias et al. Jan 2003 B1
6505060 Norris Jan 2003 B1
6505061 Larson Jan 2003 B2
6505133 Hanna et al. Jan 2003 B1
6510329 Heckel Jan 2003 B2
6515273 Al-Ali Feb 2003 B2
6517497 Rymut et al. Feb 2003 B2
6519486 Edgar, Jr. et al. Feb 2003 B1
6519487 Parker Feb 2003 B1
6520918 Stergiopoulos et al. Feb 2003 B1
6522398 Cadell et al. Feb 2003 B2
6525386 Mills et al. Feb 2003 B1
6526300 Kiani et al. Feb 2003 B1
6526301 Larsen et al. Feb 2003 B2
6528809 Thomas et al. Mar 2003 B1
6534012 Hazen et al. Mar 2003 B1
6537225 Mills Mar 2003 B1
6541756 Schulz et al. Apr 2003 B2
6542763 Yamashita et al. Apr 2003 B1
6542764 Al-Ali et al. Apr 2003 B1
6545652 Tsuji Apr 2003 B1
6546267 Sugiura et al. Apr 2003 B1
6553241 Mannheimer et al. Apr 2003 B2
6564077 Mortara May 2003 B2
6571113 Fein et al. May 2003 B1
6580086 Schulz et al. Jun 2003 B1
6582964 Samsoondar et al. Jun 2003 B1
6584336 Ali et al. Jun 2003 B1
6584413 Keenan et al. Jun 2003 B1
6587196 Stippick et al. Jul 2003 B1
6587199 Luu Jul 2003 B1
6591123 Fein et al. Jul 2003 B2
6594511 Stone et al. Jul 2003 B2
6594518 Benaron et al. Jul 2003 B1
6595316 Cybulski et al. Jul 2003 B2
6597932 Tian et al. Jul 2003 B2
6597933 Kiani et al. Jul 2003 B2
6600940 Fein et al. Jul 2003 B1
6606509 Schmitt Aug 2003 B2
6606510 Swedlow et al. Aug 2003 B2
6606511 Ali et al. Aug 2003 B1
6609016 Lynn Aug 2003 B1
6611698 Yamashita et al. Aug 2003 B1
6614521 Samsoondar et al. Sep 2003 B2
6615064 Aldrich Sep 2003 B1
6615151 Scecina et al. Sep 2003 B1
6618602 Levin Sep 2003 B2
6622095 Kobayashi et al. Sep 2003 B2
6628975 Fein et al. Sep 2003 B1
6631281 Kastle Oct 2003 B1
6632181 Flaherty et al. Oct 2003 B2
6635559 Greenwald et al. Oct 2003 B2
6639668 Trepagnier Oct 2003 B1
6640116 Diab Oct 2003 B2
6640117 Makarewicz et al. Oct 2003 B2
6643530 Diab et al. Nov 2003 B2
6645142 Braig et al. Nov 2003 B2
6647280 Bahr et al. Nov 2003 B2
6650917 Diab et al. Nov 2003 B2
6654623 Kastle Nov 2003 B1
6654624 Diab et al. Nov 2003 B2
6657717 Cadell et al. Dec 2003 B2
6658276 Kiani et al. Dec 2003 B2
6658277 Wasserman Dec 2003 B2
6661161 Lanzo et al. Dec 2003 B1
6662033 Casciani et al. Dec 2003 B2
6665551 Suzuki Dec 2003 B1
6668183 Hicks et al. Dec 2003 B2
6671526 Aoyagi et al. Dec 2003 B1
6671531 Al-Ali Dec 2003 B2
6675031 Porges et al. Jan 2004 B1
6675106 Keenan et al. Jan 2004 B1
6676600 Conero et al. Jan 2004 B1
6678543 Diab et al. Jan 2004 B2
6681126 Solenberger Jan 2004 B2
6684090 Ali et al. Jan 2004 B2
6684091 Parker Jan 2004 B2
6687620 Haaland et al. Feb 2004 B1
6690466 Miller et al. Feb 2004 B2
6694157 Stone et al. Feb 2004 B1
6697655 Sueppel et al. Feb 2004 B2
6697656 Al-Ali Feb 2004 B1
6697657 Shehada et al. Feb 2004 B1
6697658 Al-Ali Feb 2004 B2
RE38476 Diab et al. Mar 2004 E
6699194 Diab et al. Mar 2004 B1
6701170 Stetson Mar 2004 B2
6708049 Berson et al. Mar 2004 B1
6711503 Haaland Mar 2004 B2
6714803 Mortz Mar 2004 B1
6714804 Al-Ali et al. Mar 2004 B2
6714805 Jeon et al. Mar 2004 B2
RE38492 Diab et al. Apr 2004 E
6719705 Mills Apr 2004 B2
6720734 Norris Apr 2004 B2
6721582 Trepagnier et al. Apr 2004 B2
6721584 Baker, Jr. et al. Apr 2004 B2
6721585 Parker Apr 2004 B1
6725074 Kastle Apr 2004 B1
6725075 Al-Ali Apr 2004 B2
6726634 Freeman Apr 2004 B2
6728560 Kollias et al. Apr 2004 B2
6735459 Parker May 2004 B2
6738652 Mattu et al. May 2004 B2
6741875 Pawluczyk et al. May 2004 B1
6741876 Scecina et al. May 2004 B1
6743172 Blike Jun 2004 B1
6745060 Diab et al. Jun 2004 B2
6745061 Hicks et al. Jun 2004 B1
6748253 Norris et al. Jun 2004 B2
6748254 O'Neil et al. Jun 2004 B2
6754515 Pologe Jun 2004 B1
6754516 Mannheimer Jun 2004 B2
6760607 Al-Ali Jul 2004 B2
6760609 Jacques Jul 2004 B2
6766038 Sakuma et al. Jul 2004 B1
6770028 Ali et al. Aug 2004 B1
6771994 Kiani et al. Aug 2004 B2
6773397 Kelly Aug 2004 B2
6778923 Norris et al. Aug 2004 B2
6780158 Yarita Aug 2004 B2
6788849 Pawluczyk Sep 2004 B1
6788965 Ruchti et al. Sep 2004 B2
6792300 Diab et al. Sep 2004 B1
6800373 Gorczyca Oct 2004 B2
6801797 Mannheimer et al. Oct 2004 B2
6801799 Mendelson Oct 2004 B2
6810277 Edgar, Jr. et al. Oct 2004 B2
6813511 Diab et al. Nov 2004 B2
6816241 Grubisic Nov 2004 B2
6816741 Diab Nov 2004 B2
6819950 Mills Nov 2004 B2
6822564 Al-Ali Nov 2004 B2
6825619 Norris Nov 2004 B2
6826419 Diab et al. Nov 2004 B2
6829496 Nagai et al. Dec 2004 B2
6829501 Nielsen et al. Dec 2004 B2
6830711 Mills et al. Dec 2004 B2
6836679 Baker, Jr. et al. Dec 2004 B2
6839579 Chin Jan 2005 B1
6839580 Zonios et al. Jan 2005 B2
6839581 El-Solh et al. Jan 2005 B1
6839582 Heckel Jan 2005 B2
6842702 Haaland et al. Jan 2005 B2
6845256 Chin et al. Jan 2005 B2
6847835 Yamanishi Jan 2005 B1
6850787 Weber et al. Feb 2005 B2
6850788 Al-Ali Feb 2005 B2
6852083 Caro et al. Feb 2005 B2
6861639 Al-Ali Mar 2005 B2
6861641 Adams Mar 2005 B1
6869402 Arnold Mar 2005 B2
6876931 Lorenz et al. Apr 2005 B2
6882874 Huiku Apr 2005 B2
6898452 Al-Ali et al. May 2005 B2
6912049 Pawluczyk et al. Jun 2005 B2
6917422 Samsoondar et al. Jul 2005 B2
6918878 Brodnick Jul 2005 B2
6919566 Cadell Jul 2005 B1
6920345 Al-Ali et al. Jul 2005 B2
6921367 Mills Jul 2005 B2
6922645 Haaland et al. Jul 2005 B2
6928311 Pawluczyk et al. Aug 2005 B1
6931268 Kiani-Azarbayjany et al. Aug 2005 B1
6931269 Terry Aug 2005 B2
6934570 Kiani et al. Aug 2005 B2
6937736 Toda Aug 2005 B2
6939305 Flaherty et al. Sep 2005 B2
6943348 Coffin, IV Sep 2005 B1
6944487 Maynard et al. Sep 2005 B2
6949075 Hatlesad et al. Sep 2005 B2
6950687 Al-Ali Sep 2005 B2
6956572 Zaleski Oct 2005 B2
6956649 Acosta et al. Oct 2005 B2
6961598 Diab Nov 2005 B2
6970792 Diab Nov 2005 B1
6975891 Pawluczyk Dec 2005 B2
6979812 Al-Ali Dec 2005 B2
6985764 Mason et al. Jan 2006 B2
6987994 Mortz Jan 2006 B1
6990364 Ruchti et al. Jan 2006 B2
6993371 Kiani et al. Jan 2006 B2
6996427 Ali et al. Feb 2006 B2
6998247 Monfre et al. Feb 2006 B2
6999904 Weber et al. Feb 2006 B2
7001337 Dekker Feb 2006 B2
7003338 Weber et al. Feb 2006 B2
7003339 Diab et al. Feb 2006 B2
7006856 Baker, Jr. et al. Feb 2006 B2
7015451 Dalke et al. Mar 2006 B2
7024233 Ali et al. Apr 2006 B2
7027849 Al-Ali Apr 2006 B2
7030749 Al-Ali Apr 2006 B2
7039449 Al-Ali May 2006 B2
7041060 Flaherty et al. May 2006 B2
7044918 Diab May 2006 B2
7048687 Reuss et al. May 2006 B1
7067893 Mills et al. Jun 2006 B2
D526719 Richie, Jr. et al. Aug 2006 S
7096052 Mason et al. Aug 2006 B2
7096054 Abdul-Hafiz et al. Aug 2006 B2
7096060 Arand et al. Aug 2006 B2
7112173 Kantorovich et al. Sep 2006 B1
D529616 Deros et al. Oct 2006 S
7132641 Schulz et al. Nov 2006 B2
7133710 Acosta et al. Nov 2006 B2
7142901 Kiani et al. Nov 2006 B2
7149561 Diab Dec 2006 B2
7186966 Al-Ali Mar 2007 B2
7190261 Al-Ali Mar 2007 B2
7194306 Turcott Mar 2007 B1
7215894 Kobayashi et al. May 2007 B2
7215984 Diab et al. May 2007 B2
7215986 Diab et al. May 2007 B2
7221971 Diab et al. May 2007 B2
7225006 Al-Ali et al. May 2007 B2
7225007 Al-Ali et al. May 2007 B2
RE39672 Shehada et al. Jun 2007 E
7239905 Kiani-Azarbayjany et al. Jul 2007 B2
7245953 Parker Jul 2007 B1
7248910 Li Jul 2007 B2
7254429 Schurman et al. Aug 2007 B2
7254431 Al-Ali et al. Aug 2007 B2
7254433 Diab et al. Aug 2007 B2
7254434 Schulz et al. Aug 2007 B2
7272425 Al-Ali Sep 2007 B2
7274955 Kiani et al. Sep 2007 B2
D554263 Al-Ali et al. Oct 2007 S
7280858 Al-Ali et al. Oct 2007 B2
7289835 Mansfield et al. Oct 2007 B2
7292883 De Felice et al. Nov 2007 B2
7295866 Al-Ali Nov 2007 B2
7299080 Acosta et al. Nov 2007 B2
7328053 Diab et al. Feb 2008 B1
7332784 Mills et al. Feb 2008 B2
7340287 Mason et al. Mar 2008 B2
7341559 Schulz et al. Mar 2008 B2
7343186 Lamego et al. Mar 2008 B2
D566282 Al-Ali et al. Apr 2008 S
7355512 Al-Ali Apr 2008 B1
7356365 Schurman Apr 2008 B2
7371981 Abdul-Hafiz May 2008 B2
7373193 Al-Ali et al. May 2008 B2
7373194 Weber et al. May 2008 B2
7376453 Diab et al. May 2008 B1
7377794 Al-Ali et al. May 2008 B2
7377899 Weber et al. May 2008 B2
7383070 Diab et al. Jun 2008 B2
7395158 Monfre et al. Jul 2008 B2
7398115 Lynn Jul 2008 B2
7415297 Al-Ali et al. Aug 2008 B2
7416531 Mohler Aug 2008 B2
7428432 Ali et al. Sep 2008 B2
7438683 Al-Ali et al. Oct 2008 B2
7440787 Diab Oct 2008 B2
7454240 Diab et al. Nov 2008 B2
7457652 Porges et al. Nov 2008 B2
7467002 Weber et al. Dec 2008 B2
7469157 Diab et al. Dec 2008 B2
7471969 Diab et al. Dec 2008 B2
7471971 Diab et al. Dec 2008 B2
7483729 Al-Ali et al. Jan 2009 B2
7483730 Diab et al. Jan 2009 B2
7489958 Diab et al. Feb 2009 B2
7496391 Diab et al. Feb 2009 B2
7496393 Diab et al. Feb 2009 B2
D587657 Al-Ali et al. Mar 2009 S
7499741 Diab et al. Mar 2009 B2
7499835 Weber et al. Mar 2009 B2
7500950 Al-Ali et al. Mar 2009 B2
7509154 Diab et al. Mar 2009 B2
7509494 Al-Ali Mar 2009 B2
7510849 Schurman et al. Mar 2009 B2
7514725 Wojtczuk et al. Apr 2009 B2
7519406 Blank et al. Apr 2009 B2
7526328 Diab et al. Apr 2009 B2
D592507 Wachman et al. May 2009 S
7530942 Diab May 2009 B1
7530949 Al Ali et al. May 2009 B2
7530955 Diab et al. May 2009 B2
7539533 Tran May 2009 B2
7563110 Al-Ali et al. Jul 2009 B2
7593230 Abul-Haj et al. Sep 2009 B2
7596398 Al-Ali et al. Sep 2009 B2
7606608 Blank et al. Oct 2009 B2
7606861 Killcommons et al. Oct 2009 B2
7618375 Flaherty et al. Nov 2009 B2
7620674 Ruchti et al. Nov 2009 B2
D606659 Kiani et al. Dec 2009 S
7629039 Eckerbom et al. Dec 2009 B2
7640140 Ruchti et al. Dec 2009 B2
7647083 Al-Ali et al. Jan 2010 B2
D609193 Al-Ali et al. Feb 2010 S
7670726 Lu Mar 2010 B2
7679519 Lindner et al. Mar 2010 B2
D614305 Al-Ali et al. Apr 2010 S
7690378 Turcott Apr 2010 B1
7691070 Comanducci Apr 2010 B2
7697966 Monfre et al. Apr 2010 B2
7698105 Ruchti et al. Apr 2010 B2
RE41317 Parker May 2010 E
RE41333 Blank et al. May 2010 E
7729733 Al-Ali et al. Jun 2010 B2
7734320 Al-Ali Jun 2010 B2
7761127 Al-Ali et al. Jul 2010 B2
7761128 Al-Ali et al. Jul 2010 B2
7764982 Dalke et al. Jul 2010 B2
D621516 Kiani et al. Aug 2010 S
7791155 Diab Sep 2010 B2
7801581 Diab Sep 2010 B2
7822452 Schurman et al. Oct 2010 B2
RE41912 Parker Nov 2010 E
7844313 Kiani et al. Nov 2010 B2
7844314 Al-Ali Nov 2010 B2
7844315 Al-Ali Nov 2010 B2
7856207 Martch et al. Dec 2010 B2
7865222 Weber et al. Jan 2011 B2
7873497 Weber et al. Jan 2011 B2
7880606 Al-Ali Feb 2011 B2
7880626 Al-Ali et al. Feb 2011 B2
7891355 Al-Ali et al. Feb 2011 B2
7894868 Al-Ali et al. Feb 2011 B2
7899507 Al-Ali et al. Mar 2011 B2
7899518 Trepagnier et al. Mar 2011 B2
7904132 Weber et al. Mar 2011 B2
7909772 Popov et al. Mar 2011 B2
7910875 Al-Ali Mar 2011 B2
7919713 Al-Ali et al. Apr 2011 B2
7937128 Al-Ali May 2011 B2
7937129 Mason et al. May 2011 B2
7937130 Diab et al. May 2011 B2
7941199 Kiani May 2011 B2
7951086 Flaherty et al. May 2011 B2
7957780 Lamego et al. Jun 2011 B2
7962188 Kiani et al. Jun 2011 B2
7962190 Diab et al. Jun 2011 B1
7976472 Kiani Jul 2011 B2
7988637 Diab Aug 2011 B2
7990382 Kiani Aug 2011 B2
7991446 Ali et al. Aug 2011 B2
8000761 Al-Ali Aug 2011 B2
8008088 Bellott et al. Aug 2011 B2
RE42753 Kiani-Azarbayjany et al. Sep 2011 E
8019400 Diab et al. Sep 2011 B2
8028701 Al-Ali et al. Oct 2011 B2
8029765 Bellott et al. Oct 2011 B2
8036727 Schurman et al. Oct 2011 B2
8036728 Diab et al. Oct 2011 B2
8046040 Ali et al. Oct 2011 B2
8046041 Diab et al. Oct 2011 B2
8046042 Diab et al. Oct 2011 B2
8048040 Kiani Nov 2011 B2
8050728 Al-Ali et al. Nov 2011 B2
8103325 Swedlow Jan 2012 B2
RE43169 Parker Feb 2012 E
8118620 Al-Ali et al. Feb 2012 B2
8126528 Diab et al. Feb 2012 B2
8128572 Diab et al. Mar 2012 B2
8130105 Al-Ali et al. Mar 2012 B2
8145287 Diab et al. Mar 2012 B2
8150487 Diab et al. Apr 2012 B2
8175672 Parker May 2012 B2
8180420 Diab et al. May 2012 B2
8182443 Kiani May 2012 B1
8185180 Diab et al. May 2012 B2
8190223 Al-Ali et al. May 2012 B2
8190227 Diab et al. May 2012 B2
8203438 Kiani et al. Jun 2012 B2
8203704 Merritt et al. Jun 2012 B2
8204566 Schurman et al. Jun 2012 B2
8219172 Schurman et al. Jul 2012 B2
8224411 Al-Ali et al. Jul 2012 B2
8228181 Al-Ali Jul 2012 B2
8229532 Davis Jul 2012 B2
8229533 Diab et al. Jul 2012 B2
8233955 Al-Ali et al. Jul 2012 B2
8244325 Al-Ali et al. Aug 2012 B2
8255026 Al-Ali Aug 2012 B1
8255027 Al-Ali et al. Aug 2012 B2
8255028 Al-Ali et al. Aug 2012 B2
8257089 Lecat Sep 2012 B2
8260577 Weber et al. Sep 2012 B2
8265291 Bridger et al. Sep 2012 B2
8265723 McHale et al. Sep 2012 B1
8274360 Sampath et al. Sep 2012 B2
8280473 Al-Ali Oct 2012 B2
8301217 Al-Ali et al. Oct 2012 B2
8306596 Schurman et al. Nov 2012 B2
8310336 Muhsin et al. Nov 2012 B2
8315683 Al-Ali et al. Nov 2012 B2
RE43860 Parker Dec 2012 E
8336822 MacGregor et al. Dec 2012 B2
8337403 Al-Ali et al. Dec 2012 B2
8346330 Lamego Jan 2013 B2
8353842 Al-Ali et al. Jan 2013 B2
8355766 MacNeish, III et al. Jan 2013 B2
8359080 Diab et al. Jan 2013 B2
8364223 Al-Ali et al. Jan 2013 B2
8364226 Diab et al. Jan 2013 B2
8374665 Lamego Feb 2013 B2
8385995 Al-Ali et al. Feb 2013 B2
8385996 Smith et al. Feb 2013 B2
8388353 Kiani et al. Mar 2013 B2
8399822 Al-Ali Mar 2013 B2
8401602 Kiani Mar 2013 B2
8405608 Al-Ali et al. Mar 2013 B2
8414449 Heap et al. Apr 2013 B2
8414499 Al-Ali et al. Apr 2013 B2
8418524 Al-Ali Apr 2013 B2
8423106 Lamego et al. Apr 2013 B2
8428967 Olsen et al. Apr 2013 B2
8430817 Al-Ali et al. Apr 2013 B1
8437825 Dalvi et al. May 2013 B2
8449469 Banet et al. May 2013 B2
8455290 Siskavich Jun 2013 B2
8457703 Al-Ali Jun 2013 B2
8457707 Kiani Jun 2013 B2
8463349 Diab et al. Jun 2013 B2
8466286 Bellott et al. Jun 2013 B2
8471713 Poeze et al. Jun 2013 B2
8473020 Kiani et al. Jun 2013 B2
8483787 Al-Ali et al. Jul 2013 B2
8489364 Weber et al. Jul 2013 B2
8498684 Weber et al. Jul 2013 B2
8504128 Blank et al. Aug 2013 B2
8509867 Workman et al. Aug 2013 B2
8515509 Bruinsma et al. Aug 2013 B2
8523781 Al-Ali Sep 2013 B2
8529301 Al-Ali et al. Sep 2013 B2
8532727 Ali et al. Sep 2013 B2
8532728 Diab et al. Sep 2013 B2
D692145 Al-Ali et al. Oct 2013 S
8547209 Kiani et al. Oct 2013 B2
8548548 Al-Ali Oct 2013 B2
8548549 Schurman et al. Oct 2013 B2
8548550 Al-Ali et al. Oct 2013 B2
8560032 Al-Ali et al. Oct 2013 B2
8560034 Diab et al. Oct 2013 B1
8570167 Al-Ali Oct 2013 B2
8570503 Vo et al. Oct 2013 B2
8571617 Reichgott et al. Oct 2013 B2
8571618 Lamego et al. Oct 2013 B1
8571619 Al-Ali et al. Oct 2013 B2
8577431 Lamego et al. Nov 2013 B2
8581732 Al-Ali et al. Nov 2013 B2
8584345 Al-Ali et al. Nov 2013 B2
8588880 Abdul-Hafiz et al. Nov 2013 B2
8600467 Al-Ali et al. Dec 2013 B2
8606342 Diab Dec 2013 B2
8626255 Al-Ali et al. Jan 2014 B2
8630691 Lamego et al. Jan 2014 B2
8634889 Al-Ali et al. Jan 2014 B2
8641631 Sierra et al. Feb 2014 B2
8652060 Al-Ali Feb 2014 B2
8663107 Kiani Mar 2014 B2
8666468 Al-Ali Mar 2014 B1
8667967 Al-Ali et al. Mar 2014 B2
8670811 O'Reilly Mar 2014 B2
8670814 Diab et al. Mar 2014 B2
8676286 Weber et al. Mar 2014 B2
8682407 Ai-Ali Mar 2014 B2
RE44823 Parker Apr 2014 E
RE44875 Kiani et al. Apr 2014 E
8688183 Bruinsma et al. Apr 2014 B2
8690799 Telfort et al. Apr 2014 B2
8700112 Kiani Apr 2014 B2
8702627 Telfort et al. Apr 2014 B2
8706179 Parker Apr 2014 B2
8712494 MacNeish, III et al. Apr 2014 B1
8715206 Telfort et al. May 2014 B2
8718735 Lamego et al. May 2014 B2
8718737 Diab et al. May 2014 B2
8718738 Blank et al. May 2014 B2
8720249 Al-Ali May 2014 B2
8721541 Al-Ali et al. May 2014 B2
8721542 Al-Ali et al. May 2014 B2
8723677 Kiani May 2014 B1
8740792 Kiani et al. Jun 2014 B1
8754776 Poeze et al. Jun 2014 B2
8755535 Telfort et al. Jun 2014 B2
8755856 Diab et al. Jun 2014 B2
8755872 Marinow Jun 2014 B1
8761850 Lamego Jun 2014 B2
8764671 Kiani Jul 2014 B2
8768423 Shakespeare et al. Jul 2014 B2
8771204 Telfort et al. Jul 2014 B2
8777634 Kiani et al. Jul 2014 B2
8781543 Diab et al. Jul 2014 B2
8781544 Al-Ali et al. Jul 2014 B2
8781549 Al-Ali et al. Jul 2014 B2
8788003 Schurman et al. Jul 2014 B2
8790268 Al-Ali Jul 2014 B2
8801613 Al-Ali et al. Aug 2014 B2
8821397 Al-Ali et al. Sep 2014 B2
8821415 Al-Ali et al. Sep 2014 B2
8830449 Lamego et al. Sep 2014 B1
8831700 Schurman et al. Sep 2014 B2
8840549 Al-Ali et al. Sep 2014 B2
8847740 Kiani et al. Sep 2014 B2
8849365 Smith et al. Sep 2014 B2
8852094 Al-Ali et al. Oct 2014 B2
8852994 Wojtczuk et al. Oct 2014 B2
8868147 Stippick et al. Oct 2014 B2
8868150 Al-Ali et al. Oct 2014 B2
8870792 Al-Ali et al. Oct 2014 B2
8886271 Kiani et al. Nov 2014 B2
8888539 Al-Ali et al. Nov 2014 B2
8888708 Diab et al. Nov 2014 B2
8892180 Weber et al. Nov 2014 B2
8897847 Al-Ali Nov 2014 B2
8909310 Lamego et al. Dec 2014 B2
8911377 Al-Ali Dec 2014 B2
8912909 Al-Ali et al. Dec 2014 B2
8920317 Al-Ali et al. Dec 2014 B2
8921699 Al-Ali et al. Dec 2014 B2
8922382 Al-Ali et al. Dec 2014 B2
8929964 Al-Ali et al. Jan 2015 B2
8942777 Diab et al. Jan 2015 B2
8948834 Diab et al. Feb 2015 B2
8948835 Diab Feb 2015 B2
8965471 Lamego Feb 2015 B2
8983564 Al-Ali Mar 2015 B2
8989831 Al-Ali et al. Mar 2015 B2
8996085 Kiani et al. Mar 2015 B2
8998809 Kiani Apr 2015 B2
9028429 Telfort et al. May 2015 B2
9037207 Al-Ali et al. May 2015 B2
9060721 Reichgott et al. Jun 2015 B2
9066666 Kiani Jun 2015 B2
9066680 Al-Ali et al. Jun 2015 B1
9072474 Al-Ali et al. Jul 2015 B2
9078560 Schurman et al. Jul 2015 B2
9084569 Weber et al. Jul 2015 B2
9095316 Welch et al. Aug 2015 B2
9106038 Telfort et al. Aug 2015 B2
9107625 Telfort et al. Aug 2015 B2
9107626 Al-Ali et al. Aug 2015 B2
9113831 Al-Ali Aug 2015 B2
9113832 Al-Ali Aug 2015 B2
9119595 Lamego Sep 2015 B2
9131881 Diab et al. Sep 2015 B2
9131882 Al-Ali et al. Sep 2015 B2
9131883 Al-Ali Sep 2015 B2
9131917 Telfort et al. Sep 2015 B2
9138180 Coverston et al. Sep 2015 B1
9138182 Al-Ali et al. Sep 2015 B2
9138192 Weber et al. Sep 2015 B2
9142117 Muhsin et al. Sep 2015 B2
9153112 Kiani et al. Oct 2015 B1
9153121 Kiani et al. Oct 2015 B2
9161696 Al-Ali et al. Oct 2015 B2
9161713 Al-Ali et al. Oct 2015 B2
9167995 Lamego et al. Oct 2015 B2
9176141 Al-Ali et al. Nov 2015 B2
9186102 Bruinsma et al. Nov 2015 B2
9192312 Al-Ali Nov 2015 B2
9192329 Al-Ali Nov 2015 B2
9192351 Telfort et al. Nov 2015 B1
9195385 Al-Ali et al. Nov 2015 B2
9211072 Kiani Dec 2015 B2
9211095 Al-Ali Dec 2015 B1
9218454 Kiani et al. Dec 2015 B2
9226696 Kiani Jan 2016 B2
9241662 Al-Ali et al. Jan 2016 B2
9245668 Vo et al. Jan 2016 B1
9259185 Abdul-Hafiz et al. Feb 2016 B2
9267572 Barker et al. Feb 2016 B2
9277880 Poeze et al. Mar 2016 B2
9289167 Diab et al. Mar 2016 B2
9295421 Kiani et al. Mar 2016 B2
9307928 Al-Ali et al. Apr 2016 B1
9323894 Kiani Apr 2016 B2
D755392 Hwang et al. May 2016 S
9326712 Kiani May 2016 B1
9333316 Kiani May 2016 B2
9339220 Lamego et al. May 2016 B2
9341565 Lamego et al. May 2016 B2
9351673 Diab et al. May 2016 B2
9351675 Al-Ali et al. May 2016 B2
9364181 Kiani et al. Jun 2016 B2
9368671 Wojtczuk et al. Jun 2016 B2
9370325 Al-Ali et al. Jun 2016 B2
9370326 McHale et al. Jun 2016 B2
9370335 Al-Ali et al. Jun 2016 B2
9375185 Ali et al. Jun 2016 B2
9386953 Al-Ali Jul 2016 B2
9386961 Al-Ali et al. Jul 2016 B2
9392945 Al-Ali et al. Jul 2016 B2
9397448 Al-Ali et al. Jul 2016 B2
9408542 Kinast et al. Aug 2016 B1
9436645 Al-Ali et al. Sep 2016 B2
9445759 Lamego et al. Sep 2016 B1
9466919 Kiani et al. Oct 2016 B2
9474474 Lamego et al. Oct 2016 B2
9480422 Al-Ali Nov 2016 B2
9480435 Olsen Nov 2016 B2
9492110 Al-Ali et al. Nov 2016 B2
9510779 Poeze et al. Dec 2016 B2
9517024 Kiani et al. Dec 2016 B2
9532722 Lamego et al. Jan 2017 B2
9538949 Al-Ali et al. Jan 2017 B2
9538980 Telfort et al. Jan 2017 B2
9549696 Lamego et al. Jan 2017 B2
9554737 Schurman et al. Jan 2017 B2
9560996 Kiani Feb 2017 B2
9560998 Al-Ali et al. Feb 2017 B2
9566019 Al-Ali et al. Feb 2017 B2
9579039 Jansen et al. Feb 2017 B2
9591975 Dalvi et al. Mar 2017 B2
9622692 Lamego et al. Apr 2017 B2
9622693 Diab Apr 2017 B2
D788312 Al-Ali et al. May 2017 S
9636055 Al Ali et al. May 2017 B2
9636056 Al-Ali May 2017 B2
9649054 Lamego et al. May 2017 B2
9662052 Al-Ali et al. May 2017 B2
9668679 Schurman et al. Jun 2017 B2
9668680 Bruinsma et al. Jun 2017 B2
9668703 Al-Ali Jun 2017 B2
9675286 Diab Jun 2017 B2
9687160 Kiani Jun 2017 B2
9693719 Al-Ali et al. Jul 2017 B2
9693737 Al-Ali Jul 2017 B2
9697928 Al-Ali et al. Jul 2017 B2
9717425 Kiani et al. Aug 2017 B2
9717458 Lamego et al. Aug 2017 B2
9724016 Al-Ali et al. Aug 2017 B1
9724024 Al-Ali Aug 2017 B2
9724025 Kiani et al. Aug 2017 B1
9730640 Diab et al. Aug 2017 B2
9743887 Al-Ali et al. Aug 2017 B2
9749232 Sampath et al. Aug 2017 B2
9750442 Olsen Sep 2017 B2
9750443 Smith et al. Sep 2017 B2
9750461 Telfort Sep 2017 B1
9775545 Al-Ali et al. Oct 2017 B2
9775546 Diab et al. Oct 2017 B2
9775570 Al-Ali Oct 2017 B2
9778079 Al-Ali et al. Oct 2017 B1
9782077 Lamego et al. Oct 2017 B2
9782110 Kiani Oct 2017 B2
9787568 Lamego et al. Oct 2017 B2
9788735 Al-Ali Oct 2017 B2
9788768 Al-Ali et al. Oct 2017 B2
9795300 Al-Ali Oct 2017 B2
9795310 Al-Ali Oct 2017 B2
9795358 Telfort et al. Oct 2017 B2
9795739 Al-Ali et al. Oct 2017 B2
9801556 Kiani Oct 2017 B2
9801588 Weber et al. Oct 2017 B2
9808188 Perea et al. Nov 2017 B1
9814418 Weber et al. Nov 2017 B2
9820691 Kiani Nov 2017 B2
9833152 Kiani et al. Dec 2017 B2
9833180 Shakespeare et al. Dec 2017 B2
9839379 Al-Ali et al. Dec 2017 B2
9839381 Weber et al. Dec 2017 B1
9847002 Kiani et al. Dec 2017 B2
9847749 Kiani et al. Dec 2017 B2
9848800 Lee et al. Dec 2017 B1
9848806 Al-Ali Dec 2017 B2
9848807 Lamego Dec 2017 B2
9861298 Eckerbom et al. Jan 2018 B2
9861304 Al-Ali et al. Jan 2018 B2
9861305 Weber et al. Jan 2018 B1
9867578 Al-Ali et al. Jan 2018 B2
9872623 Al-Ali Jan 2018 B2
9876320 Coverston et al. Jan 2018 B2
9877650 Muhsin et al. Jan 2018 B2
9877686 Al-Ali et al. Jan 2018 B2
9891079 Dalvi Feb 2018 B2
9895107 Al-Ali et al. Feb 2018 B2
9913617 Al-Ali et al. Mar 2018 B2
9924893 Schurman et al. Mar 2018 B2
9924897 Abdul-Hafiz Mar 2018 B1
9936917 Poeze et al. Apr 2018 B2
9943269 Muhsin et al. Apr 2018 B2
9949676 Al-Ali Apr 2018 B2
9955937 Telfort May 2018 B2
9965946 Al-Ali et al. May 2018 B2
9980667 Kiani et al. May 2018 B2
D820865 Muhsin et al. Jun 2018 S
9986919 Lamego et al. Jun 2018 B2
9986952 Dalvi et al. Jun 2018 B2
9989560 Poeze et al. Jun 2018 B2
9993207 Al-Ali et al. Jun 2018 B2
10007758 Al-Ali et al. Jun 2018 B2
D822215 Al-Ali et al. Jul 2018 S
D822216 Barker et al. Jul 2018 S
10010276 Al-Ali et al. Jul 2018 B2
10032002 Kiani et al. Jul 2018 B2
10039482 Al-Ali et al. Aug 2018 B2
10052037 Kinast et al. Aug 2018 B2
10058275 Al-Ali et al. Aug 2018 B2
10064562 Al-Ali Sep 2018 B2
10086138 Novak, Jr. Oct 2018 B1
10092200 Al-Ali et al. Oct 2018 B2
10092249 Kiani et al. Oct 2018 B2
10098550 Al-Ali et al. Oct 2018 B2
10098591 Al-Ali et al. Oct 2018 B2
10098610 Al-Ali et al. Oct 2018 B2
10111591 Dyell et al. Oct 2018 B2
D833624 DeJong et al. Nov 2018 S
10123726 Al-Ali et al. Nov 2018 B2
10123729 Dyell et al. Nov 2018 B2
10130289 Al-Ali et al. Nov 2018 B2
10130291 Schurman et al. Nov 2018 B2
D835282 Barker et al. Dec 2018 S
D835283 Barker et al. Dec 2018 S
D835284 Barker et al. Dec 2018 S
D835285 Barker et al. Dec 2018 S
10149616 Al-Ali et al. Dec 2018 B2
10154815 Al-Ali et al. Dec 2018 B2
10159412 Lamego et al. Dec 2018 B2
10188296 Al-Ali et al. Jan 2019 B2
10188331 Kiani et al. Jan 2019 B1
10188348 Al-Ali et al. Jan 2019 B2
RE47218 Al-Ali Feb 2019 E
RE47244 Kiani et al. Feb 2019 E
RE47249 Kiani et al. Feb 2019 E
10194847 Al-Ali Feb 2019 B2
10194848 Kiani et al. Feb 2019 B1
10201298 Al-Ali et al. Feb 2019 B2
10205272 Kiani et al. Feb 2019 B2
10205291 Scruggs et al. Feb 2019 B2
10213108 Al-Ali Feb 2019 B2
10219706 Al-Ali Mar 2019 B2
10219746 McHale et al. Mar 2019 B2
10226187 Al-Ali et al. Mar 2019 B2
10226576 Kiani Mar 2019 B2
10231657 Al-Ali et al. Mar 2019 B2
10231670 Blank et al. Mar 2019 B2
RE47353 Kiani et al. Apr 2019 E
10279247 Kiani May 2019 B2
10292664 Al-Ali May 2019 B2
10299720 Brown et al. May 2019 B2
10327337 Schmidt et al. Jun 2019 B2
10327713 Barker et al. Jun 2019 B2
10332630 Al-Ali Jun 2019 B2
10383520 Wojtczuk et al. Aug 2019 B2
10383527 Al-Ali Aug 2019 B2
10388120 Muhsin et al. Aug 2019 B2
D864120 Forrest et al. Oct 2019 S
10441181 Telfort et al. Oct 2019 B1
10441196 Eckerbom et al. Oct 2019 B2
10448844 Al-Ali et al. Oct 2019 B2
10448871 Al-Ali et al. Oct 2019 B2
10456038 Lamego et al. Oct 2019 B2
10463340 Telfort et al. Nov 2019 B2
10471159 Lapotko et al. Nov 2019 B1
10505311 Al-Ali et al. Dec 2019 B2
10524706 Telfort et al. Jan 2020 B2
10524738 Olsen Jan 2020 B2
10532174 Al-Ali Jan 2020 B2
10537285 Shreim et al. Jan 2020 B2
10542903 Al-Ali et al. Jan 2020 B2
10555678 Dalvi et al. Feb 2020 B2
10568553 O'Neil et al. Feb 2020 B2
RE47882 Al-Ali Mar 2020 E
10608817 Haider et al. Mar 2020 B2
D880477 Forrest et al. Apr 2020 S
10617302 Al-Ali et al. Apr 2020 B2
10617335 Al-Ali et al. Apr 2020 B2
10637181 Al-Ali et al. Apr 2020 B2
D886849 Muhsin et al. Jun 2020 S
D887548 Abdul-Hafiz et al. Jun 2020 S
D887549 Abdul-Hafiz et al. Jun 2020 S
10667764 Ahmed et al. Jun 2020 B2
D890708 Forrest et al. Jul 2020 S
10721785 Al-Ali Jul 2020 B2
10729402 Al-Ali et al. Aug 2020 B2
10736518 Al-Ali et al. Aug 2020 B2
10750984 Pauley et al. Aug 2020 B2
D897098 Al-Ali Sep 2020 S
10779098 Iswanto et al. Sep 2020 B2
10827961 Iyengar et al. Nov 2020 B1
10828007 Telfort et al. Nov 2020 B1
10832818 Muhsin et al. Nov 2020 B2
10849554 Shreim et al. Dec 2020 B2
10856750 Indorf Dec 2020 B2
D906970 Forrest et al. Jan 2021 S
D908213 Abdul-Hafiz et al. Jan 2021 S
10918281 Al-Ali et al. Feb 2021 B2
10932705 Muhsin et al. Mar 2021 B2
10932729 Kiani et al. Mar 2021 B2
10939878 Kiani et al. Mar 2021 B2
10956950 Al-Ali et al. Mar 2021 B2
D916135 Indorf et al. Apr 2021 S
D917046 Abdul-Hafiz et al. Apr 2021 S
D917550 Indorf et al. Apr 2021 S
D917564 Indorf et al. Apr 2021 S
D917704 Al-Ali et al. Apr 2021 S
10987066 Chandran et al. Apr 2021 B2
10991135 Al-Ali et al. Apr 2021 B2
D919094 Al-Ali et al. May 2021 S
D919100 Al-Ali et al. May 2021 S
11006867 Al-Ali May 2021 B2
D921202 Al-Ali et al. Jun 2021 S
11024064 Muhsin et al. Jun 2021 B2
11026604 Chen et al. Jun 2021 B2
D925597 Chandran et al. Jul 2021 S
D927699 Al-Ali et al. Aug 2021 S
11076777 Lee et al. Aug 2021 B2
11114188 Poeze et al. Sep 2021 B2
D933232 Al-Ali et al. Oct 2021 S
D933233 Al-Ali et al. Oct 2021 S
D933234 Al-Ali et al. Oct 2021 S
11145408 Sampath et al. Oct 2021 B2
11147518 Al-Ali et al. Oct 2021 B1
11185262 Al-Ali et al. Nov 2021 B2
11191484 Kiani et al. Dec 2021 B2
D946596 Ahmed Mar 2022 S
D946597 Ahmed Mar 2022 S
D946598 Ahmed Mar 2022 S
D946617 Ahmed Mar 2022 S
11272839 Al-Ali et al. Mar 2022 B2
11289199 Al-Ali Mar 2022 B2
RE49034 Al-Ali Apr 2022 E
11298021 Muhsin et al. Apr 2022 B2
D950580 Ahmed May 2022 S
D950599 Ahmed May 2022 S
D950738 Al-Ali et al. May 2022 S
D957648 Al-Ali Jul 2022 S
11382567 O'Brien et al. Jul 2022 B2
11389093 Triman et al. Jul 2022 B2
11406286 Al-Ali et al. Aug 2022 B2
11417426 Muhsin et al. Aug 2022 B2
11439329 Lamego Sep 2022 B2
11445948 Scruggs et al. Sep 2022 B2
D965789 Al-Ali et al. Oct 2022 S
D967433 Al-Ali et al. Oct 2022 S
11464410 Muhsin Oct 2022 B2
11504058 Sharma et al. Nov 2022 B1
11504066 Dalvi et al. Nov 2022 B1
D971933 Ahmed Dec 2022 S
D973072 Ahmed Dec 2022 S
D973685 Ahmed Dec 2022 S
D973686 Ahmed Dec 2022 S
D974193 Forrest et al. Jan 2023 S
D979516 Al-Ali et al. Feb 2023 S
11571152 Al-Ali et al. Feb 2023 B2
D980091 Forrest et al. Mar 2023 S
11596363 Lamego Mar 2023 B2
11627919 Kiani et al. Apr 2023 B2
11637437 Al-Ali et al. Apr 2023 B2
D985498 Al-Ali et al. May 2023 S
11653862 Dalvi et al. May 2023 B2
D989112 Muhsin et al. Jun 2023 S
D989327 Al-Ali et al. Jun 2023 S
11678829 Al-Ali et al. Jun 2023 B2
11679579 Al-Ali Jun 2023 B2
11684296 Vo et al. Jun 2023 B2
11692934 Normand et al. Jul 2023 B2
11701043 Al-Ali et al. Jul 2023 B2
D997365 Hwang Aug 2023 S
11721105 Ranasinghe et al. Aug 2023 B2
11730379 Ahmed et al. Aug 2023 B2
D998625 Indorf et al. Sep 2023 S
D998630 Indorf et al. Sep 2023 S
D998631 Indorf et al. Sep 2023 S
D999244 Indorf et al. Sep 2023 S
D999245 Indorf et al. Sep 2023 S
D999246 Indorf et al. Sep 2023 S
11766198 Pauley et al. Sep 2023 B2
D1000975 Al-Ali et al. Oct 2023 S
11803623 Kiani et al. Oct 2023 B2
11832940 Diab et al. Dec 2023 B2
D1013179 Al-Ali et al. Jan 2024 S
11872156 Telfort et al. Jan 2024 B2
11879960 Ranasinghe et al. Jan 2024 B2
11883129 Olsen Jan 2024 B2
D1022729 Forrest et al. Apr 2024 S
11951186 Krishnamani et al. Apr 2024 B2
11974833 Forrest et al. May 2024 B2
11986067 Al-Ali et al. May 2024 B2
11986289 Dalvi et al. May 2024 B2
11986305 Al-Ali et al. May 2024 B2
12004869 Kiani et al. Jun 2024 B2
12014328 Wachman et al. Jun 2024 B2
D1036293 Al-Ali et al. Jul 2024 S
12029844 Pauley et al. Jul 2024 B2
12048534 Vo et al. Jul 2024 B2
12064217 Ahmed et al. Aug 2024 B2
D1041511 Indorf et al. Sep 2024 S
12076159 Belur Nagaraj et al. Sep 2024 B2
20010034477 Mansfield et al. Oct 2001 A1
20010039483 Brand et al. Nov 2001 A1
20010044700 Kobayashi et al. Nov 2001 A1
20010045532 Schulz et al. Nov 2001 A1
20020010401 Bushmakin et al. Jan 2002 A1
20020021269 Rast Feb 2002 A1
20020026107 Kiani et al. Feb 2002 A1
20020035315 Ali et al. Mar 2002 A1
20020035318 Mannheimer et al. Mar 2002 A1
20020038078 Ito Mar 2002 A1
20020038081 Fein et al. Mar 2002 A1
20020051290 Hannington May 2002 A1
20020058864 Mansfield et al. May 2002 A1
20020059047 Haaland May 2002 A1
20020068858 Braig et al. Jun 2002 A1
20020082488 Al-Ali et al. Jun 2002 A1
20020095076 Krausman et al. Jul 2002 A1
20020095077 Swedlow et al. Jul 2002 A1
20020095078 Mannheimer et al. Jul 2002 A1
20020095090 Caro et al. Jul 2002 A1
20020111748 Kobayashi et al. Aug 2002 A1
20020115919 Al-Ali Aug 2002 A1
20020133080 Apruzzese et al. Sep 2002 A1
20020154665 Funabashi et al. Oct 2002 A1
20020156353 Larson Oct 2002 A1
20020159002 Chang Oct 2002 A1
20020161291 Kiani et al. Oct 2002 A1
20020165440 Mason et al. Nov 2002 A1
20020183819 Struble Dec 2002 A1
20020198442 Rantala et al. Dec 2002 A1
20030013975 Kiani Jan 2003 A1
20030018243 Gerhardt et al. Jan 2003 A1
20030045784 Palatnik et al. Mar 2003 A1
20030045785 Diab et al. Mar 2003 A1
20030049232 Page et al. Mar 2003 A1
20030109775 O'Neil et al. Jun 2003 A1
20030116769 Song et al. Jun 2003 A1
20030117296 Seely Jun 2003 A1
20030120160 Yarita Jun 2003 A1
20030120164 Nielsen et al. Jun 2003 A1
20030135099 Al-Ali Jul 2003 A1
20030135129 Cusimano et al. Jul 2003 A1
20030139657 Solenberger Jul 2003 A1
20030144582 Cohen et al. Jul 2003 A1
20030156288 Barnum et al. Aug 2003 A1
20030160257 Bader et al. Aug 2003 A1
20030195402 Fein et al. Oct 2003 A1
20030212312 Coffin, IV et al. Nov 2003 A1
20040006261 Swedlow et al. Jan 2004 A1
20040019285 Eigler et al. Jan 2004 A1
20040033618 Haass et al. Feb 2004 A1
20040034898 Bruegl Feb 2004 A1
20040059209 Al-Ali et al. Mar 2004 A1
20040064259 Haaland et al. Apr 2004 A1
20040081621 Arndt et al. Apr 2004 A1
20040092805 Yarita May 2004 A1
20040097797 Porges et al. May 2004 A1
20040106163 Workman, Jr. et al. Jun 2004 A1
20040133087 Ali et al. Jul 2004 A1
20040138538 Stetson Jul 2004 A1
20040138540 Baker, Jr. et al. Jul 2004 A1
20040147822 Al-Ali et al. Jul 2004 A1
20040147823 Kiani et al. Jul 2004 A1
20040158132 Zaleski Aug 2004 A1
20040158134 Diab et al. Aug 2004 A1
20040158135 Baker, Jr. et al. Aug 2004 A1
20040158162 Narimatsu Aug 2004 A1
20040162472 Berson et al. Aug 2004 A1
20040167382 Gardner et al. Aug 2004 A1
20040171940 Narimatsu Sep 2004 A1
20040176670 Takamura et al. Sep 2004 A1
20040181134 Baker, Jr. et al. Sep 2004 A1
20040199063 O'Neil et al. Oct 2004 A1
20040204639 Casciani et al. Oct 2004 A1
20040204868 Maynard et al. Oct 2004 A1
20040229391 Ohya et al. Nov 2004 A1
20040262046 Simon et al. Dec 2004 A1
20040267103 Li et al. Dec 2004 A1
20040267140 Ito et al. Dec 2004 A1
20050011488 Doucet Jan 2005 A1
20050033128 Ali et al. Feb 2005 A1
20050043902 Haaland et al. Feb 2005 A1
20050049469 Aoyagi et al. Mar 2005 A1
20050054908 Blank et al. Mar 2005 A1
20050055276 Kiani et al. Mar 2005 A1
20050070773 Chin et al. Mar 2005 A1
20050070775 Chin et al. Mar 2005 A1
20050075546 Samsoondar et al. Apr 2005 A1
20050085704 Schulz et al. Apr 2005 A1
20050085735 Baker, Jr. et al. Apr 2005 A1
20050115561 Stahmann et al. Jun 2005 A1
20050124871 Baker, Jr. et al. Jun 2005 A1
20050143634 Baker, Jr. et al. Jun 2005 A1
20050143943 Brown Jun 2005 A1
20050148834 Hull et al. Jul 2005 A1
20050184895 Petersen et al. Aug 2005 A1
20050187446 Norstrom et al. Aug 2005 A1
20050187447 Chew et al. Aug 2005 A1
20050187448 Petersen et al. Aug 2005 A1
20050187449 Chew et al. Aug 2005 A1
20050187450 Chew et al. Aug 2005 A1
20050187452 Petersen et al. Aug 2005 A1
20050187453 Petersen et al. Aug 2005 A1
20050197549 Baker, Jr. Sep 2005 A1
20050197579 Baker, Jr. Sep 2005 A1
20050197793 Baker, Jr. Sep 2005 A1
20050203357 Debreczeny et al. Sep 2005 A1
20050207943 Puzey Sep 2005 A1
20050209515 Hockersmith et al. Sep 2005 A1
20050228253 Debreczeny Oct 2005 A1
20050234317 Kiani Oct 2005 A1
20050250997 Takedo et al. Nov 2005 A1
20050283059 Iyer et al. Dec 2005 A1
20060030764 Porges et al. Feb 2006 A1
20060073719 Kiani Apr 2006 A1
20060079792 Finburgh et al. Apr 2006 A1
20060161054 Reuss et al. Jul 2006 A1
20060189871 Al-Ali et al. Aug 2006 A1
20060210120 Rowe et al. Sep 2006 A1
20060211922 Al-Ali et al. Sep 2006 A1
20060211923 Al-Ali et al. Sep 2006 A1
20060211924 Dalke et al. Sep 2006 A1
20060211925 Lamego et al. Sep 2006 A1
20060211932 Al-Ali et al. Sep 2006 A1
20060226992 Al-Ali et al. Oct 2006 A1
20060229509 Al-Ali et al. Oct 2006 A1
20060238358 Al-Ali et al. Oct 2006 A1
20060241358 Al-Ali et al. Oct 2006 A1
20060241363 Al-Ali et al. Oct 2006 A1
20060264718 Ruchti et al. Nov 2006 A1
20070073116 Kiani et al. Mar 2007 A1
20070073124 Li Mar 2007 A1
20070078311 Al-Ali et al. Apr 2007 A1
20070093701 Myers et al. Apr 2007 A1
20070129616 Rantala Jun 2007 A1
20070149864 Laakkonen Jun 2007 A1
20070149865 Laakkonen Jun 2007 A1
20070180140 Welch et al. Aug 2007 A1
20070185393 Zhou et al. Aug 2007 A1
20070185397 Govari et al. Aug 2007 A1
20070244377 Cozad et al. Oct 2007 A1
20070282478 Al-Ali et al. Dec 2007 A1
20080064965 Jay et al. Mar 2008 A1
20080094228 Welch et al. Apr 2008 A1
20080103375 Kiani May 2008 A1
20080221418 Al-Ali et al. Sep 2008 A1
20080281174 Dietiker Nov 2008 A1
20090028173 Bliss et al. Jan 2009 A1
20090036759 Ault et al. Feb 2009 A1
20090093687 Telfort et al. Apr 2009 A1
20090095926 MacNeish, III Apr 2009 A1
20090163775 Barrett et al. Jun 2009 A1
20090171170 Li et al. Jul 2009 A1
20090171175 Li et al. Jul 2009 A1
20090175466 Elko et al. Jul 2009 A1
20090190774 Wang et al. Jul 2009 A1
20090247849 McCutcheon et al. Oct 2009 A1
20090247924 Lamego et al. Oct 2009 A1
20090247984 Lamego et al. Oct 2009 A1
20090275813 Davis Nov 2009 A1
20090275844 Al-Ali Nov 2009 A1
20090299157 Telfort et al. Dec 2009 A1
20100004518 Vo et al. Jan 2010 A1
20100030040 Poeze et al. Feb 2010 A1
20100069725 Al-Ali Mar 2010 A1
20100099964 O'Reilly et al. Apr 2010 A1
20100234718 Sampath et al. Sep 2010 A1
20100261979 Al-Ali et al. Oct 2010 A1
20100270257 Wachman et al. Oct 2010 A1
20100317936 Al-Ali et al. Dec 2010 A1
20110001605 Kiani et al. Jan 2011 A1
20110009719 Al-Ali et al. Jan 2011 A1
20110028802 Addison et al. Feb 2011 A1
20110028806 Merritt et al. Feb 2011 A1
20110028809 Goodman Feb 2011 A1
20110040197 Welch et al. Feb 2011 A1
20110082711 Poeze et al. Apr 2011 A1
20110087081 Kiani et al. Apr 2011 A1
20110105854 Kiani et al. May 2011 A1
20110118561 Tari et al. May 2011 A1
20110125060 Telfort et al. May 2011 A1
20110137297 Kiani et al. Jun 2011 A1
20110172498 Olsen et al. Jul 2011 A1
20110172967 Al-Ali et al. Jul 2011 A1
20110208015 Welch et al. Aug 2011 A1
20110209915 Telfort et al. Sep 2011 A1
20110213212 Al-Ali Sep 2011 A1
20110230733 Al-Ali Sep 2011 A1
20110237911 Lamego et al. Sep 2011 A1
20110237914 Lamego et al. Sep 2011 A1
20110237969 Eckerbom et al. Sep 2011 A1
20110288383 Diab Nov 2011 A1
20120041316 Al Ali et al. Feb 2012 A1
20120046530 Al-Ali et al. Feb 2012 A1
20120046557 Kiani Feb 2012 A1
20120059267 Lamego et al. Mar 2012 A1
20120088984 Al-Ali et al. Apr 2012 A1
20120116175 Al-Ali et al. May 2012 A1
20120123231 O'Reilly May 2012 A1
20120161970 Al-Ali et al. Jun 2012 A1
20120165629 Merritt et al. Jun 2012 A1
20120006076 Jansen et al. Jul 2012 A1
20120179006 Jansen et al. Jul 2012 A1
20120209082 Al-Ali Aug 2012 A1
20120209084 Olsen et al. Aug 2012 A1
20120226117 Lamego et al. Sep 2012 A1
20120227739 Kiani Sep 2012 A1
20120232359 Al-Ali et al. Sep 2012 A1
20120232363 Al-Ali et al. Sep 2012 A1
20120265039 Kiani Oct 2012 A1
20120283524 Kiani et al. Nov 2012 A1
20120286955 Welch et al. Nov 2012 A1
20120296178 Lamego et al. Nov 2012 A1
20120319816 Al-Ali Dec 2012 A1
20120330112 Lamego et al. Dec 2012 A1
20130023775 Lamego et al. Jan 2013 A1
20130041591 Lamego Feb 2013 A1
20130045685 Kiani Feb 2013 A1
20130046204 Lamego et al. Feb 2013 A1
20130060108 Schurman et al. Mar 2013 A1
20130060147 Welch et al. Mar 2013 A1
20130079610 Al-Ali Mar 2013 A1
20130096405 Garfio Apr 2013 A1
20130096936 Sampath et al. Apr 2013 A1
20130109935 Al-Ali et al. May 2013 A1
20130162433 Muhsin et al. Jun 2013 A1
20130178749 Lamego Jul 2013 A1
20130190581 Al-Ali et al. Jul 2013 A1
20130197328 Diab et al. Aug 2013 A1
20130211214 Olsen Aug 2013 A1
20130243021 Siskavich Sep 2013 A1
20130253334 Al-Ali et al. Sep 2013 A1
20130267804 Al-Ali Oct 2013 A1
20130274571 Diab et al. Oct 2013 A1
20130274572 Al-Ali et al. Oct 2013 A1
20130296672 O'Neil et al. Nov 2013 A1
20130296713 Al-Ali et al. Nov 2013 A1
20130317327 Al-Ali et al. Nov 2013 A1
20130317370 Dalvi et al. Nov 2013 A1
20130324808 Al-Ali et al. Dec 2013 A1
20130324817 Diab Dec 2013 A1
20130331660 Al-Ali et al. Dec 2013 A1
20130331670 Kiani Dec 2013 A1
20130338461 Lamego et al. Dec 2013 A1
20130345921 Al-Ali et al. Dec 2013 A1
20140012100 Al-Ali et al. Jan 2014 A1
20140025306 Weber et al. Jan 2014 A1
20140031650 Weber et al. Jan 2014 A1
20140034353 Al-Ali et al. Feb 2014 A1
20140051952 Reichgott et al. Feb 2014 A1
20140051953 Lamego et al. Feb 2014 A1
20140051954 Al-Ali et al. Feb 2014 A1
20140058230 Abdul-Hafiz et al. Feb 2014 A1
20140066783 Kiani et al. Mar 2014 A1
20140077956 Sampath et al. Mar 2014 A1
20140081097 Al-Ali et al. Mar 2014 A1
20140081100 Muhsin et al. Mar 2014 A1
20140081175 Telfort Mar 2014 A1
20140094667 Schurman et al. Apr 2014 A1
20140100434 Diab et al. Apr 2014 A1
20140114199 Lamego et al. Apr 2014 A1
20140120564 Workman et al. May 2014 A1
20140121482 Merritt et al. May 2014 A1
20140121483 Kiani May 2014 A1
20140125495 Al-Ali May 2014 A1
20140127137 Bellott et al. May 2014 A1
20140128696 Al-Ali May 2014 A1
20140128699 Al-Ali et al. May 2014 A1
20140129702 Lamego et al. May 2014 A1
20140135588 Al-Ali et al. May 2014 A1
20140142399 Al-Ali et al. May 2014 A1
20140142401 Al-Ali et al. May 2014 A1
20140142402 Al-Ali et al. May 2014 A1
20140163344 Al-Ali Jun 2014 A1
20140163402 Lamego et al. Jun 2014 A1
20140166076 Kiani et al. Jun 2014 A1
20140171763 Diab Jun 2014 A1
20140180038 Kiani Jun 2014 A1
20140180154 Sierra et al. Jun 2014 A1
20140180160 Brown et al. Jun 2014 A1
20140187973 Brown et al. Jul 2014 A1
20140194709 Al-Ali et al. Jul 2014 A1
20140194711 Al-Ali Jul 2014 A1
20140194766 Al-Ali et al. Jul 2014 A1
20140200420 Ai-Ai Jul 2014 A1
20140200422 Weber et al. Jul 2014 A1
20140206963 Al-Ali Jul 2014 A1
20140213864 Abdul-Hafiz et al. Jul 2014 A1
20140243627 Diab et al. Aug 2014 A1
20140266790 Al-Ali et al. Sep 2014 A1
20140275808 Poeze et al. Sep 2014 A1
20140275835 Lamego et al. Sep 2014 A1
20140275871 Lamego et al. Sep 2014 A1
20140275872 Merritt et al. Sep 2014 A1
20140275881 Lamego et al. Sep 2014 A1
20140276115 Dalvi et al. Sep 2014 A1
20140288400 Diab et al. Sep 2014 A1
20140296664 Bruinsma et al. Oct 2014 A1
20140303520 Telfort et al. Oct 2014 A1
20140309506 Lamego et al. Oct 2014 A1
20140309559 Telfort et al. Oct 2014 A1
20140316217 Purdon et al. Oct 2014 A1
20140316218 Purdon et al. Oct 2014 A1
20140316228 Blank et al. Oct 2014 A1
20140323825 Al-Ali et al. Oct 2014 A1
20140323897 Brown et al. Oct 2014 A1
20140323898 Purdon et al. Oct 2014 A1
20140330092 Al-Ali et al. Nov 2014 A1
20140330098 Merritt et al. Nov 2014 A1
20140330099 Al-Ali et al. Nov 2014 A1
20140333440 Kiani Nov 2014 A1
20140336481 Shakespeare et al. Nov 2014 A1
20140343436 Kiani Nov 2014 A1
20140357966 Al-Ali et al. Dec 2014 A1
20150005600 Blank et al. Jan 2015 A1
20150011907 Purdon et al. Jan 2015 A1
20150012231 Poeze et al. Jan 2015 A1
20150018650 Al-Ali et al. Jan 2015 A1
20150025406 Al-Ali Jan 2015 A1
20150032029 Al-Ali et al. Jan 2015 A1
20150038859 Dalvi et al. Feb 2015 A1
20150045637 Dalvi Feb 2015 A1
20150051462 Olsen Feb 2015 A1
20150073241 Lamego Mar 2015 A1
20150080754 Purdon et al. Mar 2015 A1
20150087936 Al-Ali et al. Mar 2015 A1
20150087938 Al-Ali et al. Mar 2015 A1
20150094546 Al-Ali Apr 2015 A1
20150097701 Muhsin et al. Apr 2015 A1
20150099950 Al-Ali et al. Apr 2015 A1
20150099951 Al-Ali et al. Apr 2015 A1
20150099955 Al-Ali et al. Apr 2015 A1
20150101844 Al-Ali et al. Apr 2015 A1
20150106121 Muhsin et al. Apr 2015 A1
20150112151 Muhsin et al. Apr 2015 A1
20150116076 Al-Ali et al. Apr 2015 A1
20150126830 Schurman et al. May 2015 A1
20150133755 Smith et al. May 2015 A1
20150141781 Weber et al. May 2015 A1
20150165312 Kiani Jun 2015 A1
20150196237 Lamego Jul 2015 A1
20150196249 Brown et al. Jul 2015 A1
20150201874 Diab Jul 2015 A1
20150208966 Al-Ali Jul 2015 A1
20150216459 Al-Ali et al. Aug 2015 A1
20150230755 Al-Ali et al. Aug 2015 A1
20150238722 Al-Ali Aug 2015 A1
20150245773 Lamego et al. Sep 2015 A1
20150245794 Al-Ali Sep 2015 A1
20150257689 Al-Ali et al. Sep 2015 A1
20150272514 Kiani et al. Oct 2015 A1
20150351697 Weber et al. Dec 2015 A1
20150351704 Kiani et al. Dec 2015 A1
20150359429 Al-Ali et al. Dec 2015 A1
20150366472 Kiani Dec 2015 A1
20150366507 Blank et al. Dec 2015 A1
20150374298 Al-Ali et al. Dec 2015 A1
20150380875 Coverston et al. Dec 2015 A1
20160000362 Diab et al. Jan 2016 A1
20160007930 Weber et al. Jan 2016 A1
20160029932 Al-Ali Feb 2016 A1
20160029933 Al-Ali et al. Feb 2016 A1
20160045118 Kiani Feb 2016 A1
20160051205 Al-Ali et al. Feb 2016 A1
20160058338 Schurman et al. Mar 2016 A1
20160058347 Reichgott et al. Mar 2016 A1
20160066823 Al-Ali et al. Mar 2016 A1
20160066824 Al-Ali et al. Mar 2016 A1
20160066879 Telfort et al. Mar 2016 A1
20160072429 Kiani et al. Mar 2016 A1
20160081552 Wojtczuk et al. Mar 2016 A1
20160095543 Telfort et al. Apr 2016 A1
20160095548 Al-Ali et al. Apr 2016 A1
20160103598 Al-Ali et al. Apr 2016 A1
20160113527 Al-Ali Apr 2016 A1
20160143548 Al-Ali May 2016 A1
20160166182 Al-Ali et al. Jun 2016 A1
20160166183 Poeze et al. Jun 2016 A1
20160166188 Bruinsma et al. Jun 2016 A1
20160166210 Al-Ali Jun 2016 A1
20160192869 Kiani et al. Jul 2016 A1
20160196388 Lamego Jul 2016 A1
20160197436 Barker et al. Jul 2016 A1
20160213281 Eckerbom et al. Jul 2016 A1
20160228043 O'Neil et al. Aug 2016 A1
20160233632 Scruggs et al. Aug 2016 A1
20160234944 Schmidt et al. Aug 2016 A1
20160270735 Diab et al. Sep 2016 A1
20160283665 Sampath et al. Sep 2016 A1
20160287090 Al-Ali et al. Oct 2016 A1
20160287786 Kiani Oct 2016 A1
20160296169 McHale et al. Oct 2016 A1
20160310052 Al-Ali et al. Oct 2016 A1
20160314260 Kiani Oct 2016 A1
20160324486 Al-Ali et al. Nov 2016 A1
20160324488 Olsen Nov 2016 A1
20160327984 Al-Ali et al. Nov 2016 A1
20160328528 Al-Ali et al. Nov 2016 A1
20160331332 Al-Ali Nov 2016 A1
20160367173 Dalvi et al. Dec 2016 A1
20170000394 Al-Ali et al. Jan 2017 A1
20170007134 Al-Ali et al. Jan 2017 A1
20170007190 Al-Ali et al. Jan 2017 A1
20170007198 Al-Ali et al. Jan 2017 A1
20170014083 Diab et al. Jan 2017 A1
20170014084 Al-Ali et al. Jan 2017 A1
20170021099 Al-Ali et al. Jan 2017 A1
20170024748 Haider Jan 2017 A1
20170027456 Kinast et al. Feb 2017 A1
20170042488 Muhsin Feb 2017 A1
20170055851 Ai-Ai Mar 2017 A1
20170055882 Al-Ali et al. Mar 2017 A1
20170055887 Ai-Ali Mar 2017 A1
20170055896 Al-Ali Mar 2017 A1
20170079594 Telfort et al. Mar 2017 A1
20170086723 Al-Ali et al. Mar 2017 A1
20170143281 Olsen May 2017 A1
20170147774 Kiani May 2017 A1
20170156620 Al-Ali et al. Jun 2017 A1
20170173632 Al-Ali Jun 2017 A1
20170187146 Kiani et al. Jun 2017 A1
20170188919 Al-Ali et al. Jul 2017 A1
20170196464 Jansen et al. Jul 2017 A1
20170196470 Lamego et al. Jul 2017 A1
20170224262 Al-Ali Aug 2017 A1
20170228516 Sampath et al. Aug 2017 A1
20170245790 Al-Ali et al. Aug 2017 A1
20170251974 Shreim et al. Sep 2017 A1
20170251975 Shreim et al. Sep 2017 A1
20170258403 Abdul-Hafiz et al. Sep 2017 A1
20170311851 Schurman et al. Nov 2017 A1
20170311891 Kiani et al. Nov 2017 A1
20170325728 Al-Ali et al. Nov 2017 A1
20170332976 Al-Ali Nov 2017 A1
20170340293 Al-Ali et al. Nov 2017 A1
20170360310 Kiani Dec 2017 A1
20170367632 Al-Ali et al. Dec 2017 A1
20180008146 Al-Ali et al. Jan 2018 A1
20180013562 Haider et al. Jan 2018 A1
20180014752 Al-Ali et al. Jan 2018 A1
20180028124 Al-Ali et al. Feb 2018 A1
20180055385 Al-Ali Mar 2018 A1
20180055390 Kiani et al. Mar 2018 A1
20180055430 Diab et al. Mar 2018 A1
20180064381 Shakespeare et al. Mar 2018 A1
20180069776 Lamego et al. Mar 2018 A1
20180070867 Smith et al. Mar 2018 A1
20180082767 Al-Ali et al. Mar 2018 A1
20180085068 Telfort Mar 2018 A1
20180087937 Al-Ali et al. Mar 2018 A1
20180103874 Lee et al. Apr 2018 A1
20180103905 Kiani Apr 2018 A1
20180110478 Al-Ali Apr 2018 A1
20180116575 Perea et al. May 2018 A1
20180125368 Lamego et al. May 2018 A1
20180125430 Al-Ali et al. May 2018 A1
20180125445 Telfort et al. May 2018 A1
20180130325 Kiani et al. May 2018 A1
20180132769 Weber et al. May 2018 A1
20180132770 Lamego May 2018 A1
20180146901 Al-Ali et al. May 2018 A1
20180146902 Kiani et al. May 2018 A1
20180153442 Eckerbom et al. Jun 2018 A1
20180153446 Kiani Jun 2018 A1
20180153447 Al-Ali et al. Jun 2018 A1
20180153448 Weber et al. Jun 2018 A1
20180161499 Al-Ali et al. Jun 2018 A1
20180168491 Al-Ali et al. Jun 2018 A1
20180174679 Sampath et al. Jun 2018 A1
20180174680 Sampath et al. Jun 2018 A1
20180182484 Sampath et al. Jun 2018 A1
20180184917 Kiani Jul 2018 A1
20180192924 Al-Ali Jul 2018 A1
20180192953 Shreim et al. Jul 2018 A1
20180192955 Al-Ali et al. Jul 2018 A1
20180199871 Pauley et al. Jul 2018 A1
20180206795 Al-Ali Jul 2018 A1
20180206815 Telfort Jul 2018 A1
20180213583 Al-Ali Jul 2018 A1
20180214031 Kiani et al. Aug 2018 A1
20180214090 Al-Ali et al. Aug 2018 A1
20180218792 Muhsin et al. Aug 2018 A1
20180225960 Al-Ali et al. Aug 2018 A1
20180238718 Dalvi Aug 2018 A1
20180242853 Al-Ali Aug 2018 A1
20180242921 Muhsin et al. Aug 2018 A1
20180242923 Al-Ali et al. Aug 2018 A1
20180242924 Barker et al. Aug 2018 A1
20180242926 Muhsin et al. Aug 2018 A1
20180247353 Al-Ali et al. Aug 2018 A1
20180247712 Muhsin et al. Aug 2018 A1
20180249933 Schurman et al. Sep 2018 A1
20180253947 Muhsin et al. Sep 2018 A1
20180256087 Al-Ali et al. Sep 2018 A1
20180256113 Weber et al. Sep 2018 A1
20180285094 Housel et al. Oct 2018 A1
20180289325 Poeze et al. Oct 2018 A1
20180289337 Al-Ali et al. Oct 2018 A1
20180296161 Shreim et al. Oct 2018 A1
20180300919 Muhsin et al. Oct 2018 A1
20180310822 Indorf et al. Nov 2018 A1
20180310823 Al-Ali et al. Nov 2018 A1
20180317826 Muhsin et al. Nov 2018 A1
20180317841 Novak, Jr. Nov 2018 A1
20180333055 Lamego et al. Nov 2018 A1
20180333087 Al-Ali Nov 2018 A1
20190000317 Muhsin et al. Jan 2019 A1
20190000362 Kiani et al. Jan 2019 A1
20190015023 Monfre Jan 2019 A1
20190021638 Al-Ali et al. Jan 2019 A1
20190029574 Schurman et al. Jan 2019 A1
20190029578 Al-Ali et al. Jan 2019 A1
20190038143 Al-Ali Feb 2019 A1
20190058280 Al-Ali et al. Feb 2019 A1
20190058281 Al-Ali et al. Feb 2019 A1
20190069813 Al-Ali Mar 2019 A1
20190069814 Al-Ali Mar 2019 A1
20190076028 Al-Ali et al. Mar 2019 A1
20190117070 Muhsin et al. Apr 2019 A1
20190200941 Chandran et al. Jul 2019 A1
20190239787 Pauley et al. Aug 2019 A1
20190320906 Olsen Oct 2019 A1
20190374139 Kiani et al. Dec 2019 A1
20190374173 Kiani et al. Dec 2019 A1
20190374713 Kiani et al. Dec 2019 A1
20200021930 Iswanto et al. Jan 2020 A1
20200060869 Telfort et al. Feb 2020 A1
20200111552 Ahmed Apr 2020 A1
20200113435 Muhsin Apr 2020 A1
20200113488 Al-Ali et al. Apr 2020 A1
20200113496 Scruggs et al. Apr 2020 A1
20200113497 Triman et al. Apr 2020 A1
20200113520 Abdul-Hafiz et al. Apr 2020 A1
20200138288 Al-Ali et al. May 2020 A1
20200138368 Kiani et al. May 2020 A1
20200163597 Dalvi et al. May 2020 A1
20200196877 Vo et al. Jun 2020 A1
20200253474 Muhsin et al. Aug 2020 A1
20200253544 Belur Nagaraj et al. Aug 2020 A1
20200275841 Telfort et al. Sep 2020 A1
20200288983 Telfort et al. Sep 2020 A1
20200321793 Al-Ali et al. Oct 2020 A1
20200329983 Al-Ali et al. Oct 2020 A1
20200329984 Al-Ali et al. Oct 2020 A1
20200329993 Al-Ali et al. Oct 2020 A1
20200330037 Al-Ali et al. Oct 2020 A1
20210022628 Telfort et al. Jan 2021 A1
20210104173 Pauley et al. Apr 2021 A1
20210113121 Diab et al. Apr 2021 A1
20210117525 Kiani et al. Apr 2021 A1
20210118581 Kiani et al. Apr 2021 A1
20210121582 Krishnamani et al. Apr 2021 A1
20210161465 Barker et al. Jun 2021 A1
20210236729 Kiani et al. Aug 2021 A1
20210256267 Ranasinghe et al. Aug 2021 A1
20210256835 Ranasinghe et al. Aug 2021 A1
20210275101 Vo et al. Sep 2021 A1
20210290060 Ahmed Sep 2021 A1
20210290072 Forrest Sep 2021 A1
20210290080 Ahmed Sep 2021 A1
20210290120 Al-Ali Sep 2021 A1
20210290177 Novak, Jr. Sep 2021 A1
20210290184 Ahmed Sep 2021 A1
20210296008 Novak, Jr. Sep 2021 A1
20210330228 Olsen et al. Oct 2021 A1
20210386382 Olsen et al. Dec 2021 A1
20210402110 Pauley et al. Dec 2021 A1
20220026355 Normand et al. Jan 2022 A1
20220039707 Sharma et al. Feb 2022 A1
20220053892 Al-Ali et al. Feb 2022 A1
20220071562 Kiani Mar 2022 A1
20220096603 Kiani et al. Mar 2022 A1
20220151521 Krishnamani et al. May 2022 A1
20220218244 Kiani et al. Jul 2022 A1
20220287574 Telfort et al. Sep 2022 A1
20220296161 Al-Ali et al. Sep 2022 A1
20220361819 Al-Ali et al. Nov 2022 A1
20220379059 Yu et al. Dec 2022 A1
20220392610 Kiani et al. Dec 2022 A1
20230028745 Al-Ali Jan 2023 A1
20230038389 Vo Feb 2023 A1
20230045647 Vo Feb 2023 A1
20230058052 Al-Ali Feb 2023 A1
20230058342 Kiani Feb 2023 A1
20230069789 Koo et al. Mar 2023 A1
20230087671 Telfort et al. Mar 2023 A1
20230110152 Forrest et al. Apr 2023 A1
20230111198 Yu et al. Apr 2023 A1
20230115397 Vo et al. Apr 2023 A1
20230116371 Mills et al. Apr 2023 A1
20230135297 Kiani et al. May 2023 A1
20230138098 Telfort et al. May 2023 A1
20230145155 Krishnamani et al. May 2023 A1
20230147750 Barker et al. May 2023 A1
20230210417 Al-Ali et al. Jul 2023 A1
20230222805 Muhsin et al. Jul 2023 A1
20230222887 Muhsin et al. Jul 2023 A1
20230226331 Kiani et al. Jul 2023 A1
20230284916 Telfort Sep 2023 A1
20230284943 Scruggs et al. Sep 2023 A1
20230301562 Scruggs et al. Sep 2023 A1
20230346993 Kiani et al. Nov 2023 A1
20230368221 Haider Nov 2023 A1
20230371893 Al-Ali et al. Nov 2023 A1
20230389837 Krishnamani et al. Dec 2023 A1
20240016418 Devadoss et al. Jan 2024 A1
20240016419 Devadoss et al. Jan 2024 A1
20240047061 Al-Ali et al. Feb 2024 A1
20240049310 Al-Ali et al. Feb 2024 A1
20240049986 Al-Ali et al. Feb 2024 A1
20240081656 DeJong et al. Mar 2024 A1
20240122486 Kiani Apr 2024 A1
20240180456 Ai-Ali Jun 2024 A1
20240188872 Al-Ali et al. Jun 2024 A1
20240245855 Vo et al. Jul 2024 A1
20240260894 Olsen Aug 2024 A1
20240267698 Telfort et al. Aug 2024 A1
20240277233 Al-Ali Aug 2024 A1
20240277280 Al-Ali Aug 2024 A1
20240298920 Fernkbist et al. Sep 2024 A1
Foreign Referenced Citations (163)
Number Date Country
2262236 Apr 2008 CA
3244695 Oct 1985 DE
112010004682.4 Dec 2010 DE
0 231 379 Aug 1987 EP
0 419 223 Mar 1991 EP
0 569 670 Feb 1993 EP
0 529 412 Mar 1993 EP
0 675 540 Oct 1995 EP
0 675 541 Oct 1995 EP
0 469 395 Feb 1996 EP
0 417 447 Oct 1997 EP
0 606 356 Jun 1998 EP
0 734 221 Jul 1998 EP
0 716 628 Dec 1998 EP
0 659 058 Jan 1999 EP
0 956 820 Nov 1999 EP
1 080 683 Mar 2001 EP
1 207 536 May 2002 EP
1 860 990 Dec 2007 EP
1 860 992 Dec 2007 EP
2 014 234 Jan 2009 EP
1 895 892 May 2010 EP
2 286 721 Feb 2011 EP
2 305 104 Apr 2011 EP
2 476 369 Jul 2012 EP
2 139 383 Feb 2013 EP
2 847 796 Jun 2004 FR
2 358 546 Jul 2001 GB
2 487 882 Aug 2012 GB
60059900 Apr 1985 JP
61-028172 Feb 1986 JP
62-000324 Jan 1987 JP
62-014898 Jan 1987 JP
63-275327 Nov 1988 JP
64-500495 Feb 1989 JP
02-126829 May 1990 JP
02-145457 Dec 1990 JP
03-252604 Nov 1991 JP
05-200017 Aug 1993 JP
05-207993 Aug 1993 JP
H06-178776 Jun 1994 JP
06-505903 Jul 1994 JP
06-237013 Aug 1994 JP
H07-391 Jan 1995 JP
H07-171089 Jul 1995 JP
H07-171090 Jul 1995 JP
07-281618 Oct 1995 JP
07-325546 Dec 1995 JP
09-108203 Apr 1997 JP
0 9-192120 Jul 1997 JP
09-308623 Dec 1997 JP
01-309872 Jun 1998 JP
10-155755 Jun 1998 JP
10-216112 Aug 1998 JP
10-509352 Sep 1998 JP
10-269344 Oct 1998 JP
10-295676 Nov 1998 JP
10-305026 Nov 1998 JP
11-037932 Feb 1999 JP
2001-050713 May 1999 JP
11-163412 Jun 1999 JP
11-164826 Jun 1999 JP
11-506834 Jun 1999 JP
11-183377 Jul 1999 JP
11-508691 Jul 1999 JP
2000-116625 Apr 2000 JP
2000-199880 Jul 2000 JP
2001-504256 Mar 2001 JP
2002-150821 May 2002 JP
2002-516689 Jun 2002 JP
2002-228579 Aug 2002 JP
2002-525151 Aug 2002 JP
2002-315739 Oct 2002 JP
2002-352609 Dec 2002 JP
2003-507718 Feb 2003 JP
2003-084108 Mar 2003 JP
2003-521985 Jul 2003 JP
2003-329719 Nov 2003 JP
2004-070179 Mar 2004 JP
2004-510467 Apr 2004 JP
2004-173866 Jun 2004 JP
2004-226277 Aug 2004 JP
2004-296736 Oct 2004 JP
2004-532526 Oct 2004 JP
2004-327760 Nov 2004 JP
2005-501589 Jan 2005 JP
2005-253478 Sep 2005 JP
2007-558237 Mar 2006 JP
2008-505706 Feb 2008 JP
4879913 Dec 2011 JP
2012-110746 Jun 2012 JP
2012-130756 Jul 2012 JP
5096174 Sep 2012 JP
5166619 Mar 2013 JP
5456976 Jan 2014 JP
WO 88001150 Feb 1988 WO
WO 88002020 Feb 1988 WO
WO 92016142 Oct 1992 WO
WO 93006776 Apr 1993 WO
WO 94005207 Mar 1994 WO
WO 94013207 Jun 1994 WO
WO 95005621 Feb 1995 WO
WO 95016387 Jun 1995 WO
WO 95029632 Nov 1995 WO
WO 96013208 May 1996 WO
WO 96041138 Dec 1996 WO
WO 97001985 Jan 1997 WO
WO 97029678 Aug 1997 WO
WO 97029710 Aug 1997 WO
WO 98043071 Oct 1998 WO
WO 99053277 Oct 1999 WO
WO 00010462 Mar 2000 WO
WO 00018290 Apr 2000 WO
WO 00042911 Jul 2000 WO
WO 00059374 Oct 2000 WO
WO 01013790 Mar 2001 WO
WO 01030414 May 2001 WO
WO 01034033 May 2001 WO
WO 01058347 Aug 2001 WO
WO 01078059 Oct 2001 WO
WO 01087005 Nov 2001 WO
WO 01097691 Dec 2001 WO
WO 02003042 Jan 2002 WO
WO 02017780 Mar 2002 WO
WO 02024067 Mar 2002 WO
WO 02026123 Apr 2002 WO
WO 02089664 Nov 2002 WO
WO 03020129 Mar 2003 WO
WO 03058646 Jul 2003 WO
WO 03068060 Aug 2003 WO
WO 03077761 Sep 2003 WO
WO 03087737 Oct 2003 WO
WO 04000111 Dec 2003 WO
WO 04004411 Jan 2004 WO
WO 04034898 Apr 2004 WO
WO 04038801 May 2004 WO
WO 05004712 Jan 2005 WO
WO 05011488 Feb 2005 WO
WO 05096931 Oct 2005 WO
WO 05099562 Oct 2005 WO
WO 06017117 Feb 2006 WO
WO 06094107 Sep 2006 WO
WO 06094155 Sep 2006 WO
WO 06094168 Sep 2006 WO
WO 06094169 Sep 2006 WO
WO 06094170 Sep 2006 WO
WO 06094171 Sep 2006 WO
WO 06094279 Sep 2006 WO
WO 2009094108 Sep 2006 WO
WO 06115580 Nov 2006 WO
WO 2006118654 Nov 2006 WO
WO 2008017246 Feb 2008 WO
WO 2008148172 Dec 2008 WO
WO 2009013835 Jan 2009 WO
WO 2009093159 Jul 2009 WO
WO 2009137524 Nov 2009 WO
WO 2009155593 Dec 2009 WO
WO 2011047207 Apr 2011 WO
WO 2011047209 Apr 2011 WO
WO 2011047213 Apr 2011 WO
WO 2011047216 Apr 2011 WO
WO 2011147211 Apr 2011 WO
WO 2011069122 Jun 2011 WO
Non-Patent Literature Citations (102)
Entry
US 8,845,543 B2, 09/2014, Diab et al. (withdrawn)
US 2022/0192529 A1, 06/2022, Al-Ali et al. (withdrawn)
US 2024/0016391 A1, 01/2024, Lapotko et al. (withdrawn)
Analog Devices, “12-Bit Serial Input Multiplying D/A Converter, DAC8043A, Analog Devices, Inc.,” 2000.
“Application Note 84 Use of Add-Only Memory for Secure Storage of Monetary Equivalent Data,” Dallas Semiconductor, Jun. 22, 1999, in 5 pages.
Avago Technologies, “HCNR200 and HCNR201, High-Linearity Analog Optocouplers,” Data Sheet, Avago Technologies, Nov. 18, 2008.
Burritt, Mary F.; Current Analytical Approaches to Measuring Blood Analytes; vol. 36; No. 8(B); 1990.
Canadian Office Action in Application No. 2562258 mailed Jun. 22, 2012.
Chambrin, M-C., “Alarms in the intensive care unit: how can the number of false alarms be reduced?”; Critical Care Aug. 2001, vol. 5 No. 4; p. 1-5.
Dallas Semiconductor Corp: DS2430A Announcement, retrieved Jun. 10, 1998, in 2 pages. https://web.archive.org/web/19980610045525/http://dalsemi.com/News_Center/New_Products/1996/2430a.html.
Eldor et al., “A device for monitoring respiration during anesthesia; the para-tracheal monitor”, Canadian Journal of Anesthesia, 1990, vol. 9, No. 1, p. 95-98.
European Exam Report re EPO App. No. 10162402.1, dated Mar. 4, 2013.
European Exam Report, re EP Application No. 06 736 771.4, dated Dec. 14, 2015.
European Examination Report dated Apr. 1, 2010, re EP App. No. 08 744 412.1-2319.
European Examination Report dated Mar. 18, 2011, re EP App. No. 08 744 412.1-2319.
European Examination Report dated Sep. 2, 2010, re EP App. No. 08 744 412.1-2319.
European Examination Report, re EP Application No. 06736799.5, dated Nov. 30, 2012.
European Examination Report, re EP Application No. 06736799.5, dated Oct. 28, 2014.
European Examination Report, re EP Application No. 12163719.3, dated Feb. 6, 2013.
European Extended Search Report of European Application No. 12163719.3, dated of Jun. 18, 2012, in 6 pages.
European Extended Search Report re EPO App. No. 10162402.1, SR dated Aug. 9, 2010.
European Extended Search Report, re EP Application No. 10 18 1436, completion date Nov. 26, 2010.
European Office Action in Application No. 03711767.8, dated May 18, 2011.
European Office Action in Application No. 057320954, dated Mar. 30, 2012.
European Office Action in Application No. 057320954, dated Oct. 25, 2011.
European Office Action in Application No. 09743510.1, dated Oct. 10, 2011.
European Office Action re EP Application No. 06 736 799.5, dated Nov. 30, 2012.
European Search Report, re EP Application No. 10 19 1029, dated Jun. 5, 2012.
European Supplemental Partial European Search Report for EP Application No. 05732095.4, dated Jun. 26, 2009 in 4 pages.
Favennec, J.M. “Smart sensors in industry.” J. Phys. E: Sci. Instrum. 20(9): Sep. 1987, pp. 1087-1090.
Gorges, M. et al., “Improving Alarm Performance in the Medical Intensive Care Unit Using Delays and Clinical Context”; Technology, Computing, and Simulation; vol. 108, No. 5, May 2009; p. 1546-1552.
Hall, et al., Jeffrey W.; Near-Infrared Spectrophotometry: A New Dimension in Clinical Chemistry; vol. 38; No. 9; 1992.
Images showing tear down of a Measurement Specialties' stethoscope, Images taken on Sep. 7, 2007, in 38 pages.
Imhoff, M. et al., “Alarm Algorithms in Critical Care Monitoring”; Anesth Analg 2006;102:1525-37.
International Preliminary Report on Patentability in US/2010/052758 mailed Apr. 17, 2012.
International Preliminary Report on Patentability in US/2010/052760 mailed Apr. 17, 2012.
International Preliminary Report on Patentability in US/2010/052763 mailed Apr. 17, 2012.
International Preliminary Report on Patentability in US/2010/058981 dated Jun. 14, 2012.
International Search Report and Written Opinion in PCT/CA2003/000536 dated Dec. 11, 2003.
International Search Report and Written Opinion in PCT/US2009/042902, mailed Dec. 8, 2009.
International Search Report and Written Opinion in PCT/US2009/069287, mailed Jun. 30, 2010, in 22 pages.
International Search Report and Written Opinion in PCT/US2010/052754, mailed Jul. 27, 2011.
International Search Report and Written Opinion in PCT/US2010/052756, mailed Feb. 6, 2012.
International Search Report and Written Opinion in PCT/US2010/052760, mailed Mar. 8, 2011 in 11 pages.
International Search Report and Written Opinion in PCT/US2010/052763, mailed May 13, 2011.
International Search Report and Written Opinion, re PCT App. No. PCT/US2006/007506, dated Jul. 17, 2006.
International Search Report for PCT/US2006/007516, mailed on Jan. 11, 2007, in 4 pages.
International Search Report of International Application No. PCT/US2008/058327, Mailing Date of Jun. 30, 2009, in 12 pages.
International Search Report; PCT/US2006/007387; Date of Mailing Jul. 17, 2006; pp. 1-9.
International Search Report; PCT/US2006/007388; Date of Mailing Jul. 17, 2006; pp. 1-9.
International Search Report; PCT/US2006/007389; Date of Mailing Jul. 17, 2006; pp. 1-9.
International Search Report; PCT/US2006/007506; Date of Mailing Jul. 17, 2006; pp. 1-10.
International Search Report; PCT/US2006/007536; Date of Mailing Jul. 17, 2006; pp. 1-9.
International Search Report; PCT/US2006/007537; Date of Mailing Jul. 17, 2006; pp. 1-10.
International Search Report; PCT/US2006/007538; Date of Mailing Jul. 17, 2006; pp. 1-9.
International Search Report; PCT/US2006/007539; Date of Mailing Jul. 17, 2006; pp. 1-9.
International Search Report; PCT/US2006/007540; Date of Mailing Jul. 17, 2006; pp. 1-9.
International Search Report; PCT/US2006/007958; Date of Mailing Jul. 17, 2006; pp. 1-8.
Japanese Final Office Action in Application No. 2007-506626, dated Aug. 26, 2011.
Japanese Final Office Action re Amendments re JP Application No. 2007-558249, dated Apr. 17, 2012.
Japanese First Office Action (Notice of Reasons for Rejection), re JP App. No. 2007-558207, dated Jun. 28, 2011.
Japanese First Office Action (Notice of Reasons for Rejection), re JP App. No. 2007-558247, dated Jun. 28, 2011.
Japanese Office Action (Decision of Rejection), re JP Application No. JP 2007-558328, dated Jun. 25, 2013.
Japanese Office Action (Notice of Allowance), re JP App. No. 2007-558247, dated Oct. 24, 2011.
Japanese Office Action (Notice of Reasons for Rejection) re JP App. No. 2007-558246, dated Jun. 28, 2011.
Japanese Office Action (Notice of Reasons for Rejection), re JP App. No. 2007-558238, dated Jun. 28, 2011.
Japanese Office Action (Official Inquiry) re JP App. No. 2007-558246, dated Dec. 11, 2012.
Japanese Office Action (Official Inquiry), re JP App. No. 2007-558238/Appeal No. 2012-004053, dated Dec. 11, 2012.
Japanese Office Action (Reasons for Rejection) re JP App. No. 2007-558246, dated Nov. 1, 2011.
Japanese Office Action in Application No. 2007-506626, dated Mar. 1, 2011.
Japanese Office Action in Application No. 2007-506626, dated May 10, 2012.
Japanese Office Action re JP Application No. 2007-558245, mailed Oct. 29, 2013.
Japanese Office Action re JP Application No. 2007-558249, dated Aug. 28, 2012.
Japanese Office Action re JP Application No. 2007-558249, dated Jul. 13, 2011.
Japanese Office Action re JP Application No. 2007-558249, dated Nov. 8, 2011.
Japanese Office Action re JP Application No. JP 2007-558208, dated Aug. 23, 2011.
Japanese Office Action re JP Application No. JP 2007-558248, dated Nov. 27, 2012.
Japanese Office Action re JP Application No. JP 2007-558248, dated Nov. 8, 2011.
Japanese Office Action re JP Application No. 2007-558209, dated Oct. 25, 2011.
Japanese Office Action re JP Application No. 2007-558209, dated Oct. 30, 2012.
Japanese Office Action re JP Application No. 2007-558245, dated Jan. 15, 2013.
Japanese Office Action re JP Application No. 2007-558245, dated Oct. 25, 2011.
Japanese Office Action, re JP Application No. 2007-558237, dated Aug. 1, 2011.
Japanese Office Action, re JP Application No. 2012-045419, dated Jun. 26, 2012.
Japanese Office Action, re JP Application No. JP 2007-558237, dated Oct. 16, 2012.
Japanese Office Action/Notice of Reasons for Rejection, re Application No. 2000-606119, mailed Nov. 4, 2009.
Jones, K.L., et al. “A Protocol for Automatic Sensor Detection and Identification in a Wireless Biodevice Network,” IEEE, Jun. 1998, 6 pages.
Kuenstner, et al., J. Todd; Measurement of Hemoglobin in Unlysed Blood by Near-Infrared Spectroscopy; vol. 48; No. 4, 1994.
Manzke, et al., B., Multi Wavelength Pulse Oximetry in the Measurement of Hemoglobin Fractions; vol. 2676, date unknown.
“Medical.” 50 Ways to Touch Memory. 3rd ed. Dallas: Dallas Semiconductor Corporation, Aug. 1994: pp. 24-25. Print.
Naumenko, E. K.; Choice of Wavelengths for Stable Determination of Concentrations of Hemoglobin Derivatives from Absorption Spectra of Erythrocytes; vol. 63; No. 1; pp. 60-66 Jan.-Feb. 1996; Original article submitted Nov. 3, 1994.
Office Action dated Jul. 12, 2017 in European Application No. 06736771.4.
Office Action dated Jun. 19, 2017 in German Application No. 11 2010 004 682.4.
Office Action in GB Application No. GB1209231.8, dated Nov. 24, 2016.
PCT Invitation to Pay Fees and Initial Search Report in PCT/US2010/052754, dated Mar. 15, 2011.
Schmitt, Joseph M.; Simple Photon Diffusion Anaylsis of the Effects of Multiple Scattering on Pulse Oximetry; Mar. 14, 1991; revised Aug. 30, 1991.
Schmitt, Joseph M.; Zhou, Guan-Xiong; Miller, Justin, Measurement of Blood Hematocrit by Dual-wavelength Near-IR Photoplethysmography, published May 1992, Proc. SPIE vol. 1641, p. 150-161, Physiological Monitoring and Early Detection Diagnostic Methods, Thomas S. Mang; Ed. (SPIE homepage), in 12 pages.
Schnapp, et al., L.M.; Pulse Oximetry. Uses and Abuses.; Chest 1990; 98; 1244-1250001 10.1378/Chest.98.5.1244.
Sierra, G., et al.: “Monitoring Respiratory Rate Based on Tracheal Sounds. First Experiences”, Proceedings of the 26th Annual International Conference of the IEEE EMBS, Sep. 2004, pp. 317-320.
Subramanian, S., et al. “Design for Constraint Violation Detection in Safety-Critical Systems,” IEEE, Nov. 1998: pp. 1-8.
Watt, R. C., “Alarms and Anesthesia. Challenges in the design of Intelligent systems for Patient Monitoring”; IEEE Engineering in Medicine and biology; Dec. 1993, p. 34-41.
WelchAllyn OEM Technologies, ECG ASIC, ECG 3-lead, 5-lead, 12-lead and RESP Signal Processing, ECG ASIC Part No. 000.91163 (2001).
Related Publications (1)
Number Date Country
20230117147 A1 Apr 2023 US
Provisional Applications (1)
Number Date Country
61266984 Dec 2009 US
Continuations (3)
Number Date Country
Parent 16911770 Jun 2020 US
Child 18068269 US
Parent 14321638 Jul 2014 US
Child 16911770 US
Parent 12960325 Dec 2010 US
Child 14321638 US